US8106171B2	NNP	O
-	:	O
Nel-related	JJ	O
type	NN	O
1	CD	O
polypeptide	NN	O
-	:	O
Google	NN	O
Patents	NNS	O
Info	NNP	O
Links	NNP	O
Images	NNP	O
Classifications	NNP	O
Abstract	NNP	O
Description	NNP	O
CROSS-REFERENCE	NNP	O
TO	NNP	O
RELATED	NNP	O
APPLICATIONS	NNP	O
This	DT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
12/510,074	CD	O
,	,	O
filed	VBN	O
Jul	NNP	O
.	.	O
27	CD	O
,	,	O
2009	CD	O
(	(	O
allowed	VBN	O
)	)	O
;	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
11/774,330	CD	O
,	,	O
filed	VBN	O
Jul	NNP	O
.	.	O
6	CD	O
,	,	O
2007	CD	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
7,592,438	CD	O
)	)	O
;	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Continuation	NN	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
10/781,841	CD	O
,	,	O
filed	VBD	O
Feb.	NNP	O
20	CD	O
,	,	O
2004	CD	O
(	(	O
abandoned	VBN	O
)	)	O
;	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
10/342,276	CD	O
,	,	O
filed	VBD	O
Jan.	NNP	O
15	CD	O
,	,	O
2003	CD	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
7,420,048	CD	O
)	)	O
;	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/976,165	CD	O
,	,	O
filed	VBN	O
Oct.	NNP	O
15	CD	O
,	,	O
2001	CD	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,562,947	CD	O
)	)	O
;	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/565,538	CD	O
,	,	O
filed	VBD	O
May	NNP	O
5	CD	O
,	,	O
2000	CD	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,333,404	CD	O
)	)	O
;	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/273,565	CD	O
,	,	O
filed	VBN	O
Mar	NNP	O
.	.	O
22	CD	O
,	,	O
1999	CD	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,166,190	CD	O
)	)	O
;	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/055,699	CD	O
,	,	O
filed	VBN	O
Apr	NNP	O
.	.	O
7	CD	O
,	,	O
1998	CD	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,005,088	CD	O
)	)	O
;	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
08/820,170	CD	O
,	,	O
filed	VBN	O
Mar	NNP	O
.	.	O
19	CD	O
,	,	O
1997	CD	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,831,058	CD	O
)	)	O
;	:	O
the	DT	O
disclosure	NN	O
of	IN	O
each	DT	O
of	IN	O
which	WDT	O
is	VBZ	O
incorporated	VBN	O
herein	NN	O
by	IN	O
reference	NN	O
.	.	O
TECHNICAL	NNP	O
FIELD	NNP	O
The	DT	O
present	JJ	O
invention	NN	O
relates	VBZ	O
to	TO	O
a	DT	O
gene	NN	O
useful	JJ	O
as	IN	O
an	DT	O
indicator	NN	O
in	IN	O
the	DT	O
prophylaxis	NN	O
,	,	O
diagnosis	NN	O
and	CC	O
treatment	NN	O
of	IN	O
diseases	NNS	O
in	IN	O
humans	NNS	O
.	.	O
More	RBR	O
particularly	RB	O
,	,	O
it	PRP	O
relates	VBZ	O
to	TO	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
analogous	JJ	O
to	TO	O
rat	VB	O
,	,	O
mouse	NN	O
,	,	O
yeast	NN	O
,	,	O
nematode	NN	O
and	CC	O
known	VBN	O
human	JJ	O
genes	NNS	O
,	,	O
among	IN	O
others	NNS	O
,	,	O
and	CC	O
utilizable	JJ	O
,	,	O
after	IN	O
cDNA	NN	O
analysis	NN	O
thereof	NN	O
,	,	O
chromosome	NN	O
mapping	NN	O
of	IN	O
cDNA	NN	O
and	CC	O
function	NN	O
analysis	NN	O
of	IN	O
cDNA	NN	O
,	,	O
in	IN	O
gene	NN	O
diagnosis	NN	O
using	VBG	O
said	VBD	O
gene	NN	O
and	CC	O
in	IN	O
developing	VBG	O
a	DT	O
novel	JJ	O
therapeutic	JJ	O
method	NN	O
.	.	O
BACKGROUND	NNP	O
ART	NNP	O
The	DT	O
genetic	JJ	O
information	NN	O
of	IN	O
a	DT	O
living	JJ	O
thing	NN	O
has	VBZ	O
been	VBN	O
accumulated	VBN	O
as	IN	O
sequences	NNS	O
(	(	O
DNA	NNP	O
)	)	O
of	IN	O
four	CD	O
bases	NNS	O
,	,	O
namely	RB	O
A	NNP	O
,	,	O
C	NNP	O
,	,	O
G	NNP	O
and	CC	O
T	NNP	O
,	,	O
which	WDT	O
exist	VBP	O
in	IN	O
cell	NN	O
nuclei	NN	O
.	.	O
Said	NNP	O
genetic	JJ	O
information	NN	O
has	VBZ	O
been	VBN	O
preserved	VBN	O
for	IN	O
line	NN	O
preservation	NN	O
and	CC	O
ontogeny	NN	O
of	IN	O
each	DT	O
individual	JJ	O
living	NN	O
thing	NN	O
.	.	O
In	IN	O
the	DT	O
case	NN	O
of	IN	O
human	JJ	O
being	VBG	O
,	,	O
the	DT	O
number	NN	O
of	IN	O
said	VBD	O
bases	NNS	O
is	VBZ	O
said	VBD	O
to	TO	O
be	VB	O
about	RB	O
3	CD	O
billion	CD	O
(	(	O
3×109	CD	O
)	)	O
and	CC	O
supposedly	RB	O
there	EX	O
are	VBP	O
50	CD	O
to	TO	O
100	CD	O
thousand	NN	O
genes	NNS	O
therein	RB	O
.	.	O
Such	JJ	O
genetic	JJ	O
information	NN	O
serves	NNS	O
to	TO	O
maintain	VB	O
biological	JJ	O
phenomena	NNS	O
in	IN	O
that	DT	O
regulatory	JJ	O
proteins	NNS	O
,	,	O
structural	JJ	O
proteins	NNS	O
and	CC	O
enzymes	NNS	O
are	VBP	O
produced	VBN	O
via	IN	O
such	JJ	O
route	NN	O
that	IN	O
mRNA	NN	O
is	VBZ	O
transcribed	VBN	O
from	IN	O
a	DT	O
gene	NN	O
(	(	O
DNA	NNP	O
)	)	O
and	CC	O
then	RB	O
translated	VBD	O
into	IN	O
a	DT	O
protein	NN	O
.	.	O
Abnormalities	NNS	O
in	IN	O
said	VBD	O
route	NN	O
from	IN	O
gene	NN	O
to	TO	O
protein	VB	O
translation	NN	O
are	VBP	O
considered	VBN	O
to	TO	O
be	VB	O
causative	JJ	O
of	IN	O
abnormalities	NNS	O
of	IN	O
life	NN	O
supporting	VBG	O
systems	NNS	O
,	,	O
for	IN	O
example	NN	O
in	IN	O
cell	NN	O
proliferation	NN	O
and	CC	O
differentiation	NN	O
,	,	O
hence	RB	O
causative	NN	O
of	IN	O
various	JJ	O
diseases	NNS	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
gene	NN	O
analyses	NNS	O
so	RB	O
far	RB	O
made	VBN	O
,	,	O
a	DT	O
number	NN	O
of	IN	O
genes	NNS	O
which	WDT	O
may	MD	O
be	VB	O
expected	VBN	O
to	TO	O
serve	VB	O
as	IN	O
useful	JJ	O
materials	NNS	O
in	IN	O
drug	NN	O
development	NN	O
,	,	O
have	VBP	O
been	VBN	O
found	VBN	O
,	,	O
for	IN	O
example	NN	O
genes	NNS	O
for	IN	O
various	JJ	O
receptors	NNS	O
such	JJ	O
as	IN	O
insulin	NN	O
receptor	NN	O
and	CC	O
LDL	NNP	O
receptor	NN	O
,	,	O
genes	NNS	O
involved	VBN	O
in	IN	O
cell	NN	O
proliferation	NN	O
and	CC	O
differentiation	NN	O
and	CC	O
genes	NNS	O
for	IN	O
metabolic	JJ	O
enzymes	NNS	O
such	JJ	O
as	IN	O
proteases	NNS	O
,	,	O
ATPase	NNP	O
and	CC	O
superoxide	JJ	O
dismutases	NNS	O
.	.	O
However	RB	O
,	,	O
analysis	NN	O
of	IN	O
human	JJ	O
genes	NNS	O
and	CC	O
studies	NNS	O
of	IN	O
the	DT	O
functions	NNS	O
of	IN	O
the	DT	O
genes	NNS	O
analyzed	VBD	O
and	CC	O
of	IN	O
the	DT	O
relations	NNS	O
between	IN	O
the	DT	O
genes	NNS	O
analyzed	VBN	O
and	CC	O
various	JJ	O
diseases	NNS	O
have	VBP	O
been	VBN	O
just	RB	O
begun	VBN	O
and	CC	O
many	JJ	O
points	NNS	O
remain	VBP	O
unknown	JJ	O
.	.	O
Further	JJ	O
analysis	NN	O
of	IN	O
novel	JJ	O
genes	NNS	O
,	,	O
analysis	NN	O
of	IN	O
the	DT	O
functions	NNS	O
thereof	VBP	O
,	,	O
studies	NNS	O
of	IN	O
the	DT	O
relations	NNS	O
between	IN	O
the	DT	O
genes	NNS	O
analyzed	VBN	O
and	CC	O
diseases	NNS	O
,	,	O
and	CC	O
studies	NNS	O
for	IN	O
applying	VBG	O
the	DT	O
genes	NNS	O
analyzed	VBN	O
to	TO	O
gene	NN	O
diagnosis	NN	O
or	CC	O
for	IN	O
medicinal	JJ	O
purposes	NNS	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
are	VBP	O
therefore	RB	O
desired	VBN	O
in	IN	O
the	DT	O
relevant	JJ	O
art	NN	O
.	.	O
If	IN	O
such	PDT	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
as	IN	O
mentioned	VBN	O
above	IN	O
can	MD	O
be	VB	O
provided	VBN	O
,	,	O
it	PRP	O
will	MD	O
be	VB	O
possible	JJ	O
to	TO	O
analyze	VB	O
the	DT	O
level	NN	O
of	IN	O
expression	NN	O
thereof	NN	O
in	IN	O
each	DT	O
cell	NN	O
and	CC	O
the	DT	O
structure	NN	O
and	CC	O
function	NN	O
thereof	NN	O
and	CC	O
,	,	O
through	IN	O
expression	NN	O
product	NN	O
analysis	NN	O
and	CC	O
other	JJ	O
studies	NNS	O
,	,	O
it	PRP	O
may	MD	O
become	VB	O
possible	JJ	O
to	TO	O
reveal	VB	O
the	DT	O
pathogenesis	NN	O
of	IN	O
a	DT	O
disease	NN	O
associated	VBN	O
therewith	NN	O
,	,	O
for	IN	O
example	NN	O
a	DT	O
genopathy	NN	O
or	CC	O
cancer	NN	O
,	,	O
or	CC	O
diagnose	VB	O
and	CC	O
treat	VB	O
said	VBD	O
disease	NN	O
,	,	O
for	IN	O
instance	NN	O
.	.	O
It	PRP	O
is	VBZ	O
an	DT	O
object	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
such	PDT	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
.	.	O
For	IN	O
attaining	VBG	O
the	DT	O
above	NN	O
object	NN	O
,	,	O
the	DT	O
present	JJ	O
inventors	NNS	O
made	VBD	O
intensive	JJ	O
investigations	NNS	O
and	CC	O
obtained	VBD	O
the	DT	O
findings	NNS	O
mentioned	VBN	O
below	IN	O
.	.	O
Based	VBN	O
thereon	NN	O
,	,	O
the	DT	O
present	JJ	O
invention	NN	O
has	VBZ	O
now	RB	O
been	VBN	O
completed	VBN	O
.	.	O
DISCLOSURE	NNP	O
OF	NNP	O
INVENTION	NNP	O
Thus	NNP	O
,	,	O
the	DT	O
present	JJ	O
inventors	NNS	O
synthesized	VBD	O
cDNAs	NNS	O
based	VBN	O
on	IN	O
mRNAs	NN	O
extracted	VBN	O
from	IN	O
various	JJ	O
tissues	NNS	O
,	,	O
inclusive	NN	O
of	IN	O
human	JJ	O
fetal	JJ	O
brain	NN	O
,	,	O
adult	NN	O
blood	NN	O
vessels	NNS	O
and	CC	O
placenta	NN	O
,	,	O
constructed	VBN	O
libraries	NNS	O
by	IN	O
inserting	VBG	O
them	PRP	O
into	IN	O
vectors	NNS	O
,	,	O
allowing	VBG	O
colonies	NNS	O
of	IN	O
Escherichia	NNP	O
coli	NNS	O
transformed	VBD	O
with	IN	O
said	VBD	O
libraries	NNS	O
to	TO	O
form	VB	O
on	IN	O
agar	NN	O
medium	NN	O
,	,	O
picked	VBD	O
up	RP	O
colonies	NNS	O
at	IN	O
random	NN	O
and	CC	O
transferred	VBD	O
to	TO	O
96-well	CD	O
micro	NN	O
plates	NNS	O
and	CC	O
registered	VBD	O
a	DT	O
large	JJ	O
number	NN	O
of	IN	O
human	JJ	O
gene-containing	NN	O
E.	NNP	O
coli	NNS	O
clones	NNS	O
.	.	O
Each	DT	O
clone	NN	O
thus	RB	O
registered	VBD	O
was	VBD	O
cultivated	VBN	O
on	IN	O
a	DT	O
small	JJ	O
size	NN	O
,	,	O
DNA	NNP	O
was	VBD	O
extracted	VBN	O
and	CC	O
purified	VBN	O
,	,	O
the	DT	O
four	CD	O
base-specifically	RB	O
terminating	VBG	O
extension	NN	O
reactions	NNS	O
were	VBD	O
carried	VBN	O
out	RP	O
by	IN	O
the	DT	O
dideoxy	NN	O
chain	NN	O
terminator	NN	O
method	NN	O
using	VBG	O
the	DT	O
cDNA	NN	O
extracted	VBD	O
as	IN	O
a	DT	O
template	NN	O
,	,	O
and	CC	O
the	DT	O
base	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
gene	NN	O
was	VBD	O
determined	VBN	O
over	IN	O
about	RB	O
400	CD	O
bases	NNS	O
from	IN	O
the	DT	O
5′	CD	O
terminus	NN	O
thereof	NN	O
using	VBG	O
an	DT	O
automatic	JJ	O
DNA	NN	O
sequencer	NN	O
.	.	O
Based	VBN	O
on	IN	O
the	DT	O
thus-obtained	JJ	O
base	NN	O
sequence	NN	O
information	NN	O
,	,	O
a	DT	O
novel	JJ	O
family	NN	O
gene	NN	O
analogous	JJ	O
to	TO	O
known	VB	O
genes	NNS	O
of	IN	O
animal	NN	O
and	CC	O
plant	NN	O
species	NNS	O
such	JJ	O
as	IN	O
bacteria	NNS	O
,	,	O
yeasts	NNS	O
,	,	O
nematodes	NNS	O
,	,	O
mice	NN	O
and	CC	O
humans	NNS	O
was	VBD	O
searched	VBN	O
for	IN	O
.	.	O
The	DT	O
method	NN	O
of	IN	O
the	DT	O
above-mentioned	JJ	O
cDNA	NN	O
analysis	NN	O
is	VBZ	O
detailedly	RB	O
described	VBN	O
in	IN	O
the	DT	O
literature	NN	O
by	IN	O
Fujiwara	NNP	O
,	,	O
one	CD	O
of	IN	O
the	DT	O
present	JJ	O
inventors	NNS	O
[	VBP	O
Fujiwara	NNP	B
,	,	I
Tsutomu	NNP	I
,	,	I
Saibo	NNP	I
Kogaku	NNP	I
(	(	I
Cell	NNP	I
Engineering	NNP	I
)	)	I
,	,	I
14	CD	I
,	,	I
645-654	CD	I
(	(	I
1995	CD	I
)	)	I
]	NN	O
.	.	O
Among	IN	O
this	DT	O
group	NN	O
,	,	O
there	EX	O
are	VBP	O
novel	JJ	O
receptors	NNS	O
,	,	O
DNA	NNP	O
binding	VBG	O
domain-containing	JJ	O
transcription	NN	O
regulating	VBG	O
factors	NNS	O
,	,	O
signal	JJ	O
transmission	NN	O
system	NN	O
factors	NNS	O
,	,	O
metabolic	JJ	O
enzymes	NNS	O
and	CC	O
so	RB	O
forth	JJ	O
.	.	O
Based	VBN	O
on	IN	O
the	DT	O
homology	NN	O
of	IN	O
the	DT	O
novel	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
as	IN	O
obtained	VBN	O
by	IN	O
gene	NN	O
analysis	NN	O
to	TO	O
the	DT	O
genes	NNS	O
analogous	JJ	O
thereto	NN	O
,	,	O
the	DT	O
product	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
hence	RB	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
protein	NN	O
,	,	O
can	MD	O
approximately	RB	O
be	VB	O
estimated	VBN	O
by	IN	O
analogy	NN	O
.	.	O
Furthermore	RB	O
,	,	O
such	JJ	O
functions	NNS	O
as	IN	O
enzyme	JJ	O
activity	NN	O
and	CC	O
binding	VBG	O
ability	NN	O
can	MD	O
be	VB	O
investigated	VBN	O
by	IN	O
inserting	VBG	O
the	DT	O
candidate	NN	O
gene	NN	O
into	IN	O
an	DT	O
expression	NN	O
vector	NN	O
to	TO	O
give	VB	O
a	DT	O
recombinant	NN	O
.	.	O
According	VBG	O
to	TO	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
there	EX	O
are	VBP	O
provided	VBN	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
characterized	VBN	O
by	IN	O
containing	VBG	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
coding	VBG	O
for	IN	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
defined	VBN	O
by	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
,	,	O
:4	NNP	O
,	,	O
:7	NNP	O
,	,	O
:10	NNP	O
,	,	O
:13	NNP	O
,	,	O
:16	NNP	O
,	,	O
:19	NNP	O
,	,	O
:22	NNP	O
,	,	O
:25	NNP	O
,	,	O
:28	NNP	O
,	,	O
:31	NNP	O
,	,	O
:34	NNP	O
,	,	O
:37	NNP	O
or	CC	O
40	CD	O
,	,	O
a	DT	O
human	JJ	O
gene	NN	O
characterized	VBN	O
by	IN	O
containing	VBG	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
defined	VBN	O
by	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
:5	NNP	O
,	,	O
:8	NNP	O
,	,	O
:11	NNP	O
,	,	O
:14	NNP	O
,	,	O
:17	NNP	O
,	,	O
:20	NNP	O
,	,	O
:23	NNP	O
,	,	O
:26	NNP	O
,	,	O
:29	NNP	O
,	,	O
:32	NNP	O
,	,	O
:35	NNP	O
,	,	O
:38	NNP	O
or	CC	O
:41	NNP	O
,	,	O
respectively	RB	O
coding	VBG	O
for	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
mentioned	VBN	O
above	IN	O
,	,	O
and	CC	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
characterized	VBN	O
by	IN	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
defined	VBN	O
by	IN	O
SEQ	NNP	O
ID	NNP	O
NO:3	NNP	O
,	,	O
:6	NNP	O
,	,	O
:9	NNP	O
,	,	O
:12	NNP	O
,	,	O
:15	NNP	O
,	,	O
:18	NNP	O
,	,	O
:21	NNP	O
,	,	O
:24	NNP	O
,	,	O
:27	NNP	O
,	,	O
:30	NNP	O
,	,	O
:33	NNP	O
,	,	O
:36	NNP	O
,	,	O
:39	NNP	O
or	CC	O
:42	NNP	O
.	.	O
The	DT	O
symbols	NNS	O
used	VBD	O
herein	NN	O
for	IN	O
indicating	VBG	O
amino	JJ	O
acids	NNS	O
,	,	O
peptides	NNS	O
,	,	O
nucleotides	NNS	O
,	,	O
nucleotide	JJ	O
sequences	NNS	O
and	CC	O
so	RB	O
on	IN	O
are	VBP	O
those	DT	O
recommended	VBN	O
by	IN	O
IUPAC	NNP	O
and	CC	O
IUB	NNP	O
or	CC	O
in	IN	O
“	JJ	O
Guideline	NNP	O
for	IN	O
drafting	VBG	O
specifications	NNS	O
etc	FW	O
.	.	O
including	VBG	O
nucleotide	JJ	O
sequences	NNS	O
or	CC	O
amino	NN	O
acid	JJ	O
sequences	NNS	O
”	VBP	O
(	(	O
edited	VBN	O
by	IN	O
the	DT	O
Japanese	JJ	O
Patent	NNP	O
Office	NNP	O
)	)	O
,	,	O
or	CC	O
those	DT	O
in	IN	O
conventional	JJ	O
use	NN	O
in	IN	O
the	DT	O
relevant	JJ	O
field	NN	O
of	IN	O
art	NN	O
.	.	O
As	IN	O
specific	JJ	O
examples	NNS	O
of	IN	O
such	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
there	EX	O
may	MD	O
be	VB	O
mentioned	VBN	O
genes	NNS	O
deducible	JJ	O
from	IN	O
the	DT	O
DNA	NNP	O
sequences	NNS	O
of	IN	O
the	DT	O
clones	NNS	O
designated	VBN	O
as	IN	O
“	JJ	O
GEN-501D08	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-080G01	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-025F07	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-076C09	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-331G07	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-163D09	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-078D05TA13	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-423A12	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-092E10	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-428B12	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-073E07	NNP	O
”	NNP	O
,	,	O
“	NNP	O
GEN-093E05	NNP	O
”	NNP	O
and	CC	O
“	NNP	O
GEN-077A09	NNP	O
”	NNP	O
shown	VBN	O
later	RB	O
herein	NN	O
in	IN	O
Examples	NNP	O
1	CD	O
to	TO	O
11	CD	O
.	.	O
The	DT	O
respective	JJ	O
nucleotide	JJ	O
sequences	NNS	O
are	VBP	O
as	IN	O
shown	VBN	O
in	IN	O
the	DT	O
sequence	NN	O
listing	NN	O
.	.	O
These	DT	O
clones	NNS	O
have	VBP	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
comprising	VBG	O
nucleotides	NNS	O
(	(	O
nucleic	JJ	O
acid	NN	O
)	)	O
respectively	RB	O
coding	VBG	O
for	IN	O
the	DT	O
amino	NN	O
acids	NNS	O
shown	VBN	O
in	IN	O
the	DT	O
sequence	NN	O
listing	NN	O
.	.	O
Their	PRP$	O
molecular	JJ	O
weights	NNS	O
were	VBD	O
calculated	VBN	O
at	IN	O
the	DT	O
values	NNS	O
shown	VBN	O
later	RB	O
herein	NN	O
in	IN	O
the	DT	O
respective	JJ	O
examples	NNS	O
.	.	O
Hereinafter	NNP	O
,	,	O
these	DT	O
human	JJ	O
genes	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
are	VBP	O
sometimes	RB	O
referred	VBN	O
to	TO	O
as	IN	O
the	DT	O
designation	NN	O
used	VBN	O
in	IN	O
Examples	NNP	O
1	CD	O
to	TO	O
11	CD	O
.	.	O
In	IN	O
the	DT	O
following	NN	O
,	,	O
the	DT	O
human	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
described	VBN	O
in	IN	O
further	JJ	O
detail	NN	O
.	.	O
As	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
each	DT	O
human	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
analogous	JJ	O
to	TO	O
rat	VB	O
,	,	O
mouse	NN	O
,	,	O
yeast	NN	O
,	,	O
nematode	NN	O
and	CC	O
known	VBN	O
human	JJ	O
genes	NNS	O
,	,	O
among	IN	O
others	NNS	O
,	,	O
and	CC	O
can	MD	O
be	VB	O
utilized	VBN	O
in	IN	O
human	JJ	O
gene	NN	O
analysis	NN	O
based	VBN	O
on	IN	O
the	DT	O
information	NN	O
about	IN	O
the	DT	O
genes	NNS	O
analogous	JJ	O
thereto	NN	O
and	CC	O
in	IN	O
studying	VBG	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
gene	NN	O
analyzed	VBD	O
and	CC	O
the	DT	O
relation	NN	O
between	IN	O
the	DT	O
gene	NN	O
analyzed	VBD	O
and	CC	O
a	DT	O
disease	NN	O
.	.	O
It	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
use	VB	O
said	VBD	O
gene	NN	O
in	IN	O
gene	NN	O
diagnosis	NN	O
of	IN	O
the	DT	O
disease	NN	O
associated	VBN	O
therewith	NN	O
and	CC	O
in	IN	O
exploitation	NN	O
studies	NNS	O
of	IN	O
said	VBD	O
gene	NN	O
for	IN	O
medicinal	JJ	O
purposes	NNS	O
.	.	O
The	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
represented	VBN	O
in	IN	O
terms	NNS	O
of	IN	O
a	DT	O
single-stranded	JJ	O
DNA	NNP	O
sequence	NN	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
.	.	O
It	PRP	O
is	VBZ	O
to	TO	O
be	VB	O
noted	VBN	O
,	,	O
however	RB	O
,	,	O
that	IN	O
the	DT	O
present	JJ	O
invention	NN	O
also	RB	O
includes	VBZ	O
a	DT	O
DNA	NN	O
sequence	NN	O
complementary	JJ	O
to	TO	O
such	VB	O
a	DT	O
single-stranded	JJ	O
DNA	NNP	O
sequence	NN	O
and	CC	O
a	DT	O
component	NN	O
comprising	VBG	O
both	DT	O
.	.	O
The	DT	O
sequence	NN	O
of	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:3n−1	NNP	O
(	(	O
where	WRB	O
n	NN	O
is	VBZ	O
an	DT	O
integer	NN	O
of	IN	O
1	CD	O
to	TO	O
14	CD	O
)	)	O
is	VBZ	O
merely	RB	O
an	DT	O
example	NN	O
of	IN	O
the	DT	O
codon	NN	O
combination	NN	O
encoding	VBG	O
the	DT	O
respective	JJ	O
amino	NN	O
acid	NN	O
residues	NNS	O
.	.	O
The	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
not	RB	O
limited	JJ	O
thereto	NN	O
but	CC	O
can	MD	O
of	IN	O
course	NN	O
have	VBP	O
a	DT	O
DNA	NN	O
sequence	NN	O
in	IN	O
which	WDT	O
the	DT	O
codons	NNS	O
are	VBP	O
arbitrarily	RB	O
selected	VBN	O
and	CC	O
combined	VBN	O
for	IN	O
the	DT	O
respective	JJ	O
amino	NN	O
acid	NN	O
residues	NNS	O
.	.	O
The	DT	O
codon	NN	O
selection	NN	O
can	MD	O
be	VB	O
made	VBN	O
in	IN	O
the	DT	O
conventional	JJ	O
manner	NN	O
,	,	O
for	IN	O
example	NN	O
taking	VBG	O
into	IN	O
consideration	NN	O
the	DT	O
codon	NN	O
utilization	NN	O
frequencies	NNS	O
in	IN	O
the	DT	O
host	NN	O
to	TO	O
be	VB	O
used	VBN	O
[	JJ	O
Nucl	NNP	B
.	.	I
Acids	NNP	I
Res.	NNP	I
,	,	I
9	CD	I
,	,	I
43-74	CD	I
(	(	I
1981	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
further	RBR	O
includes	VBZ	O
DNA	NNP	O
sequences	NNS	O
coding	VBG	O
for	IN	O
functional	JJ	O
equivalents	NNS	O
derived	VBN	O
from	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
mentioned	VBN	O
above	IN	O
by	IN	O
partial	JJ	O
amino	NN	O
acid	NN	O
or	CC	O
amino	NN	O
acid	JJ	O
sequence	NN	O
substitution	NN	O
,	,	O
deletion	NN	O
or	CC	O
addition	NN	O
.	.	O
These	DT	O
polypeptides	NNS	O
may	MD	O
be	VB	O
produced	VBN	O
by	IN	O
spontaneous	JJ	O
modification	NN	O
(	(	O
mutation	NN	O
)	)	O
or	CC	O
may	MD	O
be	VB	O
obtained	VBN	O
by	IN	O
posttranslational	JJ	O
modification	NN	O
or	CC	O
by	IN	O
modifying	VBG	O
the	DT	O
natural	JJ	O
gene	NN	O
(	(	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
)	)	O
by	IN	O
a	DT	O
technique	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
,	,	O
for	IN	O
example	NN	O
by	IN	O
site-specific	JJ	O
mutagenesis	NN	O
[	NNP	O
Methods	NNP	B
in	IN	I
Enzymology	NNP	I
,	,	I
154	CD	I
,	,	I
p.	NN	I
350	CD	I
,	,	I
367-382	CD	I
(	(	I
1987	CD	I
)	)	I
;	:	O
ibid.	NN	B
,	,	I
100	CD	I
,	,	I
p.	NN	I
468	CD	I
(	(	I
1983	CD	I
)	)	I
;	:	O
Nucleic	NNP	B
Acids	NNP	I
Research	NNP	I
,	,	I
12	CD	I
,	,	I
p.	NN	I
9441	CD	I
(	(	I
1984	CD	I
)	)	I
;	:	O
Zoku	NNP	B
Seikagaku	NNP	I
Jikken	NNP	I
Koza	NNP	I
(	(	I
Sequel	NNP	I
to	TO	I
Experiments	NNS	I
in	IN	I
Biochemistry	NNP	I
)	)	I
1	CD	I
,	,	I
“	JJ	I
Idensi	NNP	I
Kenkyu-ho	NNP	I
(	(	I
Methods	NNP	I
in	IN	I
Gene	NNP	I
Research	NNP	I
)	)	I
II	NNP	I
”	NNP	I
,	,	I
edited	VBN	I
by	IN	I
the	DT	I
Japan	NNP	I
Biochemical	NNP	I
Society	NNP	I
,	,	I
p.	VBZ	I
105	CD	I
(	(	I
1986	CD	I
)	)	I
]	NN	O
or	CC	O
synthesizing	VBG	O
mutant	JJ	O
DNAs	NNP	O
by	IN	O
a	DT	O
chemical	JJ	O
synthetic	JJ	O
technique	NN	O
such	JJ	O
as	IN	O
the	DT	O
phosphotriester	NN	O
method	NN	O
or	CC	O
phosphoamidite	VB	O
method	JJ	O
[	NNP	O
J	NNP	B
.	.	I
Am	NNP	I
.	.	I
Chem	NNP	I
.	.	I
Soc.	NNP	I
,	,	I
89	CD	I
,	,	I
p.	NN	I
4801	CD	I
(	(	I
1967	CD	I
)	)	I
;	:	O
ibid.	NN	B
,	,	I
91	CD	I
,	,	I
p.	NN	I
3350	CD	I
(	(	I
1969	CD	I
)	)	I
;	:	O
Science	NNP	B
,	,	I
150	CD	I
,	,	I
p.	NN	I
178	CD	I
(	(	I
1968	CD	I
)	)	I
;	:	O
Tetrahedron	NNP	B
Lett.	NNP	I
,	,	I
22	CD	I
,	,	I
p.	NN	I
1859	CD	I
(	(	I
1981	CD	I
)	)	I
;	:	O
ibid.	NN	B
,	,	I
24	CD	I
,	,	I
p.	NN	I
245	CD	I
(	(	I
1983	CD	I
)	)	I
]	NN	O
,	,	O
or	CC	O
by	IN	O
utilizing	VBG	O
the	DT	O
techniques	NNS	O
mentioned	VBN	O
above	IN	O
in	IN	O
combination	NN	O
.	.	O
The	DT	O
protein	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
expressed	VBN	O
readily	RB	O
and	CC	O
stably	RB	O
by	IN	O
utilizing	VBG	O
said	VBD	O
gene	NN	O
,	,	O
for	IN	O
example	NN	O
inserting	VBG	O
it	PRP	O
into	IN	O
a	DT	O
vector	NN	O
for	IN	O
use	NN	O
with	IN	O
a	DT	O
microorganism	NN	O
and	CC	O
cultivating	VBG	O
the	DT	O
microorganism	NN	O
thus	RB	O
transformed	VBN	O
.	.	O
The	DT	O
protein	NN	O
obtained	VBN	O
by	IN	O
utilizing	VBG	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
specific	JJ	O
antibody	NN	O
production	NN	O
.	.	O
In	IN	O
this	DT	O
case	NN	O
,	,	O
the	DT	O
protein	NN	O
producible	NN	O
in	IN	O
large	JJ	O
quantities	NNS	O
by	IN	O
the	DT	O
genetic	JJ	O
engineering	NN	O
technique	NN	O
mentioned	VBN	O
above	IN	O
can	MD	O
be	VB	O
used	VBN	O
as	IN	O
the	DT	O
component	NN	O
to	TO	O
serve	VB	O
as	IN	O
an	DT	O
antigen	NN	O
.	.	O
The	DT	O
antibody	NN	O
obtained	VBD	O
may	MD	O
be	VB	O
polyclonal	JJ	O
or	CC	O
monoclonal	JJ	O
and	CC	O
can	MD	O
be	VB	O
advantageously	RB	O
used	VBN	O
in	IN	O
the	DT	O
purification	NN	O
,	,	O
assay	RB	O
,	,	O
discrimination	NN	O
or	CC	O
identification	NN	O
of	IN	O
the	DT	O
corresponding	JJ	O
protein	NN	O
.	.	O
The	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
readily	RB	O
produced	VBN	O
based	VBN	O
on	IN	O
the	DT	O
sequence	NN	O
information	NN	O
thereof	NN	O
disclosed	VBD	O
herein	NN	O
by	IN	O
using	VBG	O
general	JJ	O
genetic	JJ	O
engineering	NN	O
techniques	NNS	O
[	VBP	O
cf	NN	O
.	.	O
e.g	NN	O
.	.	O
Molecular	JJ	B
Cloning	NNP	I
,	,	I
2nd	CD	I
Ed.	NNP	I
,	,	I
Cold	NNP	I
Spring	NNP	I
Harbor	NNP	I
Laboratory	NNP	I
Press	NNP	I
(	(	I
1989	CD	I
)	)	I
;	:	O
Zoku	NNP	B
Seikagaku	NNP	I
Jikken	NNP	I
Koza	NNP	I
,	,	I
“	NNP	I
Idenshi	NNP	I
Kenkyu-ho	NNP	I
I	PRP	I
,	,	I
II	NNP	I
and	CC	I
III	NNP	I
”	NNP	I
,	,	I
edited	VBN	I
by	IN	I
the	DT	I
Japan	NNP	I
Biochemical	NNP	I
Society	NNP	I
(	(	I
1986	CD	I
)	)	I
]	NN	O
.	.	O
This	DT	O
can	MD	O
be	VB	O
achieved	VBN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
by	IN	O
selecting	VBG	O
a	DT	O
desired	VBN	O
clone	NN	O
from	IN	O
a	DT	O
human	JJ	O
cDNA	NN	O
library	NN	O
(	(	O
prepared	VBN	O
in	IN	O
the	DT	O
conventional	JJ	O
manner	NN	O
from	IN	O
appropriate	JJ	O
cells	NNS	O
of	IN	O
origin	NN	O
in	IN	O
which	WDT	O
the	DT	O
gene	NN	O
is	VBZ	O
expressed	VBN	O
)	)	O
using	VBG	O
a	DT	O
probe	NN	O
or	CC	O
antibody	NN	O
specific	JJ	O
to	TO	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
[	NNP	O
e.g	NN	O
.	.	O
Proc	NNP	B
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
78	CD	I
,	,	I
6613	CD	I
(	(	I
1981	CD	I
)	)	I
;	:	O
Science	NNP	B
,	,	I
222	CD	I
,	,	I
778	CD	I
(	(	I
1983	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
cells	NNS	O
of	IN	O
origin	NN	O
to	TO	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
above	JJ	O
method	NN	O
are	VBP	O
,	,	O
for	IN	O
example	NN	O
,	,	O
cells	NNS	O
or	CC	O
tissues	NNS	O
in	IN	O
which	WDT	O
the	DT	O
gene	NN	O
in	IN	O
question	NN	O
is	VBZ	O
expressed	VBN	O
,	,	O
or	CC	O
cultured	VBD	O
cells	NNS	O
derived	VBN	O
therefrom	NN	O
.	.	O
Separation	NN	O
of	IN	O
total	JJ	O
RNA	NNP	O
,	,	O
separation	NN	O
and	CC	O
purification	NN	O
of	IN	O
mRNA	NN	O
,	,	O
conversion	NN	O
to	TO	O
(	(	O
synthesis	NN	O
of	IN	O
)	)	O
cDNA	NN	O
,	,	O
cloning	VBG	O
thereof	NN	O
and	CC	O
so	RB	O
on	IN	O
can	MD	O
be	VB	O
carried	VBN	O
out	RP	O
by	IN	O
conventional	JJ	O
methods	NNS	O
.	.	O
cDNA	NN	O
libraries	NNS	O
are	VBP	O
also	RB	O
commercially	RB	O
available	JJ	O
and	CC	O
such	JJ	O
cDNA	NN	O
libraries	NNS	O
,	,	O
for	IN	O
example	NN	O
various	JJ	O
cDNA	NN	O
libraries	NNS	O
available	JJ	O
from	IN	O
Clontech	NNP	O
Lab	NNP	O
.	.	O
Inc.	NNP	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
above	JJ	O
method	NN	O
.	.	O
Screening	NN	O
of	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
from	IN	O
these	DT	O
cDNA	NN	O
libraries	NNS	O
can	MD	O
be	VB	O
carried	VBN	O
out	RP	O
by	IN	O
the	DT	O
conventional	JJ	O
method	NN	O
mentioned	VBN	O
above	IN	O
.	.	O
These	DT	O
screening	VBG	O
methods	NNS	O
include	VBP	O
,	,	O
for	IN	O
example	NN	O
,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
selecting	VBG	O
a	DT	O
cDNA	NN	O
clone	NN	O
by	IN	O
immunological	JJ	O
screening	VBG	O
using	VBG	O
an	DT	O
antibody	NN	O
specific	JJ	O
to	TO	O
the	DT	O
protein	NN	O
produced	VBN	O
by	IN	O
the	DT	O
corresponding	JJ	O
cDNA	NN	O
,	,	O
the	DT	O
technique	NN	O
of	IN	O
plaque	NN	O
or	CC	O
colony	NN	O
hybridization	NN	O
using	VBG	O
probes	NNS	O
selectively	RB	O
binding	VBG	O
to	TO	O
the	DT	O
desired	VBN	O
DNA	NNP	O
sequence	NN	O
,	,	O
or	CC	O
a	DT	O
combination	NN	O
of	IN	O
these	DT	O
.	.	O
As	IN	O
regards	NNS	O
the	DT	O
probe	NN	O
to	TO	O
be	VB	O
used	VBN	O
here	RB	O
,	,	O
a	DT	O
DNA	NN	O
sequence	NN	O
chemically	RB	O
synthesized	VBD	O
based	VBN	O
on	IN	O
the	DT	O
information	NN	O
about	IN	O
the	DT	O
DNA	NNP	O
sequence	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
generally	RB	O
used	VBN	O
.	.	O
It	PRP	O
is	VBZ	O
of	IN	O
course	NN	O
possible	JJ	O
to	TO	O
use	VB	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
or	CC	O
fragments	NNS	O
thereof	CC	O
as	IN	O
the	DT	O
proble	NN	O
.	.	O
Furthermore	RB	O
,	,	O
a	DT	O
sense	NN	O
primer	NN	O
and	CC	O
an	DT	O
antisense	JJ	O
primer	NN	O
designed	VBN	O
based	VBN	O
on	IN	O
the	DT	O
information	NN	O
about	IN	O
the	DT	O
partial	JJ	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
a	DT	O
natural	JJ	O
extract	NN	O
isolated	VBN	O
and	CC	O
purified	VBN	O
from	IN	O
cells	NNS	O
or	CC	O
a	DT	O
tissue	NN	O
can	MD	O
be	VB	O
used	VBN	O
as	IN	O
probes	NNS	O
for	IN	O
screening	NN	O
.	.	O
For	IN	O
obtaining	VBG	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
the	DT	O
technique	NN	O
of	IN	O
DNA/RNA	NNP	O
amplification	NN	O
by	IN	O
the	DT	O
PCR	NNP	O
method	NN	O
[	NNP	O
Science	NNP	B
,	,	I
230	CD	I
,	,	I
1350-1354	CD	I
(	(	I
1984	CD	I
)	)	I
]	NN	O
can	MD	O
suitably	RB	O
be	VB	O
employed	VBN	O
.	.	O
Particularly	RB	O
when	WRB	O
the	DT	O
full-length	JJ	O
cDNA	NN	O
can	MD	O
hardly	RB	O
be	VB	O
obtained	VBN	O
from	IN	O
the	DT	O
library	NN	O
,	,	O
the	DT	O
RACE	NNP	O
method	NN	O
(	(	O
rapid	JJ	O
amplification	NN	O
of	IN	O
cDNA	NN	O
ends	NNS	O
;	:	O
Jikken	NNP	B
Igaku	NNP	I
(	(	I
Experimental	NNP	I
Medicine	NNP	I
)	)	I
,	,	I
12	CD	I
(	(	I
6	CD	I
)	)	I
,	,	I
35-38	JJ	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
,	,	O
in	IN	O
particular	JJ	O
the	DT	O
5′RACE	CD	O
method	NN	O
[	NNP	O
Frohman	NNP	B
,	,	I
M.	NNP	I
A.	NN	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
85	CD	I
,	,	I
8998-9002	CD	I
(	(	I
1988	CD	I
)	)	I
]	NN	O
is	VBZ	O
preferably	RB	O
employed	VBN	O
.	.	O
The	DT	O
primers	NNS	O
to	TO	O
be	VB	O
used	VBN	O
in	IN	O
such	JJ	O
PCR	NNP	O
method	NN	O
can	MD	O
be	VB	O
appropriately	RB	O
designed	VBN	O
based	VBN	O
on	IN	O
the	DT	O
sequence	NN	O
information	NN	O
of	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
as	IN	O
disclosed	VBN	O
herein	NN	O
and	CC	O
can	MD	O
be	VB	O
synthesized	VBN	O
by	IN	O
a	DT	O
conventional	JJ	O
method	NN	O
.	.	O
The	DT	O
amplified	JJ	O
DNA/RNA	NNP	O
fragment	NN	O
can	MD	O
be	VB	O
isolated	VBN	O
and	CC	O
purified	VBN	O
by	IN	O
a	DT	O
conventional	JJ	O
method	NN	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
for	IN	O
example	NN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
thus-obtained	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
or	CC	O
any	DT	O
of	IN	O
various	JJ	O
DNA	NNP	O
fragments	NNS	O
can	MD	O
be	VB	O
determined	VBN	O
by	IN	O
a	DT	O
conventional	JJ	O
method	NN	O
,	,	O
for	IN	O
example	NN	O
the	DT	O
dideoxy	NN	O
method	NN	O
[	NNP	O
Proc	NNP	B
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
74	CD	I
,	,	I
5463-5467	CD	I
(	(	I
1977	CD	I
)	)	I
]	NN	O
or	CC	O
the	DT	O
Maxam-Gilbert	JJ	O
method	NN	O
[	NNP	O
Methods	NNP	B
in	IN	I
Enzymology	NNP	I
,	,	I
65	CD	I
,	,	I
499	CD	I
(	(	I
1980	CD	I
)	)	I
]	NN	O
.	.	O
Such	JJ	O
nucleotide	JJ	O
sequence	NN	O
determination	NN	O
can	MD	O
be	VB	O
readily	RB	O
performed	VBN	O
using	VBG	O
a	DT	O
commercially	RB	O
available	JJ	O
sequence	NN	O
kit	NN	O
as	RB	O
well	RB	O
.	.	O
When	WRB	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
used	VBN	O
and	CC	O
conventional	JJ	O
techniques	NNS	O
of	IN	O
recombinant	JJ	O
DNA	NNP	O
technology	NN	O
[	NNP	O
see	VBP	O
e.g	NN	O
.	.	O
Science	NN	B
,	,	I
224	CD	I
,	,	I
p.	NN	I
1431	CD	I
(	(	I
1984	CD	I
)	)	I
;	:	O
Biochem	NNP	B
.	.	I
Biophys	NNP	I
.	.	I
Res	NNP	I
.	.	I
Comm.	NNP	I
,	,	I
130	CD	I
,	,	I
p.	NN	I
692	CD	I
(	(	I
1985	CD	I
)	)	I
;	:	O
Proc	NNP	B
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
80	CD	I
,	,	I
p.	NN	I
5990	CD	I
(	(	I
1983	CD	I
)	)	I
and	CC	O
the	DT	O
references	NNS	O
cited	VBD	O
above	IN	O
]	NN	O
are	VBP	O
followed	VBN	O
,	,	O
a	DT	O
recombinant	JJ	O
protein	NN	O
can	MD	O
be	VB	O
obtained	VBN	O
.	.	O
More	RBR	O
detailedly	RB	O
,	,	O
said	VBD	O
protein	NN	O
can	MD	O
be	VB	O
produced	VBN	O
by	IN	O
constructing	VBG	O
a	DT	O
recombinant	JJ	O
DNA	NN	O
enabling	VBG	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
be	VB	O
expressed	VBN	O
in	IN	O
host	NN	O
cells	NNS	O
,	,	O
introducing	VBG	O
it	PRP	O
into	IN	O
host	NN	O
cells	NNS	O
for	IN	O
transformation	NN	O
thereof	NN	O
and	CC	O
cultivating	VBG	O
the	DT	O
resulting	VBG	O
transformant	NN	O
.	.	O
In	IN	O
that	DT	O
case	NN	O
,	,	O
the	DT	O
host	NN	O
cells	NNS	O
may	MD	O
be	VB	O
eukaryotic	JJ	O
or	CC	O
prokaryotic	JJ	O
.	.	O
The	DT	O
eukaryotic	JJ	O
cells	NNS	O
include	VBP	O
vertebrate	JJ	O
cells	NNS	O
,	,	O
yeast	NN	O
cells	NNS	O
and	CC	O
so	RB	O
on	IN	O
,	,	O
and	CC	O
the	DT	O
vertebrate	NN	O
cells	NNS	O
include	VBP	O
,	,	O
but	CC	O
are	VBP	O
not	RB	O
limited	VBN	O
to	TO	O
,	,	O
simian	JJ	O
cells	NNS	O
named	VBN	O
COS	NNP	O
cells	NNS	O
[	NNP	O
Cell	NNP	B
,	,	I
23	CD	I
,	,	I
175-182	CD	I
(	(	I
1981	CD	I
)	)	I
]	NN	O
,	,	O
Chinese	JJ	O
hamster	NN	O
ovary	JJ	O
cells	NNS	O
and	CC	O
a	DT	O
dihydrofolate	JJ	O
reductase-deficient	NN	O
cell	NN	O
line	NN	O
derived	VBN	O
therefrom	IN	O
[	NNP	O
Proc	NNP	B
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
77	CD	I
,	,	I
4216-4220	CD	I
(	(	I
1980	CD	I
)	)	I
]	NN	O
and	CC	O
the	DT	O
like	JJ	O
,	,	O
which	WDT	O
are	VBP	O
frequently	RB	O
used	VBN	O
.	.	O
As	IN	O
regards	NNS	O
the	DT	O
expression	NN	O
vector	NN	O
to	TO	O
be	VB	O
used	VBN	O
with	IN	O
vertebrate	JJ	O
cells	NNS	O
,	,	O
an	DT	O
expression	NN	O
vector	NN	O
having	VBG	O
a	DT	O
promoter	NN	O
located	VBN	O
upstream	NN	O
of	IN	O
the	DT	O
gene	NN	O
to	TO	O
be	VB	O
expressed	VBN	O
,	,	O
RNA	NNP	O
splicing	VBG	O
sites	NNS	O
,	,	O
a	DT	O
polyadenylation	NN	O
site	NN	O
and	CC	O
a	DT	O
transcription	NN	O
termination	NN	O
sequence	NN	O
can	MD	O
be	VB	O
generally	RB	O
used	VBN	O
.	.	O
This	DT	O
may	MD	O
further	RB	O
have	VB	O
an	DT	O
origin	NN	O
of	IN	O
replication	NN	O
as	IN	O
necessary	JJ	O
.	.	O
As	IN	O
an	DT	O
example	NN	O
of	IN	O
said	VBD	O
expression	NN	O
vector	NN	O
,	,	O
there	EX	O
may	MD	O
be	VB	O
mentioned	VBN	O
pSV2dhfr	JJ	O
[	NNP	O
Mol	NNP	B
.	.	I
Cell	NNP	I
.	.	I
Biol.	NNP	I
,	,	I
1	CD	I
,	,	I
854	CD	I
(	(	I
1981	CD	I
)	)	I
]	NN	O
,	,	O
which	WDT	O
has	VBZ	O
the	DT	O
SV40	NNP	O
early	JJ	O
promoter	NN	O
.	.	O
As	IN	O
for	IN	O
the	DT	O
eukaryotic	JJ	O
microorganisms	NNS	O
,	,	O
yeasts	NNS	O
are	VBP	O
generally	RB	O
and	CC	O
frequently	RB	O
used	VBN	O
and	CC	O
,	,	O
among	IN	O
them	PRP	O
,	,	O
yeasts	NNS	O
of	IN	O
the	DT	O
genus	NN	O
Saccharomyces	NNS	O
can	MD	O
be	VB	O
used	VBN	O
with	IN	O
advantage	NN	O
.	.	O
As	IN	O
regards	NNS	O
the	DT	O
expression	NN	O
vector	NN	O
for	IN	O
use	NN	O
with	IN	O
said	VBD	O
yeasts	NNS	O
and	CC	O
other	JJ	O
eukaryotic	JJ	O
microorganisms	NNS	O
,	,	O
pAM82	NN	O
[	NNP	O
Proc	NNP	B
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
80	CD	I
,	,	I
1-5	CD	I
(	(	I
1983	CD	I
)	)	I
]	NN	O
,	,	O
which	WDT	O
has	VBZ	O
the	DT	O
acid	JJ	O
phosphatase	NN	O
gene	NN	O
promoter	NN	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
can	MD	O
be	VB	O
used	VBN	O
.	.	O
Furthermore	RB	O
,	,	O
a	DT	O
prokaryotic	JJ	O
gene	NN	O
fused	VBD	O
vector	NN	O
can	MD	O
be	VB	O
preferably	RB	O
used	VBN	O
as	IN	O
the	DT	O
expression	NN	O
vector	NN	O
for	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
.	.	O
As	IN	O
specific	JJ	O
examples	NNS	O
of	IN	O
said	VBD	O
vector	NN	O
,	,	O
there	EX	O
may	MD	O
be	VB	O
mentioned	VBN	O
pGEX-2TK	JJ	O
and	CC	O
pGEX-4T-2	JJ	O
which	WDT	O
have	VBP	O
a	DT	O
GST	NNP	O
domain	NN	O
(	(	O
derived	VBN	O
from	IN	O
S.	NNP	O
japonicum	NN	O
)	)	O
with	IN	O
a	DT	O
molecular	JJ	O
weight	NN	O
of	IN	O
26,000	CD	O
.	.	O
Escherichia	NNP	O
coli	NNS	O
and	CC	O
Bacillus	NNP	O
subtilis	NNS	O
are	VBP	O
generally	RB	O
and	CC	O
preferably	RB	O
used	VBD	O
as	IN	O
prokaryotic	JJ	O
hosts	NNS	O
.	.	O
When	WRB	O
these	DT	O
are	VBP	O
used	VBN	O
as	IN	O
hosts	NNS	O
in	IN	O
the	DT	O
practice	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
an	DT	O
expression	NN	O
plasmid	NN	O
derived	VBN	O
from	IN	O
a	DT	O
plasmid	JJ	O
vector	NN	O
capable	JJ	O
of	IN	O
replicating	VBG	O
in	IN	O
said	VBD	O
host	NN	O
organisms	NNS	O
and	CC	O
provided	VBN	O
in	IN	O
this	DT	O
vector	NN	O
with	IN	O
a	DT	O
promoter	NN	O
and	CC	O
the	DT	O
SD	NNP	O
(	(	O
Shine	NNP	O
and	CC	O
Dalgarno	NNP	O
)	)	O
sequence	NN	O
upstream	NN	O
of	IN	O
said	VBD	O
gene	NN	O
for	IN	O
enabling	VBG	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
and	CC	O
further	RB	O
provided	VBN	O
with	IN	O
an	DT	O
initiation	NN	O
codon	NN	O
(	(	O
e.g	NN	O
.	.	O
ATG	NNP	O
)	)	O
necessary	JJ	O
for	IN	O
the	DT	O
initiation	NN	O
of	IN	O
protein	JJ	O
synthesis	NN	O
is	VBZ	O
preferably	RB	O
used	VBN	O
.	.	O
The	DT	O
Escherichia	NNP	O
coli	NN	O
strain	NN	O
K12	NNP	O
,	,	O
among	IN	O
others	NNS	O
,	,	O
is	VBZ	O
preferably	RB	O
used	VBN	O
as	IN	O
the	DT	O
host	NN	O
Escherichia	NNP	O
coli	NN	O
,	,	O
and	CC	O
pBR322	NN	O
and	CC	O
modified	VBD	O
vectors	NNS	O
derived	VBN	O
therefrom	NNS	O
are	VBP	O
generally	RB	O
and	CC	O
preferably	RB	O
used	VBD	O
as	IN	O
the	DT	O
vector	NN	O
,	,	O
while	IN	O
various	JJ	O
known	JJ	O
strains	NNS	O
and	CC	O
vectors	NNS	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
.	.	O
Examples	NNS	O
of	IN	O
the	DT	O
promoter	NN	O
which	WDT	O
can	MD	O
be	VB	O
used	VBN	O
are	VBP	O
the	DT	O
tryptophan	NN	O
(	(	O
trp	NN	O
)	)	O
promoter	NN	O
,	,	O
lpp	JJ	O
promoter	NN	O
,	,	O
lac	NN	O
promoter	NN	O
and	CC	O
PL/PR	NNP	O
promoter	NN	O
.	.	O
The	DT	O
thus-obtained	JJ	O
desired	JJ	O
recombinant	NN	O
DNA	NN	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
host	NN	O
cells	NNS	O
for	IN	O
transformation	NN	O
by	IN	O
using	VBG	O
various	JJ	O
general	JJ	O
methods	NNS	O
.	.	O
The	DT	O
transformant	NN	O
obtained	VBD	O
can	MD	O
be	VB	O
cultured	VBN	O
by	IN	O
a	DT	O
conventional	JJ	O
method	NN	O
and	CC	O
the	DT	O
culture	NN	O
leads	VBZ	O
to	TO	O
expression	NN	O
and	CC	O
production	NN	O
of	IN	O
the	DT	O
desired	JJ	O
protein	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
.	.	O
The	DT	O
medium	NN	O
to	TO	O
be	VB	O
used	VBN	O
in	IN	O
said	VBD	O
culture	NN	O
can	MD	O
suitably	RB	O
be	VB	O
selected	VBN	O
from	IN	O
among	IN	O
various	JJ	O
media	NNS	O
in	IN	O
conventional	JJ	O
use	NN	O
according	VBG	O
to	TO	O
the	DT	O
host	NN	O
cells	NNS	O
employed	VBN	O
.	.	O
The	DT	O
host	NN	O
cells	NNS	O
can	MD	O
be	VB	O
cultured	VBN	O
under	IN	O
conditions	NNS	O
suited	VBN	O
for	IN	O
the	DT	O
growth	NN	O
thereof	NN	O
.	.	O
In	IN	O
the	DT	O
above	JJ	O
manner	NN	O
,	,	O
the	DT	O
desired	VBN	O
recombinant	NN	O
protein	NN	O
is	VBZ	O
expressed	VBN	O
and	CC	O
produced	VBN	O
and	CC	O
accumulated	VBN	O
or	CC	O
secreted	VBN	O
within	IN	O
the	DT	O
transformant	JJ	O
cells	NNS	O
or	CC	O
extracellularly	RB	O
or	CC	O
on	IN	O
the	DT	O
cell	NN	O
membrane	NN	O
.	.	O
The	DT	O
recombinant	JJ	O
protein	NN	O
can	MD	O
be	VB	O
separated	VBN	O
and	CC	O
purified	VBN	O
as	IN	O
desired	VBN	O
by	IN	O
various	JJ	O
separation	NN	O
procedures	NNS	O
utilizing	VBG	O
the	DT	O
physical	JJ	O
,	,	O
chemical	NN	O
and	CC	O
other	JJ	O
properties	NNS	O
thereof	VBP	O
[	JJ	O
cf	NN	O
.	.	O
e.g	NN	O
.	.	O
“	NN	B
Seikagaku	NNP	I
(	(	I
Biochemistry	NNP	I
)	)	I
Data	NNP	I
Book	NNP	I
II	NNP	I
”	NNP	I
,	,	I
pages	VBZ	I
1175-1259	JJ	I
,	,	I
1st	CD	I
Edition	NNP	I
,	,	I
1st	CD	I
Printing	NN	I
,	,	I
published	VBN	I
Jun	NNP	I
.	.	I
23	CD	I
,	,	I
1980	CD	I
by	IN	I
Tokyo	NNP	I
Kagaku	NNP	I
Dojin	NNP	I
;	:	O
Biochemistry	NNP	B
,	,	I
25	CD	I
(	(	I
25	CD	I
)	)	I
,	,	I
8274-8277	JJ	I
(	(	I
1986	CD	I
)	)	I
;	:	O
Eur	NNP	B
.	.	I
J	NNP	I
.	.	I
Biochem.	NNP	I
,	,	I
163	CD	I
,	,	I
313-321	CD	I
(	(	I
1987	CD	I
)	)	I
]	NN	O
.	.	O
Specifically	RB	O
,	,	O
said	VBD	O
procedures	NNS	O
include	VBP	O
,	,	O
among	IN	O
others	NNS	O
,	,	O
ordinary	JJ	O
reconstitution	NN	O
treatment	NN	O
,	,	O
treatment	NN	O
with	IN	O
a	DT	O
protein	NN	O
precipitating	VBG	O
agent	NN	O
(	(	O
salting	VBG	O
out	RP	O
)	)	O
,	,	O
centrifugation	NN	O
,	,	O
osmotic	JJ	O
shock	NN	O
treatment	NN	O
,	,	O
sonication	NN	O
,	,	O
ultrafiltration	NN	O
,	,	O
various	JJ	O
liquid	JJ	O
chromatography	NN	O
techniques	NNS	O
such	JJ	O
as	IN	O
molecular	JJ	O
sieve	NN	O
chromatography	NN	O
(	(	O
gel	JJ	O
filtration	NN	O
)	)	O
,	,	O
adsorption	NN	O
chromatography	NN	O
,	,	O
ion	NN	O
exchange	NN	O
chromatography	NN	O
,	,	O
affinity	NN	O
chromatography	NN	O
and	CC	O
high-performance	NN	O
liquid	NN	O
chromatography	NN	O
(	(	O
HPLC	NNP	O
)	)	O
,	,	O
dialysis	NN	O
and	CC	O
combinations	NNS	O
thereof	VBP	O
.	.	O
Among	IN	O
them	PRP	O
,	,	O
affinity	NN	O
chromatography	NN	O
utilizing	VBG	O
a	DT	O
column	NN	O
with	IN	O
the	DT	O
desired	JJ	O
protein	NN	O
bound	NN	O
thereto	NN	O
is	VBZ	O
particularly	RB	O
preferred	VBN	O
.	.	O
Furthermore	RB	O
,	,	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
sequence	NN	O
information	NN	O
about	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
as	IN	O
revealed	VBN	O
by	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
for	IN	O
example	NN	O
by	IN	O
utilizing	VBG	O
part	NN	O
or	CC	O
the	DT	O
whole	NN	O
of	IN	O
said	VBD	O
gene	NN	O
,	,	O
it	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
detect	VB	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
in	IN	O
various	JJ	O
human	JJ	O
tissues	NNS	O
.	.	O
This	DT	O
can	MD	O
be	VB	O
performed	VBN	O
by	IN	O
a	DT	O
conventional	JJ	O
method	NN	O
,	,	O
for	IN	O
example	NN	O
by	IN	O
RNA	NNP	O
amplification	NN	O
by	IN	O
RT-PCR	NNP	O
(	(	O
reverse	JJ	O
transcribed-polymerase	NN	O
chain	NN	O
reaction	NN	O
)	)	O
[	NN	O
Kawasaki	NNP	B
,	,	I
E.	NNP	I
S.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Amplification	NNP	I
of	IN	I
RNA	NNP	I
,	,	I
in	IN	I
PCR	NNP	I
Protocol	NNP	I
,	,	I
A	NNP	I
guide	NN	I
to	TO	I
methods	NNS	I
and	CC	I
applications	NNS	I
,	,	I
Academic	NNP	I
Press	NNP	I
,	,	I
Inc.	NNP	I
,	,	I
San	NNP	I
Diego	NNP	I
,	,	I
21-27	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
,	,	O
or	CC	O
by	IN	O
northern	JJ	O
blotting	VBG	O
analysis	NN	O
[	NNP	O
Molecular	NNP	B
Cloning	NNP	I
,	,	I
Cold	NNP	I
Spring	NNP	I
Harbor	NNP	I
Laboratory	NNP	I
(	(	I
1989	CD	I
)	)	I
]	NN	O
,	,	O
with	IN	O
good	JJ	O
results	NNS	O
.	.	O
The	DT	O
primers	NNS	O
to	TO	O
be	VB	O
used	VBN	O
in	IN	O
employing	VBG	O
the	DT	O
above-mentioned	JJ	O
PCR	NNP	O
method	NN	O
are	VBP	O
not	RB	O
limited	VBN	O
to	TO	O
any	DT	O
particular	JJ	O
ones	NNS	O
provided	VBD	O
that	IN	O
they	PRP	O
are	VBP	O
specific	JJ	O
to	TO	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
and	CC	O
enable	VB	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
alone	RB	O
to	TO	O
be	VB	O
specifically	RB	O
amplified	VBN	O
.	.	O
They	PRP	O
can	MD	O
be	VB	O
designed	VBN	O
or	CC	O
selected	VBN	O
appropriately	RB	O
based	VBN	O
on	IN	O
the	DT	O
gene	NN	O
information	NN	O
provided	VBN	O
by	IN	O
the	DT	O
present	JJ	O
invention	NN	O
.	.	O
They	PRP	O
can	MD	O
have	VB	O
a	DT	O
partial	JJ	O
sequence	NN	O
comprising	VBG	O
about	RB	O
20	CD	O
to	TO	O
30	CD	O
nucleotides	NNS	O
according	VBG	O
to	TO	O
the	DT	O
established	VBN	O
practice	NN	O
.	.	O
Suitable	JJ	O
examples	NNS	O
are	VBP	O
as	IN	O
shown	VBN	O
in	IN	O
Examples	NNP	O
1	CD	O
to	TO	O
11	CD	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
present	JJ	O
invention	NN	O
also	RB	O
provides	VBZ	O
primers	NNS	O
and/or	VBP	O
probes	NNS	O
useful	JJ	O
in	IN	O
specifically	RB	O
detecting	VBG	O
such	JJ	O
novel	JJ	O
gene	NN	O
.	.	O
By	IN	O
using	VBG	O
the	DT	O
novel	JJ	O
gene	NN	O
provided	VBN	O
by	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
it	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
detect	VB	O
the	DT	O
expression	NN	O
of	IN	O
said	VBD	O
gene	NN	O
in	IN	O
various	JJ	O
tissues	NNS	O
,	,	O
analyze	VBP	O
the	DT	O
structure	NN	O
and	CC	O
function	NN	O
thereof	NN	O
and	CC	O
,	,	O
further	RB	O
,	,	O
produce	VBP	O
the	DT	O
human	JJ	O
protein	NN	O
encoded	VBN	O
by	IN	O
said	VBD	O
gene	NN	O
in	IN	O
the	DT	O
manner	NN	O
of	IN	O
genetic	JJ	O
enginnering	NN	O
.	.	O
These	DT	O
make	VBP	O
it	PRP	O
possible	JJ	O
to	TO	O
analyze	VB	O
the	DT	O
expression	NN	O
product	NN	O
,	,	O
reveal	VB	O
the	DT	O
pathology	NN	O
of	IN	O
a	DT	O
disease	NN	O
associated	VBN	O
therewith	NN	O
,	,	O
for	IN	O
example	NN	O
a	DT	O
genopathy	NN	O
or	CC	O
cancer	NN	O
,	,	O
and	CC	O
diagnose	RB	O
and	CC	O
treat	VB	O
the	DT	O
disease	NN	O
.	.	O
The	DT	O
following	JJ	O
drawings	NNS	O
are	VBP	O
referred	VBN	O
to	TO	O
in	IN	O
the	DT	O
examples	NNS	O
.	.	O
FIG	NNP	O
.	.	O
1	CD	O
shows	VBZ	O
the	DT	O
result	NN	O
obtained	VBN	O
by	IN	O
testing	VBG	O
the	DT	O
PI4	NNP	O
kinase	NN	O
activity	NN	O
of	IN	O
NPIK	NNP	O
in	IN	O
Example	NNP	O
9	CD	O
.	.	O
FIG	NNP	O
.	.	O
2	CD	O
shows	VBZ	O
the	DT	O
effect	NN	O
of	IN	O
Triton	NNP	O
X-100	NNP	O
and	CC	O
adenosine	VB	O
on	IN	O
NPIK	NNP	O
activity	NN	O
.	.	O
EXAMPLES	IN	O
The	DT	O
following	JJ	O
examples	NNS	O
illustrate	VBP	O
the	DT	O
present	JJ	O
invention	NN	O
in	IN	O
further	JJ	O
detail	NN	O
.	.	O
Example	RB	O
1	CD	O
GDP	NNP	O
Dissociation	NNP	O
Stimulator	NNP	O
Gene	NNP	O
(	(	O
1	CD	O
)	)	O
Cloning	NN	O
and	CC	O
DNA	NNP	O
Sequencing	NNP	O
of	IN	O
GDP	NNP	O
Dissociation	NNP	O
Stimulator	NNP	O
Gene	NNP	O
mRNAs	NN	O
extracted	VBD	O
from	IN	O
the	DT	O
tissues	NNS	O
of	IN	O
human	JJ	O
fetal	JJ	O
brain	NN	O
,	,	O
adult	NN	O
blood	NN	O
vessels	NNS	O
and	CC	O
placenta	NN	O
were	VBD	O
purchased	VBN	O
from	IN	O
Clontech	NNP	O
and	CC	O
used	VBN	O
as	IN	O
starting	VBG	O
materials	NNS	O
.	.	O
cDNA	NN	O
was	VBD	O
synthesized	VBN	O
from	IN	O
each	DT	O
mRNA	NN	O
and	CC	O
inserted	VBN	O
into	IN	O
the	DT	O
vector	NN	O
λZAPII	NNP	O
(	(	O
Stratagene	NNP	O
)	)	O
to	TO	O
thereby	VB	O
construct	VB	O
a	DT	O
cDNA	NN	O
library	NN	O
(	(	O
Otsuka	NNP	O
GEN	NNP	O
Research	NNP	O
Institute	NNP	O
,	,	O
Otsuka	NNP	O
Pharmaceutical	NNP	O
Co.	NNP	O
,	,	O
Ltd.	NNP	O
)	)	O
Human	NNP	O
gene-containing	JJ	O
Escherichia	NNP	O
coli	NN	O
colonies	NNS	O
were	VBD	O
allowed	VBN	O
to	TO	O
form	VB	O
on	IN	O
agar	JJ	O
medium	NN	O
by	IN	O
the	DT	O
in	IN	O
vivo	JJ	O
excision	NN	O
technique	NN	O
[	NNP	O
Short	NNP	B
,	,	I
J.	NNP	I
M.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nucleic	NNP	I
Acids	NNP	I
Res.	NNP	I
,	,	I
16	CD	I
,	,	I
7583-7600	CD	I
(	(	I
1988	CD	I
)	)	I
]	NN	O
.	.	O
Colonies	NNS	O
were	VBD	O
picked	VBN	O
up	RP	O
at	IN	O
random	NN	O
and	CC	O
human	JJ	O
gene-containing	NN	O
Escherichia	NNP	O
coli	NN	O
clones	NNS	O
were	VBD	O
registered	VBN	O
on	IN	O
96-well	NNP	O
micro	NN	O
plates	NNS	O
.	.	O
The	DT	O
clones	NNS	O
registered	VBN	O
were	VBD	O
stored	VBN	O
at	IN	O
−80°	NNP	O
C.	NNP	O
Each	DT	O
of	IN	O
the	DT	O
clones	NNS	O
registered	VBD	O
was	VBD	O
cultured	VBN	O
overnight	RB	O
in	IN	O
1.5	CD	O
ml	NN	O
of	IN	O
LB	NNP	O
medium	NN	O
,	,	O
and	CC	O
DNA	NNP	O
was	VBD	O
extracted	VBN	O
and	CC	O
purified	VBN	O
using	VBG	O
a	DT	O
model	NN	O
PI-100	NNP	O
automatic	JJ	O
plasmid	NN	O
extractor	NN	O
(	(	O
Kurabo	NNP	O
)	)	O
.	.	O
Contaminant	NNP	O
Escherichia	NNP	O
coli	VBD	O
RNA	NNP	O
was	VBD	O
decomposed	VBN	O
and	CC	O
removed	VBN	O
by	IN	O
RNase	NNP	O
treatment	NN	O
.	.	O
The	DT	O
DNA	NN	O
was	VBD	O
dissolved	VBN	O
to	TO	O
a	DT	O
final	JJ	O
volume	NN	O
of	IN	O
30	CD	O
μl	NNS	O
.	.	O
A	DT	O
2-μl	JJ	O
portion	NN	O
was	VBD	O
used	VBN	O
for	IN	O
roughly	RB	O
checking	VBG	O
the	DT	O
DNA	NN	O
size	NN	O
and	CC	O
quantity	NN	O
using	VBG	O
a	DT	O
minigel	NN	O
,	,	O
7	CD	O
μl	NN	O
was	VBD	O
used	VBN	O
for	IN	O
sequencing	VBG	O
reactions	NNS	O
and	CC	O
the	DT	O
remaining	VBG	O
portion	NN	O
(	(	O
21	CD	O
μl	NN	O
)	)	O
was	VBD	O
stored	VBN	O
as	IN	O
plasmid	JJ	O
DNA	NNP	O
at	IN	O
4°	CD	O
C.	NNP	O
This	DT	O
method	NN	O
,	,	O
after	IN	O
slight	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
program	NN	O
,	,	O
enables	VBZ	O
extraction	NN	O
of	IN	O
the	DT	O
cosmid	NN	O
,	,	O
which	WDT	O
is	VBZ	O
useful	JJ	O
also	RB	O
as	IN	O
a	DT	O
probe	NN	O
for	IN	O
FISH	NNP	O
(	(	O
fluorescence	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
)	)	O
shown	VBN	O
later	RB	O
in	IN	O
the	DT	O
examples	NNS	O
.	.	O
Then	RB	O
,	,	O
the	DT	O
dideoxy	JJ	O
terminator	NN	O
method	NN	O
of	IN	O
Sanger	NNP	O
et	FW	O
al	NN	O
.	.	O
[	JJ	O
Sanger	NNP	B
,	,	I
F.	NNP	I
,	,	I
et	NN	I
al.	NN	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
74	CD	I
,	,	I
5463-5467	CD	I
(	(	I
1977	CD	I
)	)	I
]	FW	O
using	VBG	O
T3	NNP	O
,	,	O
T7	NNP	O
or	CC	O
a	DT	O
synthetic	JJ	O
oligonucleotide	NN	O
primer	NN	O
or	CC	O
the	DT	O
cycle	NN	O
sequence	NN	O
method	NN	O
[	NNP	O
Carothers	NNP	B
,	,	I
A.	NNP	I
M.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Bio	NNP	I
.	.	I
Techniques	NNS	I
,	,	I
7	CD	I
,	,	I
494-499	CD	I
(	(	I
1989	CD	I
)	)	I
]	NN	O
comprising	VBG	O
the	DT	O
dideoxy	NN	O
chain	NN	O
terminator	NN	O
method	NN	O
plus	CC	O
PCR	NNP	O
method	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
.	.	O
These	DT	O
are	VBP	O
methods	NNS	O
of	IN	O
terminating	VBG	O
the	DT	O
extension	NN	O
reaction	NN	O
specifically	RB	O
to	TO	O
the	DT	O
four	CD	O
bases	NNS	O
using	VBG	O
a	DT	O
small	JJ	O
amount	NN	O
of	IN	O
plasmid	NN	O
DNA	NNP	O
(	(	O
about	IN	O
0.1	CD	O
to	TO	O
0.5	CD	O
μg	NN	O
)	)	O
as	IN	O
a	DT	O
template	NN	O
.	.	O
The	DT	O
sequence	NN	O
primers	NNS	O
used	VBN	O
were	VBD	O
FITC	NNP	O
(	(	O
fluorescein	JJ	O
isothiocyanate	NN	O
)	)	O
-labeled	VBD	O
ones	NNS	O
.	.	O
Generally	RB	O
,	,	O
about	IN	O
25	CD	O
cycles	NNS	O
of	IN	O
reaction	NN	O
were	VBD	O
performed	VBN	O
using	VBG	O
Taq	NNP	O
polymerase	NN	O
.	.	O
The	DT	O
PCR	NNP	O
products	NNS	O
were	VBD	O
separated	VBN	O
on	IN	O
a	DT	O
polyacrylamide	JJ	O
urea	JJ	O
gel	NN	O
and	CC	O
the	DT	O
fluorescence-labeled	JJ	O
DNA	NN	O
fragments	NNS	O
were	VBD	O
submitted	VBN	O
to	TO	O
an	DT	O
automatic	JJ	O
DNA	NN	O
sequencer	NN	O
(	(	O
ALF™	NNP	O
DNA	NNP	O
Sequencer	NNP	O
;	:	O
Pharmacia	NNP	O
)	)	O
for	IN	O
determining	VBG	O
the	DT	O
sequence	NN	O
of	IN	O
about	IN	O
400	CD	O
bases	NNS	O
from	IN	O
the	DT	O
5′	CD	O
terminus	JJ	O
side	NN	O
of	IN	O
cDNA	NN	O
.	.	O
Since	IN	O
the	DT	O
3′	CD	O
nontranslational	JJ	O
region	NN	O
is	VBZ	O
high	JJ	O
in	IN	O
heterogeneity	NN	O
for	IN	O
each	DT	O
gene	NN	O
and	CC	O
therefore	RB	O
suited	VBD	O
for	IN	O
discriminating	VBG	O
individual	JJ	O
genes	NNS	O
from	IN	O
one	CD	O
another	DT	O
,	,	O
sequencing	NN	O
was	VBD	O
performed	VBN	O
on	IN	O
the	DT	O
3′	JJ	O
side	NN	O
as	RB	O
well	RB	O
depending	VBG	O
on	IN	O
the	DT	O
situation	NN	O
.	.	O
The	DT	O
vast	JJ	O
sum	NN	O
of	IN	O
nucleotide	JJ	O
sequence	NN	O
information	NN	O
obtained	VBN	O
from	IN	O
the	DT	O
DNA	NNP	O
sequencer	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
a	DT	O
64-bit	JJ	O
DEC	NN	O
3400	CD	O
computer	NN	O
for	IN	O
homology	NN	O
analysis	NN	O
by	IN	O
the	DT	O
computer	NN	O
.	.	O
In	IN	O
the	DT	O
homology	NN	O
analysis	NN	O
,	,	O
a	DT	O
data	NN	O
base	NN	O
(	(	O
GenBank	NNP	O
,	,	O
EMBL	NNP	O
)	)	O
was	VBD	O
used	VBN	O
for	IN	O
searching	VBG	O
according	VBG	O
to	TO	O
the	DT	O
UWGCG	NNP	O
FASTA	NNP	O
program	NN	O
[	NNP	O
Pearson	NNP	B
,	,	I
W.	NNP	I
R.	NNP	I
and	CC	I
Lipman	NNP	I
,	,	I
D.	NNP	I
J.	NNP	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
85	CD	I
,	,	I
2444-2448	CD	I
(	(	I
1988	CD	I
)	)	I
]	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
arbitrary	JJ	O
selection	NN	O
by	IN	O
the	DT	O
above	JJ	O
method	NN	O
and	CC	O
of	IN	O
cDNA	NN	O
sequence	NN	O
analysis	NN	O
,	,	O
a	DT	O
clone	NN	O
designated	VBN	O
as	IN	O
GEN-501D08	NNP	O
and	CC	O
having	VBG	O
a	DT	O
0.8	CD	O
kilobase	NN	O
insert	NN	O
was	VBD	O
found	VBN	O
to	TO	O
show	VB	O
a	DT	O
high	JJ	O
level	NN	O
of	IN	O
homology	NN	O
to	TO	O
the	DT	O
C	NNP	O
terminal	JJ	O
region	NN	O
of	IN	O
the	DT	O
human	JJ	O
Ral	NNP	O
guanine	NN	O
nucleotide	IN	O
dissociation	NN	O
stimulator	NN	O
(	(	O
RalGDS	NNP	O
)	)	O
gene	NN	O
.	.	O
Since	IN	O
RalGDS	NNP	O
is	VBZ	O
considered	VBN	O
to	TO	O
play	VB	O
a	DT	O
certain	JJ	O
role	NN	O
in	IN	O
signal	JJ	O
transmission	NN	O
pathways	NNS	O
,	,	O
the	DT	O
whole	JJ	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
cDNA	NN	O
insert	JJ	O
portion	NN	O
providing	VBG	O
the	DT	O
human	JJ	O
homolog	NN	O
was	VBD	O
further	RBR	O
determined	VBN	O
.	.	O
Low-molecular	JJ	O
GTPases	NNP	O
play	VBP	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
transmitting	VBG	O
signals	NNS	O
for	IN	O
a	DT	O
number	NN	O
of	IN	O
cell	NN	O
functions	NNS	O
including	VBG	O
cell	NN	O
proliferation	NN	O
,	,	O
differentiation	NN	O
and	CC	O
transformation	NN	O
[	NNP	O
Bourne	NNP	B
,	,	I
H.	NNP	I
R.	NNP	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
348	CD	I
,	,	I
125-132	CD	I
(	(	I
1990	CD	I
)	)	I
;	:	O
Bourne	NNP	B
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
349	CD	I
,	,	I
117-127	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
.	.	O
It	PRP	O
is	VBZ	O
well	RB	O
known	VBN	O
that	IN	O
,	,	O
among	IN	O
them	PRP	O
,	,	O
those	DT	O
proteins	NNS	O
encoded	VBN	O
by	IN	O
the	DT	O
ras	NNS	O
gene	NN	O
family	NN	O
function	NN	O
as	IN	O
molecular	JJ	O
switches	NNS	O
or	CC	O
,	,	O
in	IN	O
other	JJ	O
words	NNS	O
,	,	O
the	DT	O
functions	NNS	O
of	IN	O
the	DT	O
ras	NNS	O
gene	NN	O
family	NN	O
are	VBP	O
regulated	VBN	O
by	IN	O
different	JJ	O
conditions	NNS	O
of	IN	O
binding	VBG	O
proteins	NNS	O
such	JJ	O
as	IN	O
biologically	RB	O
inactive	JJ	O
GDP-binding	JJ	O
proteins	NNS	O
or	CC	O
active	JJ	O
GDP-binding	JJ	O
proteins	NNS	O
,	,	O
and	CC	O
that	IN	O
these	DT	O
two	CD	O
conditions	NNS	O
are	VBP	O
induced	VBN	O
by	IN	O
GTPase	NNP	O
activating	VBG	O
proteins	NNS	O
(	(	O
GAPs	NNP	O
)	)	O
or	CC	O
GDS	NNP	O
.	.	O
The	DT	O
former	JJ	O
enzymes	NNS	O
induce	VBP	O
GDP	NNP	O
binding	NN	O
by	IN	O
stimulating	VBG	O
the	DT	O
hydrolysis	NN	O
of	IN	O
bound	NN	O
GTP	NNP	O
and	CC	O
the	DT	O
latter	JJ	O
enzyme	NN	O
induces	VBZ	O
the	DT	O
regular	JJ	O
GTP	NNP	O
binding	NN	O
by	IN	O
releasing	VBG	O
bound	NN	O
GDP	NNP	O
[	NNP	O
Bogusuki	NNP	B
,	,	I
M.	NNP	I
S	NNP	I
,	,	I
and	CC	I
McCormick	NNP	I
,	,	I
F.	NNP	I
,	,	I
Nature	NNP	I
,	,	I
366	CD	I
,	,	I
643-654	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
.	.	O
RalGDS	NNP	O
was	VBD	O
first	RB	O
discovered	VBN	O
as	IN	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
ras	NNS	O
gene	NN	O
family	NN	O
lacking	VBG	O
in	IN	O
transforming	VBG	O
activity	NN	O
and	CC	O
as	IN	O
a	DT	O
GDP	NNP	O
dissociation	NN	O
stimulator	NN	O
specific	JJ	O
to	TO	O
RAS	NNP	O
[	NNP	O
Chardin	NNP	B
,	,	I
P.	NNP	I
and	CC	I
Tavitian	NNP	I
,	,	I
A.	NNP	I
,	,	I
EMBO	NNP	I
J.	NNP	I
,	,	I
5	CD	I
,	,	I
2203-2208	CD	I
(	(	I
1986	CD	I
)	)	I
;	:	O
Albright	NNP	B
,	,	I
C.	NNP	I
F.	NNP	I
,	,	I
et	NN	I
al.	NN	I
,	,	I
EMBO	NNP	I
J.	NNP	I
,	,	I
12	CD	I
,	,	I
339-347	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
.	.	O
In	IN	O
addition	NN	O
to	TO	O
Ral	NNP	O
,	,	O
RalGDS	NNP	O
was	VBD	O
found	VBN	O
to	TO	O
function	NN	O
,	,	O
through	IN	O
interaction	NN	O
with	IN	O
these	DT	O
proteins	NNS	O
,	,	O
as	IN	O
an	DT	O
effector	NN	O
molecule	NN	O
for	IN	O
N-ras	NNP	O
,	,	O
H-ras	NNP	O
,	,	O
K-ras	NNP	O
and	CC	O
Rap	NNP	O
[	NNP	O
Spaargaren	NNP	B
,	,	I
M.	NNP	I
and	CC	I
Bischoff	NNP	I
,	,	I
J.	NNP	I
R.	NNP	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
91	CD	I
,	,	I
12609-12613	CD	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
cDNA	NN	O
clone	NN	O
designated	VBN	O
as	IN	O
GEN-501D08	NNP	O
is	VBZ	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:3	NNP	O
,	,	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
said	VBD	O
clone	NN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
encoded	VBN	O
by	IN	O
said	VBD	O
nucleotide	JJ	O
sequence	NN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
.	.	O
This	DT	O
cDNA	NN	O
comprises	VBZ	O
842	CD	O
nucleotides	NNS	O
,	,	O
including	VBG	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
comprising	VBG	O
366	CD	O
nucleotides	NNS	O
and	CC	O
coding	VBG	O
for	IN	O
122	CD	O
amino	JJ	O
acids	NNS	O
.	.	O
The	DT	O
translation	NN	O
initiation	NN	O
codon	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
located	VBN	O
at	IN	O
the	DT	O
28th	CD	O
nucleotide	RB	O
residue	JJ	O
.	.	O
Comparison	NNP	O
between	IN	O
the	DT	O
RalGDS	NNP	O
protein	NN	O
known	VBN	O
among	IN	O
conventional	JJ	O
databases	NNS	O
and	CC	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
deduced	VBD	O
from	IN	O
said	VBD	O
cDNA	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
protein	NN	O
encoded	VBN	O
by	IN	O
this	DT	O
cDNA	NN	O
is	VBZ	O
homologous	JJ	O
to	TO	O
the	DT	O
C	NNP	O
terminal	NN	O
domain	NN	O
of	IN	O
human	JJ	O
RalGDS	NNP	O
.	.	O
The	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
encoded	VBN	O
by	IN	O
this	DT	O
novel	JJ	O
gene	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
39.5	CD	O
%	NN	O
identical	JJ	O
with	IN	O
the	DT	O
C	NNP	O
terminal	NN	O
domain	NN	O
of	IN	O
RalGDS	NNP	O
which	WDT	O
is	VBZ	O
thought	VBN	O
to	TO	O
be	VB	O
necessary	JJ	O
for	IN	O
binding	VBG	O
to	TO	O
ras	VB	O
.	.	O
Therefore	RB	O
,	,	O
it	PRP	O
is	VBZ	O
presumable	JJ	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
that	IN	O
this	DT	O
gene	NN	O
product	NN	O
might	MD	O
interact	VB	O
with	IN	O
the	DT	O
ras	NNS	O
family	NN	O
proteins	NNS	O
or	CC	O
have	VBP	O
influence	VBN	O
on	IN	O
the	DT	O
ras-mediated	JJ	O
signal	JJ	O
transduction	NN	O
pathways	NNS	O
.	.	O
However	RB	O
,	,	O
this	DT	O
novel	JJ	O
gene	NN	O
is	VBZ	O
lacking	VBG	O
in	IN	O
the	DT	O
region	NN	O
coding	VBG	O
for	IN	O
the	DT	O
GDS	NNP	O
activity	NN	O
domain	NN	O
and	CC	O
the	DT	O
corresponding	JJ	O
protein	NN	O
seems	VBZ	O
to	TO	O
be	VB	O
different	JJ	O
in	IN	O
function	NN	O
from	IN	O
the	DT	O
GDS	NNP	O
protein	NN	O
.	.	O
This	DT	O
gene	NN	O
was	VBD	O
named	VBN	O
human	JJ	O
RalGDS	NNP	O
by	IN	O
the	DT	O
present	JJ	O
inventors	NNS	O
.	.	O
(	(	O
2	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
The	DT	O
expression	NN	O
of	IN	O
the	DT	O
RalGDS	NNP	O
protein	NN	O
mRNA	NN	O
in	IN	O
normal	JJ	O
human	JJ	O
tissues	NNS	O
was	VBD	O
evaluated	VBN	O
by	IN	O
Northern	NNP	O
blotting	VBG	O
using	VBG	O
,	,	O
as	IN	O
a	DT	O
probe	NN	O
,	,	O
the	DT	O
human	JJ	O
cDNA	NN	O
clone	NN	O
labeled	VBN	O
by	IN	O
the	DT	O
random	NN	O
oligonucleotide	IN	O
priming	VBG	O
method	NN	O
.	.	O
The	DT	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
with	IN	O
a	DT	O
human	JJ	O
MTN	NNP	O
blot	NN	O
(	(	O
Human	NNP	O
Multiple	NNP	O
Tissue	NNP	O
Northern	NNP	O
blot	NN	O
;	:	O
Clontech	NNP	O
,	,	O
Palo	NNP	O
Alto	NNP	O
,	,	O
Calif.	NNP	O
,	,	O
USA	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
protocol	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
PCR	NNP	O
amplification	NN	O
product	NN	O
from	IN	O
the	DT	O
above	JJ	O
GEN-501D08	NNP	O
clone	NN	O
was	VBD	O
labeled	VBN	O
with	IN	O
[	JJ	O
32P	CD	O
]	JJ	O
-dCTP	NNP	O
(	(	O
random-primed	JJ	O
DNA	NNP	O
labeling	VBG	O
kit	NN	O
,	,	O
Boehringer-Mannheim	NNP	O
)	)	O
for	IN	O
use	NN	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O
For	IN	O
blotting	NN	O
,	,	O
hybridization	NN	O
was	VBD	O
performed	VBN	O
overnight	RB	O
at	IN	O
42°	CD	O
C.	NNP	O
in	IN	O
a	DT	O
solution	NN	O
comprising	VBG	O
50	CD	O
%	NN	O
formamide/5×SSC/50×Denhardt	NN	O
's	POS	O
solution/0.1	NN	O
%	NN	O
SDS	NNP	O
(	(	O
containing	VBG	O
100	CD	O
μg/ml	NN	O
denatured	VBD	O
salmon	JJ	O
sperm	JJ	O
DNA	NN	O
)	)	O
.	.	O
After	IN	O
washing	VBG	O
with	IN	O
two	CD	O
portions	NNS	O
of	IN	O
2×SSC/0.01	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
room	NN	O
temperature	NN	O
,	,	O
the	DT	O
membrane	NN	O
filter	NN	O
was	VBD	O
further	RBR	O
washed	VBD	O
three	CD	O
times	NNS	O
with	IN	O
0.1×SSC/0.05	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
50°	CD	O
C.	NNP	O
for	IN	O
40	CD	O
minutes	NNS	O
.	.	O
An	DT	O
X-ray	JJ	O
film	NN	O
(	(	O
Kodak	NNP	O
)	)	O
was	VBD	O
exposed	VBN	O
to	TO	O
the	DT	O
filter	NN	O
at	IN	O
−70°	NNP	O
C.	NNP	O
for	IN	O
18	CD	O
hours	NNS	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
it	PRP	O
was	VBD	O
revealed	VBN	O
that	IN	O
a	DT	O
900-bp	JJ	O
transcript	NN	O
had	VBD	O
been	VBN	O
expressed	VBN	O
in	IN	O
all	PDT	O
the	DT	O
human	JJ	O
tissues	NNS	O
tested	VBN	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
a	DT	O
3.2-kb	JJ	O
transcript	NN	O
was	VBD	O
observed	VBN	O
specifically	RB	O
in	IN	O
the	DT	O
heart	NN	O
and	CC	O
skeletal	JJ	O
muscle	NN	O
.	.	O
The	DT	O
expression	NN	O
of	IN	O
these	DT	O
transcripts	NNS	O
differing	VBG	O
in	IN	O
size	NN	O
may	MD	O
be	VB	O
due	JJ	O
either	DT	O
to	TO	O
alternative	JJ	O
splicing	NN	O
or	CC	O
to	TO	O
cross	VB	O
hybridization	NN	O
with	IN	O
homologous	JJ	O
genes	NNS	O
.	.	O
(	(	O
3	CD	O
)	)	O
Cosmid	NNP	O
Clone	NNP	O
and	CC	O
Chromosome	NNP	O
Localization	NNP	O
by	IN	O
FISH	NNP	O
FISH	NNP	O
was	VBD	O
performed	VBN	O
by	IN	O
screening	VBG	O
a	DT	O
library	NN	O
of	IN	O
human	JJ	O
chromosomes	NNS	O
cloned	VBN	O
in	IN	O
the	DT	O
cosmid	NN	O
vector	NN	O
pWE15	NN	O
using	VBG	O
,	,	O
as	IN	O
a	DT	O
probe	NN	O
,	,	O
the	DT	O
0.8-kb	JJ	O
insert	NN	O
of	IN	O
the	DT	O
cDNA	NN	O
clone	NN	O
[	NNP	O
Sambrook	NNP	B
,	,	I
J.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Molecular	NNP	I
Cloning	NNP	I
,	,	I
2nd	CD	I
Ed.	NNP	I
,	,	I
pp	NN	I
.	.	I
3.1-3.58	JJ	I
,	,	I
Cold	NNP	I
Spring	NNP	I
Harbor	NNP	I
Laboratory	NNP	I
Press	NNP	I
,	,	I
Cold	NNP	I
Spring	NNP	I
Harbor	NNP	I
,	,	I
N.Y.	NNP	I
(	(	I
1989	CD	I
)	)	I
]	NN	O
.	.	O
FISH	NN	O
for	IN	O
chromosome	NN	O
assignment	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
by	IN	O
the	DT	O
method	NN	O
of	IN	O
Inazawa	NNP	O
et	FW	O
al	NN	O
.	.	O
which	WDT	O
comprises	VBZ	O
G-banding	NNP	O
pattern	NN	O
comparison	NN	O
for	IN	O
confirmation	NN	O
[	NNP	O
Inazawa	NNP	B
,	,	I
J.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Genomics	NNP	I
,	,	I
17	CD	I
,	,	I
153-162	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
.	.	O
For	IN	O
use	NN	O
as	IN	O
a	DT	O
probe	NN	O
,	,	O
the	DT	O
cosmid	NN	O
DNA	NNP	O
(	(	O
0.5	CD	O
μg	NN	O
)	)	O
obtained	VBD	O
from	IN	O
chromosome	NN	O
screening	NN	O
and	CC	O
corresponding	VBG	O
to	TO	O
GEN-501D08	NNP	O
was	VBD	O
labeled	VBN	O
with	IN	O
biotin-16-dUTP	NN	O
by	IN	O
nick	JJ	O
translation	NN	O
.	.	O
To	TO	O
eliminate	VB	O
the	DT	O
background	NN	O
noise	NN	O
due	JJ	O
to	TO	O
repetitive	JJ	O
sequences	NNS	O
,	,	O
0.5	CD	O
μl	NN	O
of	IN	O
sonicated	JJ	O
human	JJ	O
placenta	NN	O
DNA	NNP	O
(	(	O
10	CD	O
mg/ml	NN	O
)	)	O
was	VBD	O
added	VBN	O
to	TO	O
9.5	CD	O
μl	NN	O
of	IN	O
the	DT	O
probe	NN	O
solution	NN	O
.	.	O
The	DT	O
mixture	NN	O
was	VBD	O
denatured	VBN	O
at	IN	O
80°	CD	O
C.	NNP	O
for	IN	O
5	CD	O
minutes	NNS	O
and	CC	O
admixed	JJ	O
with	IN	O
an	DT	O
equal	JJ	O
volume	NN	O
of	IN	O
4×SSC	CD	O
containing	VBG	O
20	CD	O
%	NN	O
dextransulfate	NN	O
.	.	O
Then	RB	O
,	,	O
a	DT	O
denatured	JJ	O
slide	NN	O
was	VBD	O
sown	VBN	O
with	IN	O
the	DT	O
hybridization	NN	O
mixture	NN	O
and	CC	O
,	,	O
after	IN	O
covering	VBG	O
with	IN	O
paraffin	NN	O
,	,	O
incubated	VBN	O
in	IN	O
a	DT	O
wet	JJ	O
chamber	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
for	IN	O
16	CD	O
to	TO	O
18	CD	O
hours	NNS	O
.	.	O
After	IN	O
washing	VBG	O
with	IN	O
50	CD	O
%	NN	O
formamide/2×SSC	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
for	IN	O
15	CD	O
minutes	NNS	O
,	,	O
the	DT	O
slide	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
2×SSC	CD	O
for	IN	O
15	CD	O
minutes	NNS	O
and	CC	O
further	RB	O
with	IN	O
1×SSC	CD	O
for	IN	O
15	CD	O
minutes	NNS	O
.	.	O
The	DT	O
slide	NN	O
was	VBD	O
then	RB	O
incubated	VBN	O
in	IN	O
4×SSC	CD	O
supplemented	JJ	O
with	IN	O
“	JJ	O
1	CD	O
%	NN	O
Block	NNP	O
Ace	NNP	O
”	NNP	O
(	(	O
trademark	NN	O
;	:	O
Dainippon	NNP	O
Pharmaceutical	NNP	O
)	)	O
containing	VBG	O
avidin-FITC	JJ	O
(	(	O
5	CD	O
μg/ml	NN	O
)	)	O
at	IN	O
37°	CD	O
C.	NNP	O
for	IN	O
40	CD	O
minutes	NNS	O
.	.	O
Then	RB	O
,	,	O
the	DT	O
slide	NN	O
was	VBD	O
washed	VBN	O
with	IN	O
4×SSC	CD	O
for	IN	O
10	CD	O
minutes	NNS	O
and	CC	O
with	IN	O
4×SSC	CD	O
containing	VBG	O
0.05	CD	O
%	NN	O
Triton	NNP	O
X-100	NNP	O
for	IN	O
10	CD	O
minutes	NNS	O
and	CC	O
immersed	VBN	O
in	IN	O
an	DT	O
antifading	NN	O
PPD	NNP	O
solution	NN	O
[	NN	O
prepared	VBN	O
by	IN	O
adjusting	VBG	O
100	CD	O
mg	NN	O
of	IN	O
PPD	NNP	O
(	(	O
Wako	NNP	O
Catalog	NNP	O
No	NNP	O
.	.	O
164-015321	JJ	O
)	)	O
and	CC	O
10	CD	O
ml	NN	O
of	IN	O
PBS	NNP	O
(	(	O
−	NNP	O
)	)	O
(	(	O
pH	$	O
7.4	CD	O
)	)	O
to	TO	O
pH	VB	O
8.0	CD	O
with	IN	O
0.5	CD	O
M	NNP	O
Na2CO3/0.5	NNP	O
M	NNP	O
NaHCO3	NNP	O
(	(	O
9:1	CD	O
,	,	O
v/v	NN	O
)	)	O
buffer	NN	O
(	(	O
pH	JJ	O
9.0	CD	O
)	)	O
and	CC	O
adding	VBG	O
glycerol	NN	O
to	TO	O
make	VB	O
a	DT	O
total	JJ	O
volume	NN	O
of	IN	O
100	CD	O
ml	NNS	O
]	VBD	O
containing	VBG	O
1	CD	O
%	NN	O
DABCO	NNP	O
[	NNP	O
1	CD	O
%	NN	O
DABCO	NNP	O
(	(	O
Sigma	NNP	O
)	)	O
in	IN	O
PBS	NNP	O
(	(	O
−	NNP	O
)	)	O
:	:	O
glycerol	NN	O
1:9	CD	O
(	(	O
v	NN	O
:	:	O
v	NN	O
)	)	O
]	NN	O
,	,	O
followed	VBN	O
by	IN	O
counter	NN	O
staining	VBG	O
with	IN	O
DAPI	NNP	O
(	(	O
4,6-diamino-2-phenylindole	JJ	O
;	:	O
Sigma	NNP	O
)	)	O
.	.	O
With	IN	O
more	JJR	O
than	IN	O
100	CD	O
tested	JJ	O
cells	NNS	O
in	IN	O
the	DT	O
metaphase	NN	O
,	,	O
a	DT	O
specific	JJ	O
hybridization	NN	O
signal	NN	O
was	VBD	O
observed	VBN	O
on	IN	O
the	DT	O
chromosome	NN	O
band	NN	O
at	IN	O
6p21.3	CD	O
,	,	O
without	IN	O
any	DT	O
signal	NN	O
on	IN	O
other	JJ	O
chromosomes	NNS	O
.	.	O
It	PRP	O
was	VBD	O
thus	RB	O
confirmed	VBN	O
that	IN	O
the	DT	O
RalGDS	NNP	O
gene	NN	O
is	VBZ	O
located	VBN	O
on	IN	O
the	DT	O
chromosome	NN	O
6p21.3	CD	O
.	.	O
By	IN	O
using	VBG	O
the	DT	O
novel	JJ	O
human	JJ	O
RalGDS-associated	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
as	IN	O
obtained	VBN	O
in	IN	O
this	DT	O
example	NN	O
,	,	O
the	DT	O
expression	NN	O
of	IN	O
said	VBD	O
gene	NN	O
in	IN	O
various	JJ	O
tissues	NNS	O
can	MD	O
be	VB	O
detected	VBN	O
and	CC	O
the	DT	O
human	JJ	O
RalGDS	NNP	O
protein	NN	O
can	MD	O
be	VB	O
produced	VBN	O
in	IN	O
the	DT	O
manner	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
.	.	O
These	DT	O
are	VBP	O
expected	VBN	O
to	TO	O
enable	VB	O
studies	NNS	O
on	IN	O
the	DT	O
roles	NNS	O
of	IN	O
the	DT	O
expression	NN	O
product	NN	O
protein	NN	O
and	CC	O
ras-mediated	JJ	O
signals	NNS	O
in	IN	O
transduction	NN	O
pathways	NNS	O
as	RB	O
well	RB	O
as	IN	O
pathological	JJ	O
investigations	NNS	O
of	IN	O
diseases	NNS	O
in	IN	O
which	WDT	O
these	DT	O
are	VBP	O
involved	VBN	O
,	,	O
for	IN	O
example	NN	O
cancer	NN	O
,	,	O
and	CC	O
the	DT	O
diagnosis	NN	O
and	CC	O
treatment	NN	O
of	IN	O
such	JJ	O
diseases	NNS	O
.	.	O
Furthermore	RB	O
,	,	O
it	PRP	O
becomes	VBZ	O
possible	JJ	O
to	TO	O
study	VB	O
the	DT	O
development	NN	O
and	CC	O
progress	NN	O
of	IN	O
diseases	NNS	O
involving	VBG	O
the	DT	O
same	JJ	O
chromosomal	JJ	O
translocation	NN	O
of	IN	O
the	DT	O
RalGDS	NNP	O
protein	NN	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
for	IN	O
example	NN	O
tonic	JJ	O
spondylitis	NN	O
,	,	O
atrial	JJ	O
septal	NN	O
defect	NN	O
,	,	O
pigmentary	JJ	O
retinopathy	NN	O
,	,	O
aphasia	NN	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
Example	JJ	O
2	CD	O
Cytoskeleton-Associated	JJ	O
Protein	NNP	O
2	CD	O
Gene	NNP	O
(	(	O
CKAP2	NNP	O
Gene	NNP	O
)	)	O
(	(	O
1	CD	O
)	)	O
Cytoskeleton-Associated	JJ	O
Protein	NNP	O
2	CD	O
Gene	NNP	O
Cloning	NNP	O
and	CC	O
DNA	NNP	O
Sequencing	NNP	O
cDNA	NN	O
clones	NNS	O
were	VBD	O
arbitrarily	RB	O
chosen	VBN	O
from	IN	O
a	DT	O
human	JJ	O
fetal	NN	O
brain	NN	O
cDNA	NN	O
library	NN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
were	VBD	O
subjected	VBN	O
to	TO	O
sequence	VB	O
analysis	NN	O
and	CC	O
,	,	O
as	IN	O
a	DT	O
result	NN	O
,	,	O
a	DT	O
clone	NN	O
having	VBG	O
a	DT	O
base	NN	O
sequence	NN	O
containing	VBG	O
the	DT	O
CAP-glycine	NNP	O
domain	NN	O
of	IN	O
the	DT	O
human	JJ	O
cytoskeleton-associated	JJ	O
protein	NN	O
(	(	O
CAP	NNP	O
)	)	O
gene	NN	O
and	CC	O
highly	RB	O
homologous	JJ	O
to	TO	O
several	JJ	O
CAP	NNP	O
family	NN	O
genes	NNS	O
was	VBD	O
found	VBN	O
and	CC	O
named	VBN	O
GEN-080G01	NNP	O
.	.	O
Meanwhile	RB	O
,	,	O
the	DT	O
cytoskeleton	NN	O
occurs	VBZ	O
in	IN	O
the	DT	O
cytoplasm	NN	O
and	CC	O
just	RB	O
inside	IN	O
the	DT	O
cell	NN	O
membrane	NN	O
of	IN	O
eukaryotic	JJ	O
cells	NNS	O
and	CC	O
is	VBZ	O
a	DT	O
network	NN	O
structure	NN	O
comprising	VBG	O
complicatedly	RB	O
entangled	JJ	O
filaments	NNS	O
.	.	O
Said	NNP	O
cytoskeleton	NN	O
is	VBZ	O
constituted	VBN	O
of	IN	O
microtubules	NNS	O
composed	VBN	O
of	IN	O
tubulin	NN	O
,	,	O
microfilaments	NNS	O
composed	VBD	O
of	IN	O
actin	NN	O
,	,	O
intermediate	JJ	O
filaments	NNS	O
composed	VBN	O
of	IN	O
desmin	NN	O
and	CC	O
vimentin	NN	O
,	,	O
and	CC	O
so	RB	O
on	IN	O
.	.	O
The	DT	O
cytoskeleton	NN	O
not	RB	O
only	RB	O
acts	VBZ	O
as	IN	O
supportive	JJ	O
cellular	JJ	O
elements	NNS	O
but	CC	O
also	RB	O
isokinetically	RB	O
functions	NNS	O
to	TO	O
induce	VB	O
morphological	JJ	O
changes	NNS	O
of	IN	O
cells	NNS	O
by	IN	O
polymerization	NN	O
and	CC	O
depolymerization	NN	O
in	IN	O
the	DT	O
fibrous	JJ	O
system	NN	O
.	.	O
The	DT	O
cytoskeleton	NN	O
binds	VBZ	O
to	TO	O
intracellular	VB	O
organelles	NNS	O
,	,	O
cell	NN	O
membrane	NN	O
receptors	NNS	O
and	CC	O
ion	NN	O
channels	NNS	O
and	CC	O
thus	RB	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
intracellular	JJ	O
movement	NN	O
and	CC	O
locality	NN	O
maintenance	NN	O
thereof	NN	O
and	CC	O
,	,	O
in	IN	O
addition	NN	O
,	,	O
is	VBZ	O
said	VBD	O
to	TO	O
have	VB	O
functions	NNS	O
in	IN	O
activity	NN	O
regulation	NN	O
and	CC	O
mutual	JJ	O
information	NN	O
transmission	NN	O
.	.	O
Thus	RB	O
it	PRP	O
supposedly	RB	O
occupies	VBZ	O
a	DT	O
very	RB	O
important	JJ	O
position	NN	O
in	IN	O
physiological	JJ	O
activity	NN	O
regulation	NN	O
of	IN	O
the	DT	O
whole	JJ	O
cell	NN	O
.	.	O
In	IN	O
particular	JJ	O
,	,	O
the	DT	O
relation	NN	O
between	IN	O
canceration	NN	O
of	IN	O
cells	NNS	O
and	CC	O
qualitative	JJ	O
changes	NNS	O
of	IN	O
the	DT	O
cytoskeleton	NN	O
attracts	VBZ	O
attention	NN	O
since	IN	O
cancer	NN	O
cells	NNS	O
differ	VBP	O
in	IN	O
morphology	NN	O
and	CC	O
recognition	NN	O
response	NN	O
from	IN	O
normal	JJ	O
cells	NNS	O
.	.	O
The	DT	O
activity	NN	O
of	IN	O
this	DT	O
cytoskeleton	NN	O
is	VBZ	O
modulated	VBN	O
by	IN	O
a	DT	O
number	NN	O
of	IN	O
cytoskeleton-associated	JJ	O
proteins	NNS	O
(	(	O
CAPs	NNP	O
)	)	O
.	.	O
One	CD	O
group	NN	O
of	IN	O
CAPs	NNP	O
is	VBZ	O
characterized	VBN	O
by	IN	O
a	DT	O
glycine	JJ	O
motif	NN	O
highly	RB	O
conserved	VBN	O
and	CC	O
supposedly	RB	O
contributing	VBG	O
to	TO	O
association	NN	O
with	IN	O
microtubules	NNS	O
[	VBP	O
CAP-GLY	NNP	O
domain	NN	O
;	:	O
Riehemann	NNP	B
,	,	I
K.	NNP	I
and	CC	I
Song	NNP	I
,	,	I
C.	NNP	I
,	,	I
Trends	NNP	I
Biochem	NNP	I
.	.	I
Sci.	NNP	I
,	,	I
18	CD	I
,	,	I
82-83	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
.	.	O
Among	IN	O
the	DT	O
members	NNS	O
of	IN	O
this	DT	O
group	NN	O
of	IN	O
CAPs	NNP	O
,	,	O
there	EX	O
are	VBP	O
CLIP-170	NNP	O
,	,	O
150	CD	O
kDa	NN	O
DAP	NNP	O
(	(	O
dynein-associated	JJ	O
protein	NN	O
,	,	O
or	CC	O
dynactin	NN	O
)	)	O
,	,	O
D.	NNP	O
melanogaster	NN	O
GLUED	NNP	O
,	,	O
S.	NNP	O
cerevisiae	NN	O
BIK1	NNP	O
,	,	O
restin	NN	O
[	NN	O
Bilbe	NNP	B
,	,	I
G.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
EMBO	NNP	I
J.	NNP	I
,	,	I
11	CD	I
,	,	I
2103-2113	CD	I
(	(	I
1992	CD	I
)	)	I
]	NN	O
;	:	O
Hilliker	NNP	B
,	,	I
C.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cytogenet	NNP	I
.	.	I
Cell	NNP	I
Genet.	NNP	I
,	,	I
65	CD	I
,	,	I
172-176	CD	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
and	CC	O
C.	NNP	O
elegans	VBZ	O
13.5	CD	O
kDa	NN	O
protein	NN	O
[	NNP	O
Wilson	NNP	B
,	,	I
R.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
368	CD	I
,	,	I
32-38	CD	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
.	.	O
Except	IN	O
for	IN	O
the	DT	O
last	JJ	O
two	CD	O
proteins	NNS	O
,	,	O
direct	JJ	O
or	CC	O
indirect	JJ	O
evidences	NNS	O
have	VBP	O
suggested	VBN	O
that	IN	O
they	PRP	O
could	MD	O
interact	VB	O
with	IN	O
microtublues	NNS	O
.	.	O
The	DT	O
above-mentioned	JJ	O
CLIP-170	NNP	O
is	VBZ	O
essential	JJ	O
for	IN	O
the	DT	O
in	IN	O
vitro	JJ	O
binding	NN	O
of	IN	O
endocytic	JJ	O
vesicles	NNS	O
to	TO	O
microtubules	NNS	O
and	CC	O
colocalizes	NNS	O
with	IN	O
endocytic	JJ	O
organelles	NNS	O
[	RB	O
Rickard	NNP	B
,	,	I
J.	NNP	I
E.	NNP	I
and	CC	I
Kreis	NNP	I
,	,	I
T.	NNP	I
E.	NNP	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
18	CD	I
,	,	I
82-83	CD	I
(	(	I
1990	CD	I
)	)	I
;	:	O
Pierre	NNP	B
,	,	I
P.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
70	CD	I
,	,	I
887-900	CD	I
(	(	I
1992	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
above-mentioned	JJ	O
dynactin	NN	O
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
factors	NNS	O
constituting	VBG	O
the	DT	O
cytoplasmic	JJ	O
dynein	NN	O
motor	NN	O
,	,	O
which	WDT	O
functions	NNS	O
in	IN	O
retrograde	NN	O
vesicle	NN	O
transport	NN	O
[	NNP	O
Schroer	NNP	B
,	,	I
T.	NNP	I
A.	NN	I
and	CC	I
Sheetz	NNP	I
,	,	I
M.	NNP	I
P.	NNP	I
,	,	I
J	NNP	I
.	.	I
Cell	NNP	I
Biol.	NNP	I
,	,	I
115	CD	I
,	,	I
1309-1318	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
or	CC	O
probably	RB	O
in	IN	O
the	DT	O
movement	NN	O
of	IN	O
chromosomes	NNS	O
during	IN	O
mitosis	NN	O
[	NNP	O
Pfarr	NNP	B
,	,	I
C.	NNP	I
M.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
345	CD	I
,	,	I
263-265	CD	I
(	(	I
1990	CD	I
)	)	I
;	:	O
Steuer	NNP	B
,	,	I
E.	NNP	I
R.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
345	CD	I
,	,	I
266-268	CD	I
(	(	I
1990	CD	I
)	)	I
;	:	O
Wordeman	NNP	B
,	,	I
L.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
J	NNP	I
.	.	I
Cell	NNP	I
Biol.	NNP	I
,	,	I
114	CD	I
,	,	I
285-294	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
.	.	O
GLUED	NNP	O
,	,	O
the	DT	O
Drosophila	NNP	O
homolog	NN	O
of	IN	O
mammalian	JJ	O
dynactin	NN	O
,	,	O
is	VBZ	O
essential	JJ	O
for	IN	O
the	DT	O
viability	NN	O
of	IN	O
almost	RB	O
all	DT	O
cells	NNS	O
and	CC	O
for	IN	O
the	DT	O
proper	JJ	O
organization	NN	O
of	IN	O
some	DT	O
neurons	NNS	O
[	VBP	O
Swaroop	NNP	B
,	,	I
A.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
84	CD	I
,	,	I
6501-6505	CD	I
(	(	I
1987	CD	I
)	)	I
;	:	O
Holzbaur	NNP	B
,	,	I
E.	NNP	I
L.	NNP	I
P.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
351	CD	I
,	,	I
579-583	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
.	.	O
BIK1	NNP	O
interacts	VBZ	O
with	IN	O
microtubules	NNS	O
and	CC	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
spindle	JJ	O
formation	NN	O
during	IN	O
mitosis	NN	O
in	IN	O
yeasts	NNS	O
[	NNP	O
Trueheart	NNP	B
,	,	I
J.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Mol	NNP	I
.	.	I
Cell	NNP	I
.	.	I
Biol.	NNP	I
,	,	I
7	CD	I
,	,	I
2316-2326	CD	I
(	(	I
1987	CD	I
)	)	I
;	:	O
Berlin	NNP	B
,	,	I
V.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
J	NNP	I
.	.	I
Cell	NNP	I
Biol.	NNP	I
,	,	I
111	CD	I
,	,	I
2573-2586	CD	I
(	(	I
1990	CD	I
)	)	I
]	NN	O
.	.	O
At	IN	O
present	JJ	O
,	,	O
these	DT	O
genes	NNS	O
are	VBP	O
classified	VBN	O
under	IN	O
the	DT	O
term	NN	O
CAP	NNP	O
family	NN	O
(	(	O
CAPS	NNP	O
)	)	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
database	NN	O
searching	NN	O
,	,	O
the	DT	O
above-mentioned	JJ	O
cDNA	NN	O
clone	NN	O
of	IN	O
463-bp	JJ	O
(	(	O
excluding	VBG	O
the	DT	O
poly-A	JJ	O
signal	NN	O
)	)	O
showed	VBD	O
significant	JJ	O
homology	NN	O
in	IN	O
nucleotide	JJ	O
sequence	NN	O
with	IN	O
the	DT	O
restin	NN	O
and	CC	O
CLIP-170	NNP	O
encoding	VBG	O
genes	NNS	O
.	.	O
However	RB	O
,	,	O
said	VBD	O
clone	NN	O
was	VBD	O
lacking	VBG	O
in	IN	O
the	DT	O
5′	JJ	O
region	NN	O
as	IN	O
compared	VBN	O
with	IN	O
the	DT	O
restin	NN	O
gene	NN	O
and	CC	O
,	,	O
therefore	RB	O
,	,	O
the	DT	O
technique	NN	O
of	IN	O
5′	CD	O
RACE	NNP	O
[	NNP	O
Frohman	NNP	B
,	,	I
M.	NNP	I
A.	NN	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
85	CD	I
,	,	I
8998-9002	CD	I
(	(	I
1988	CD	I
)	)	I
]	NN	O
was	VBD	O
used	VBN	O
to	TO	O
isolate	VB	O
this	DT	O
missing	VBG	O
segment	NN	O
.	.	O
(	(	O
2	CD	O
)	)	O
5′	CD	O
RACE	NNP	O
(	(	O
5′	CD	O
Rapid	NNP	O
Amplification	NNP	O
of	IN	O
cDNA	NN	O
Ends	NNP	O
)	)	O
A	NNP	O
cDNA	NN	O
clone	NN	O
containing	VBG	O
the	DT	O
5′	CD	O
portion	NN	O
of	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
was	VBD	O
isolated	VBN	O
for	IN	O
analysis	NN	O
by	IN	O
the	DT	O
5′	CD	O
RACE	NNP	O
technique	NN	O
using	VBG	O
a	DT	O
commercial	JJ	O
kit	NN	O
(	(	O
5′-Rapid	JJ	O
AmpliFinder	NNP	O
RACE	NNP	O
kit	NN	O
,	,	O
Clontech	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
protocol	NN	O
with	IN	O
minor	JJ	O
modifications	NNS	O
,	,	O
as	IN	O
follows	VBZ	O
.	.	O
The	DT	O
gene-specific	JJ	O
primer	NN	O
P1	NNP	O
and	CC	O
primer	NN	O
P2	NNP	O
used	VBD	O
here	RB	O
were	VBD	O
synthesized	VBN	O
by	IN	O
the	DT	O
conventional	JJ	O
method	NN	O
and	CC	O
their	PRP$	O
nucleotide	JJ	O
sequences	NNS	O
are	VBP	O
as	IN	O
shown	VBN	O
below	IN	O
in	IN	O
Table	JJ	O
1	CD	O
.	.	O
The	DT	O
anchor	NN	O
primer	NN	O
used	VBN	O
was	VBD	O
the	DT	O
one	CD	O
attached	VBN	O
to	TO	O
the	DT	O
commercial	JJ	O
kit	NN	O
.	.	O
cDNA	NN	O
was	VBD	O
obtained	VBN	O
by	IN	O
reverse	JJ	O
transcription	NN	O
of	IN	O
0.1	CD	O
μg	NN	O
of	IN	O
human	JJ	O
fetal	JJ	O
brain	NN	O
poly	NN	O
(	(	O
A	DT	O
)	)	O
+RNA	NN	O
by	IN	O
the	DT	O
random	JJ	O
hexamer	NN	O
technique	NN	O
using	VBG	O
reverse	JJ	O
transcriptase	NN	O
(	(	O
Superscript™	NNP	O
II	NNP	O
,	,	O
Life	NNP	O
Technologies	NNPS	O
)	)	O
and	CC	O
the	DT	O
cDNA	NN	O
was	VBD	O
amplified	VBN	O
by	IN	O
the	DT	O
first	JJ	O
PCR	NNP	O
using	VBG	O
the	DT	O
P1	NNP	O
primer	NN	O
and	CC	O
anchor	NN	O
primer	NN	O
according	VBG	O
to	TO	O
Watanabe	NNP	O
et	FW	O
al	NN	O
.	.	O
[	NN	O
Watanabe	NNP	B
,	,	I
T.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
Genet.	NNP	I
,	,	I
in	IN	I
press	NN	I
)	)	O
.	.	O
Thus	RB	O
,	,	O
to	TO	O
0.1	CD	O
μg	NN	O
of	IN	O
the	DT	O
above-mentioned	JJ	O
cDNA	NN	O
were	VBD	O
added	VBN	O
2.5	CD	O
mM	JJ	O
dNTP/1×Taq	NN	O
buffer	NN	O
(	(	O
Takara	NNP	O
Shuzo	NNP	O
)	)	O
/0.2	VBP	O
μM	JJ	O
P1	NNP	O
primer	NN	O
,	,	O
0.2	CD	O
μM	NN	O
adaptor	NN	O
primer/0.25	NN	O
unit	NN	O
ExTaq	NNP	O
enzyme	NN	O
(	(	O
Takara	NNP	O
Shuzo	NNP	O
)	)	O
to	TO	O
make	VB	O
a	DT	O
total	JJ	O
volume	NN	O
of	IN	O
50	CD	O
μl	NN	O
,	,	O
followed	VBN	O
by	IN	O
addition	NN	O
of	IN	O
the	DT	O
anchor	NN	O
primer	NN	O
.	.	O
The	DT	O
mixture	NN	O
was	VBD	O
subjected	VBN	O
to	TO	O
PCR	NNP	O
.	.	O
Thus	RB	O
,	,	O
35	CD	O
cycles	NNS	O
of	IN	O
amplification	NN	O
were	VBD	O
performed	VBN	O
under	IN	O
the	DT	O
conditions	NNS	O
:	:	O
94°	CD	O
C.	NNP	O
for	IN	O
45	CD	O
seconds	NNS	O
,	,	O
60°	CD	O
C.	NNP	O
for	IN	O
45	CD	O
seconds	NNS	O
,	,	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
2	CD	O
minutes	NNS	O
.	.	O
Finally	RB	O
,	,	O
the	DT	O
mixture	NN	O
was	VBD	O
heated	VBN	O
at	IN	O
72°	CD	O
C.	NNP	O
for	IN	O
5	CD	O
minutes	NNS	O
.	.	O
Then	RB	O
,	,	O
1	CD	O
μl	NN	O
of	IN	O
the	DT	O
50-μl	JJ	O
first	JJ	O
PCR	NNP	O
product	NN	O
was	VBD	O
subjected	VBN	O
to	TO	O
amplification	NN	O
by	IN	O
the	DT	O
second	JJ	O
PCR	NNP	O
using	VBG	O
the	DT	O
specific	NN	O
nested	VBD	O
P2	NNP	O
primer	NN	O
and	CC	O
anchor	NN	O
primer	NN	O
.	.	O
The	DT	O
second	JJ	O
PCR	NNP	O
product	NN	O
was	VBD	O
analyzed	VBN	O
by	IN	O
1.5	CD	O
%	NN	O
agarose	JJ	O
gel	JJ	O
electrophoresis	NN	O
.	.	O
Upon	IN	O
agarose	JJ	O
gel	JJ	O
electrophoresis	NN	O
,	,	O
a	DT	O
single	JJ	O
band	NN	O
,	,	O
about	RB	O
650	CD	O
nucleotides	NNS	O
in	IN	O
size	NN	O
,	,	O
was	VBD	O
detected	VBN	O
.	.	O
The	DT	O
product	NN	O
from	IN	O
this	DT	O
band	NN	O
was	VBD	O
inserted	VBN	O
into	IN	O
a	DT	O
vector	NN	O
(	(	O
pT7Blue	NN	O
(	(	O
R	NNP	O
)	)	O
T-Vector	NNP	O
,	,	O
Novagen	NNP	O
)	)	O
and	CC	O
a	DT	O
plurality	NN	O
of	IN	O
clones	NNS	O
with	IN	O
an	DT	O
insert	NN	O
having	VBG	O
an	DT	O
appropriate	JJ	O
size	NN	O
were	VBD	O
selected	VBN	O
.	.	O
Six	CD	O
of	IN	O
the	DT	O
5′	CD	O
RACE	NNP	O
clones	NNS	O
obtained	VBN	O
from	IN	O
the	DT	O
PCR	NNP	O
product	NN	O
had	VBD	O
the	DT	O
same	JJ	O
sequence	NN	O
but	CC	O
had	VBD	O
different	JJ	O
lengths	NNS	O
.	.	O
By	IN	O
sequencing	VBG	O
two	CD	O
overlapping	VBG	O
cDNA	NN	O
clones	NNS	O
,	,	O
GEN-080G01	NNP	O
and	CC	O
GEN-080G0149	NNP	O
,	,	O
the	DT	O
protein-encoding	JJ	O
sequence	NN	O
and	CC	O
5′	CD	O
and	CC	O
3′	CD	O
flanking	NN	O
sequences	NNS	O
,	,	O
1015	CD	O
nucleotides	NNS	O
in	IN	O
total	JJ	O
length	NN	O
,	,	O
were	VBD	O
determined	VBN	O
.	.	O
Said	NNP	O
gene	NN	O
was	VBD	O
named	VBN	O
cytoskeleton-associated	JJ	O
protein	NN	O
2	CD	O
gene	NN	O
(	(	O
CKAP2	NNP	O
gene	NN	O
)	)	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequence	NN	O
obtained	VBN	O
from	IN	O
the	DT	O
above-mentioned	JJ	O
two	CD	O
overlapping	VBG	O
cDNA	NN	O
clones	NNS	O
GEN-080G01	NNP	O
and	CC	O
GEN-080G0149	NNP	O
is	VBZ	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:6	NNP	O
,	,	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
said	VBD	O
clone	NN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:5	NNP	O
,	,	O
and	CC	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
encoded	VBN	O
by	IN	O
said	VBD	O
nucleotide	JJ	O
sequence	NN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:4	NNP	O
.	.	O
As	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:6	NNP	O
,	,	O
the	DT	O
CKAP2	NNP	O
gene	NN	O
had	VBD	O
a	DT	O
relatively	RB	O
GC-rich	JJ	O
5′	CD	O
noncoding	JJ	O
region	NN	O
,	,	O
with	IN	O
incomplete	JJ	O
triplet	NN	O
repeats	NNS	O
,	,	O
(	(	O
CAG	NNP	O
)	)	O
4	CD	O
(	(	O
CGG	NNP	O
)	)	O
4	CD	O
(	(	O
CTG	NNP	O
)	)	O
(	(	O
CGG	NNP	O
)	)	O
,	,	O
occurring	VBG	O
at	IN	O
nucleotides	JJ	O
40-69	JJ	O
.	.	O
ATG	NNP	O
located	VBN	O
at	IN	O
nucleotides	JJ	O
274-276	JJ	O
is	VBZ	O
the	DT	O
presumable	JJ	O
start	NN	O
codon	NN	O
.	.	O
A	DT	O
stop	JJ	O
codon	NN	O
(	(	O
TGA	NNP	O
)	)	O
was	VBD	O
situated	VBN	O
at	IN	O
nucleotides	JJ	O
853-855	JJ	O
.	.	O
A	DT	O
polyadenylation	NN	O
signal	NN	O
(	(	O
ATTAAA	NNP	O
)	)	O
was	VBD	O
followed	VBN	O
by	IN	O
16	CD	O
nucleotides	NNS	O
before	IN	O
the	DT	O
poly	NN	O
(	(	O
A	DT	O
)	)	O
start	NN	O
.	.	O
The	DT	O
estimated	VBN	O
open	JJ	O
reading	NN	O
frame	NN	O
comprises	VBZ	O
579	CD	O
nucleotides	NNS	O
coding	VBG	O
for	IN	O
193	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
with	IN	O
a	DT	O
calculated	JJ	O
molecular	JJ	O
weight	NN	O
of	IN	O
21,800	CD	O
daltons	NNS	O
.	.	O
The	DT	O
coding	VBG	O
region	NN	O
was	VBD	O
further	RB	O
amplified	VBN	O
by	IN	O
RT-PCR	NNP	O
,	,	O
to	TO	O
eliminate	VB	O
the	DT	O
possibility	NN	O
of	IN	O
the	DT	O
synthetic	JJ	O
sequence	NN	O
obtained	VBD	O
being	VBG	O
a	DT	O
cDNA	NN	O
chimera	NN	O
.	.	O
(	(	O
2	CD	O
)	)	O
Similarity	NN	O
of	IN	O
CKAP2	NNP	O
to	TO	O
Other	JJ	O
CAPs	NNP	O
While	IN	O
sequencing	VBG	O
of	IN	O
CKAP2	NNP	O
revealed	VBD	O
homology	NN	O
with	IN	O
the	DT	O
sequences	NNS	O
of	IN	O
restin	NN	O
and	CC	O
CLIP-170	NNP	O
,	,	O
the	DT	O
homologous	JJ	O
region	NN	O
was	VBD	O
limited	VBN	O
to	TO	O
a	DT	O
short	JJ	O
sequence	NN	O
corresponding	VBG	O
to	TO	O
the	DT	O
CAP-GLY	NNP	O
domain	NN	O
.	.	O
On	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
level	NN	O
,	,	O
the	DT	O
deduced	JJ	O
CKAP2	NNP	O
was	VBD	O
highly	RB	O
homologous	JJ	O
to	TO	O
five	CD	O
other	JJ	O
CAPs	NNPS	O
in	IN	O
this	DT	O
domain	NN	O
.	.	O
CKAP2	NNP	O
was	VBD	O
lacking	VBG	O
in	IN	O
such	JJ	O
other	JJ	O
motif	NN	O
characteristics	NNS	O
of	IN	O
some	DT	O
CAPs	NNP	O
as	IN	O
the	DT	O
alpha	JJ	O
helical	JJ	O
rod	NN	O
and	CC	O
zinc	NN	O
finger	NN	O
motif	NN	O
.	.	O
The	DT	O
alpha	JJ	O
helical	JJ	O
rod	NN	O
is	VBZ	O
thought	VBN	O
to	TO	O
contribute	VB	O
to	TO	O
dimerization	NN	O
and	CC	O
to	TO	O
increase	VB	O
the	DT	O
microtubule	NN	O
binding	VBG	O
capacity	NN	O
[	NNP	O
Pierre	NNP	B
,	,	I
P.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
70	CD	I
,	,	I
887-900	CD	I
(	(	I
1992	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
lack	NN	O
of	IN	O
the	DT	O
alpha	JJ	O
helical	JJ	O
domain	NN	O
might	MD	O
mean	VB	O
that	IN	O
CKAP2	NNP	O
be	VB	O
incapable	JJ	O
of	IN	O
homo	NN	O
or	CC	O
hetero	NN	O
dimer	NN	O
formation	NN	O
.	.	O
Paralleling	VBG	O
of	IN	O
the	DT	O
CAP-GLY	NNP	O
domains	NNS	O
of	IN	O
these	DT	O
proteins	NNS	O
revealed	VBD	O
that	IN	O
other	JJ	O
conserved	VBD	O
residues	NNS	O
other	JJ	O
than	IN	O
glycine	JJ	O
residues	NNS	O
are	VBP	O
also	RB	O
found	VBN	O
in	IN	O
CKAP2	NNP	O
.	.	O
CAPs	NNP	O
having	VBG	O
a	DT	O
CAP-GLY	JJ	O
domain	NN	O
are	VBP	O
thought	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
the	DT	O
activities	NNS	O
of	IN	O
cellular	JJ	O
organelles	NNS	O
and	CC	O
the	DT	O
interactions	NNS	O
thereof	VBP	O
with	IN	O
microtubules	NNS	O
.	.	O
Since	IN	O
it	PRP	O
contains	VBZ	O
a	DT	O
CAP-GLY	JJ	O
domain	NN	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
CKAP2	NNP	O
is	VBZ	O
placed	VBN	O
in	IN	O
the	DT	O
family	NN	O
of	IN	O
CAPs	NNP	O
.	.	O
Studies	NNS	O
with	IN	O
mutants	NNS	O
of	IN	O
Glued	NNP	O
have	VBP	O
revealed	VBN	O
that	IN	O
the	DT	O
Glued	NNP	O
product	NN	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
almost	RB	O
all	DT	O
cells	NNS	O
[	NNP	O
Swaroop	NNP	B
,	,	I
A.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
84	CD	I
,	,	I
6501-6505	CD	I
(	(	I
1987	CD	I
)	)	I
]	NN	O
and	CC	O
that	IN	O
it	PRP	O
has	VBZ	O
other	JJ	O
neuron-specific	JJ	O
functions	NNS	O
in	IN	O
neuronal	JJ	O
cells	NNS	O
[	JJ	O
Meyerowitz	NNP	B
,	,	I
E.	NNP	I
M.	NNP	I
and	CC	I
Kankel	NNP	I
,	,	I
D.	NNP	I
R.	NNP	I
,	,	I
Dev	NNP	I
.	.	I
Biol.	NNP	I
,	,	I
62	CD	I
,	,	I
112-142	CD	I
(	(	I
1978	CD	I
)	)	I
]	NN	O
.	.	O
These	DT	O
microtubule-associated	JJ	O
proteins	NNS	O
are	VBP	O
thought	VBN	O
to	TO	O
function	VB	O
in	IN	O
vesicle	NN	O
transport	NN	O
and	CC	O
mitosis	NN	O
.	.	O
Because	IN	O
of	IN	O
the	DT	O
importance	NN	O
of	IN	O
the	DT	O
vesicle	NN	O
transport	NN	O
system	NN	O
in	IN	O
neuronal	JJ	O
cells	NNS	O
,	,	O
defects	NNS	O
in	IN	O
these	DT	O
components	NNS	O
might	MD	O
lead	VB	O
to	TO	O
aberrant	JJ	O
neuronal	JJ	O
systems	NNS	O
.	.	O
In	IN	O
view	NN	O
of	IN	O
the	DT	O
above	NN	O
,	,	O
CKAP2	NNP	O
might	MD	O
be	VB	O
involved	VBN	O
in	IN	O
specific	JJ	O
neuronal	JJ	O
functions	NNS	O
as	RB	O
well	RB	O
as	IN	O
in	IN	O
fundamental	JJ	O
cellular	JJ	O
functions	NNS	O
.	.	O
(	(	O
3	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
The	DT	O
expression	NN	O
of	IN	O
human	JJ	O
CKAP2	NNP	O
mRNA	NN	O
in	IN	O
normal	JJ	O
human	JJ	O
tissues	NNS	O
was	VBD	O
examined	VBN	O
by	IN	O
Northern	NNP	O
blotting	VBG	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
2	CD	O
)	)	O
using	VBG	O
the	DT	O
GEN-080G01	NNP	O
clone	NN	O
(	(	O
corresponding	VBG	O
to	TO	O
nucleotides	VB	O
553-1015	JJ	O
)	)	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
in	IN	O
all	PDT	O
the	DT	O
eight	CD	O
tissues	NNS	O
tested	VBN	O
,	,	O
namely	RB	O
human	JJ	O
heart	NN	O
,	,	O
brain	NN	O
,	,	O
placenta	NN	O
,	,	O
lung	NN	O
,	,	O
liver	NN	O
,	,	O
skeletal	JJ	O
muscle	NN	O
,	,	O
kidney	NN	O
and	CC	O
pancreas	NNS	O
,	,	O
a	DT	O
1.0	CD	O
kb	NN	O
transcript	NN	O
agreeing	VBG	O
in	IN	O
size	NN	O
with	IN	O
the	DT	O
CKAP2	NNP	O
cDNA	NN	O
was	VBD	O
detected	VBN	O
.	.	O
Said	VBD	O
1.0	CD	O
kb	NN	O
transcript	NN	O
was	VBD	O
expressed	VBN	O
at	IN	O
significantly	RB	O
higher	JJR	O
levels	NNS	O
in	IN	O
heart	NN	O
and	CC	O
brain	NN	O
than	IN	O
in	IN	O
the	DT	O
other	JJ	O
tissues	NNS	O
examined	VBN	O
.	.	O
Two	CD	O
weak	JJ	O
bands	NNS	O
,	,	O
3.4	CD	O
kb	NN	O
and	CC	O
4.6	CD	O
kb	NNS	O
,	,	O
were	VBD	O
also	RB	O
detected	VBN	O
in	IN	O
all	PDT	O
the	DT	O
tissues	NNS	O
examined	VBN	O
.	.	O
According	VBG	O
to	TO	O
the	DT	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
,	,	O
the	DT	O
3.4	CD	O
kb	NN	O
and	CC	O
4.6	CD	O
kb	NNS	O
transcripts	NNS	O
might	MD	O
possibly	RB	O
be	VB	O
derived	VBN	O
from	IN	O
the	DT	O
same	JJ	O
gene	NN	O
coding	VBG	O
for	IN	O
the	DT	O
1.0	CD	O
kb	NNS	O
CKAP2	NNP	O
by	IN	O
alternative	JJ	O
splicing	NN	O
or	CC	O
transcribed	VBN	O
from	IN	O
other	JJ	O
related	VBN	O
genes	NNS	O
.	.	O
These	DT	O
characteristics	NNS	O
of	IN	O
the	DT	O
transcripts	NNS	O
may	MD	O
indicate	VB	O
that	DT	O
CKAP2	NNP	O
might	MD	O
also	RB	O
code	VB	O
for	IN	O
a	DT	O
protein	NN	O
having	VBG	O
a	DT	O
CAP-GLY	JJ	O
domain	NN	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
alpha	JJ	O
helix	NN	O
.	.	O
(	(	O
4	CD	O
)	)	O
Cosmid	NNP	O
Cloning	NNP	O
and	CC	O
Chromosomal	NNP	O
Localization	NNP	O
by	IN	O
Direct	NNP	O
R-Banding	NNP	O
FISH	NNP	O
Two	CD	O
cosmids	NNS	O
corresponding	VBG	O
to	TO	O
the	DT	O
CKAP2	NNP	O
cDNA	NN	O
were	VBD	O
obtained	VBN	O
.	.	O
These	DT	O
two	CD	O
cosmid	NN	O
clones	NNS	O
were	VBD	O
subjected	VBN	O
to	TO	O
direct	VB	O
R-banding	NNP	O
FISH	NNP	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
3	CD	O
)	)	O
for	IN	O
chromosomal	JJ	O
locus	NN	O
mapping	NN	O
of	IN	O
CKAP2	NNP	O
.	.	O
For	IN	O
suppressing	VBG	O
the	DT	O
background	NN	O
due	JJ	O
to	TO	O
repetitive	JJ	O
sequences	NNS	O
,	,	O
a	DT	O
20-fold	JJ	O
excessive	JJ	O
amount	NN	O
of	IN	O
human	JJ	O
Cot-I	NNP	O
DNA	NNP	O
(	(	O
BRL	NNP	O
)	)	O
was	VBD	O
added	VBN	O
as	IN	O
described	VBN	O
by	IN	O
Lichter	NNP	O
et	CC	O
al	NN	O
.	.	O
[	JJ	O
Lichter	NNP	B
,	,	I
P.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
87	CD	I
,	,	I
6634-6638	CD	I
(	(	I
1990	CD	I
)	)	I
]	NN	O
.	.	O
A	DT	O
Provia	NNP	O
100	CD	O
film	NN	O
(	(	O
Fuji	NNP	O
ISO	NNP	O
100	CD	O
;	:	O
Fuji	NNP	O
Photo	NNP	O
Film	NNP	O
)	)	O
was	VBD	O
used	VBN	O
for	IN	O
photomicrography	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
CKAP2	NNP	O
was	VBD	O
mapped	VBN	O
on	IN	O
chromosome	NN	O
bands	NNS	O
19q13.11-q13.12	JJ	O
.	.	O
Two	CD	O
autosomal	JJ	O
dominant	JJ	O
neurological	JJ	O
diseases	NNS	O
have	VBP	O
been	VBN	O
localized	VBN	O
to	TO	O
this	DT	O
region	NN	O
by	IN	O
linkage	NN	O
analysis	NN	O
:	:	O
CADASIL	NNP	O
(	(	O
cerebral	JJ	O
autosomal	NN	O
dominant	JJ	O
arteriopathy	JJ	O
with	IN	O
subcortical	JJ	O
infarcts	NNS	O
and	CC	O
leukoencephalopathy	NN	O
)	)	O
between	IN	O
the	DT	O
DNA	NNP	O
markers	NNS	O
D195221	NNP	O
and	CC	O
D195222	NNP	O
,	,	O
and	CC	O
FHM	NNP	O
(	(	O
familial	JJ	O
hemiplegic	NN	O
migraine	NN	O
)	)	O
between	IN	O
D195215	NNP	O
and	CC	O
D195216	NNP	O
.	.	O
These	DT	O
two	CD	O
diseases	NNS	O
may	MD	O
be	VB	O
allelic	JJ	O
disorders	NNS	O
in	IN	O
which	WDT	O
the	DT	O
same	JJ	O
gene	NN	O
is	VBZ	O
involved	VBN	O
[	JJ	O
Tournier-Lasserve	NNP	B
,	,	I
E.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
Genet.	NNP	I
,	,	I
3	CD	I
,	,	I
256-259	CD	I
(	(	I
1993	CD	I
)	)	I
;	:	O
Joutel	NNP	B
,	,	I
A.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
Genet.	NNP	I
,	,	I
5	CD	I
,	,	I
40-45	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
.	.	O
Although	IN	O
no	DT	O
evidence	NN	O
is	VBZ	O
available	JJ	O
to	TO	O
support	VB	O
CKAP2	NNP	O
as	IN	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
FHM	NNP	O
or	CC	O
CADASIL	NNP	O
,	,	O
it	PRP	O
is	VBZ	O
conceivable	JJ	O
that	IN	O
its	PRP$	O
mutation	NN	O
might	MD	O
lead	VB	O
to	TO	O
some	DT	O
or	CC	O
other	JJ	O
neurological	JJ	O
disease	NN	O
.	.	O
By	IN	O
using	VBG	O
the	DT	O
novel	JJ	O
human	JJ	O
CKAP2	NNP	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
as	IN	O
obtained	VBN	O
in	IN	O
this	DT	O
example	NN	O
,	,	O
it	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
detect	VB	O
the	DT	O
expression	NN	O
of	IN	O
said	VBD	O
gene	NN	O
in	IN	O
various	JJ	O
tissues	NNS	O
or	CC	O
produce	VB	O
the	DT	O
human	JJ	O
CKAP2	NNP	O
gene	NN	O
in	IN	O
the	DT	O
manner	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
.	.	O
Through	IN	O
these	DT	O
,	,	O
it	PRP	O
becomes	VBZ	O
possible	JJ	O
to	TO	O
analyze	VB	O
the	DT	O
functions	NNS	O
of	IN	O
the	DT	O
human	JJ	O
CKAP2	NNP	O
system	NN	O
or	CC	O
human	JJ	O
CKAP2	NNP	O
,	,	O
which	WDT	O
is	VBZ	O
involved	VBN	O
in	IN	O
diverse	JJ	O
activities	NNS	O
essential	JJ	O
to	TO	O
cells	NNS	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
to	TO	O
diagnose	VB	O
various	JJ	O
neurological	JJ	O
diseases	NNS	O
in	IN	O
which	WDT	O
said	VBD	O
system	NN	O
or	CC	O
gene	NN	O
is	VBZ	O
involved	VBN	O
,	,	O
for	IN	O
example	NN	O
familial	JJ	O
migraine	NN	O
,	,	O
and	CC	O
to	TO	O
screen	VB	O
out	RP	O
and	CC	O
evaluate	VB	O
a	DT	O
therapeutic	JJ	O
or	CC	O
prophylactic	JJ	O
drug	NN	O
therefor	NN	O
.	.	O
Example	RB	O
3	CD	O
OTK27	NNP	O
Gene	NNP	O
(	(	O
1	CD	O
)	)	O
OTK27	NNP	O
Gene	NNP	O
Cloning	NNP	O
and	CC	O
DNA	NNP	O
Sequencing	NNP	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
sequence	NN	O
analysis	NN	O
of	IN	O
cDNA	NN	O
clones	NNS	O
arbitraily	RB	O
selected	VBN	O
from	IN	O
a	DT	O
human	JJ	O
fetal	NN	O
brain	NN	O
cDNA	NN	O
library	NN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
and	CC	O
database	NN	O
searching	NN	O
,	,	O
a	DT	O
cDNA	NN	O
clone	NN	O
,	,	O
GEN-025F07	NNP	O
,	,	O
coding	VBG	O
for	IN	O
a	DT	O
protein	NN	O
highly	RB	O
homologous	JJ	O
to	TO	O
NHP2	NNP	O
,	,	O
a	DT	O
yeast	NN	O
nucleoprotein	NN	O
[	NNP	O
Saccharomyces	NNP	B
cerevisiae	NN	I
;	:	I
Kolodrubetz	NNP	I
,	,	I
D.	NNP	I
and	CC	I
Burgum	NNP	I
,	,	I
A.	NNP	I
,	,	I
YEAST	NNP	I
,	,	I
7	CD	I
,	,	I
79-90	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
,	,	O
was	VBD	O
found	VBN	O
and	CC	O
named	VBN	O
OTK27	NNP	O
.	.	O
Nucleoproteins	NNS	O
are	VBP	O
fundamental	JJ	O
cellular	JJ	O
constituents	NNS	O
of	IN	O
chromosomes	NNS	O
,	,	O
ribosomes	NNS	O
and	CC	O
so	RB	O
forth	JJ	O
and	CC	O
are	VBP	O
thought	VBN	O
to	TO	O
play	VB	O
an	DT	O
essential	JJ	O
role	NN	O
in	IN	O
cell	NN	O
multiplication	NN	O
and	CC	O
viability	NN	O
.	.	O
The	DT	O
yeast	NN	O
nucleoprotein	NN	O
NHP2	NNP	O
,	,	O
a	DT	O
high-mobility	NN	O
group	NN	O
(	(	O
HMG	NNP	O
)	)	O
-like	IN	O
protein	NN	O
,	,	O
like	IN	O
HMG	NNP	O
,	,	O
has	VBZ	O
reportedly	RB	O
a	DT	O
function	NN	O
essential	NN	O
for	IN	O
cell	NN	O
viability	NN	O
[	NNP	O
Kolodrubetz	NNP	B
,	,	I
D.	NNP	I
and	CC	I
Burgum	NNP	I
,	,	I
A.	NNP	I
,	,	I
YEAST	NNP	I
,	,	I
7	CD	I
,	,	I
79-90	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
,	,	O
OTK27	NNP	O
gene	NN	O
,	,	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
which	WDT	O
is	VBZ	O
highly	RB	O
homologous	JJ	O
to	TO	O
the	DT	O
above-mentioned	JJ	O
yeast	NN	O
NHP2	NNP	O
gene	NN	O
,	,	O
is	VBZ	O
supposed	VBN	O
to	TO	O
be	VB	O
similar	JJ	O
in	IN	O
function	NN	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
said	VBD	O
GEN-025F07	NNP	O
clone	NN	O
was	VBD	O
found	VBN	O
to	TO	O
comprise	VB	O
1493	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:9	NNP	O
,	,	O
and	CC	O
contain	VBP	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
comprising	VBG	O
384	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:8	NNP	O
,	,	O
coding	VBG	O
for	IN	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
comprising	VBG	O
128	CD	O
amino	JJ	O
acid	NN	O
residues	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:7	NNP	O
.	.	O
The	DT	O
initiation	NN	O
codon	NN	O
was	VBD	O
located	VBN	O
at	IN	O
nucleotides	JJ	O
95-97	CD	O
of	IN	O
the	DT	O
sequence	NN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:9	NNP	O
,	,	O
and	CC	O
the	DT	O
termination	NN	O
codon	NN	O
at	IN	O
nucleotides	JJ	O
479-481	JJ	O
.	.	O
At	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
level	NN	O
,	,	O
the	DT	O
OTK27	NNP	O
protein	NN	O
was	VBD	O
highly	RB	O
homologous	JJ	O
(	(	O
38	CD	O
%	NN	O
)	)	O
to	TO	O
NHP2	NNP	O
.	.	O
It	PRP	O
was	VBD	O
83	CD	O
%	NN	O
identical	JJ	O
with	IN	O
the	DT	O
protein	NN	O
deduced	VBD	O
from	IN	O
the	DT	O
cDNA	NN	O
from	IN	O
Arabidopsis	NNP	O
thaliana	NN	O
;	:	O
Newman	NNP	B
,	,	I
T.	NNP	I
,	,	I
unpublished	VBD	I
;	:	O
GENEMBL	NNP	O
Accession	NNP	O
No	NNP	O
.	.	O
T14197	NNP	O
)	)	O
.	.	O
(	(	O
2	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
For	IN	O
examining	VBG	O
the	DT	O
expression	NN	O
of	IN	O
human	JJ	O
OTK27	NNP	O
mRNA	NN	O
in	IN	O
normal	JJ	O
human	JJ	O
tissues	NNS	O
,	,	O
the	DT	O
insert	NN	O
in	IN	O
the	DT	O
OTK27	NNP	O
cDNA	NN	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
,	,	O
the	DT	O
PCR	NNP	O
product	NN	O
was	VBD	O
purified	VBN	O
and	CC	O
labeled	VBN	O
with	IN	O
[	JJ	O
32P	CD	O
]	JJ	O
-dCTP	NNP	O
(	(	O
random-primed	JJ	O
DNA	NNP	O
labeling	VBG	O
kit	NN	O
,	,	O
Boehringer	NNP	O
Mannheim	NNP	O
)	)	O
,	,	O
and	CC	O
Northern	NNP	O
blotting	NN	O
was	VBD	O
performed	VBN	O
using	VBG	O
the	DT	O
labeled	JJ	O
product	NN	O
as	IN	O
a	DT	O
probe	NN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
2	CD	O
)	)	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
the	DT	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
,	,	O
two	CD	O
bands	NNS	O
corresponding	VBG	O
to	TO	O
possible	JJ	O
transcripts	NNS	O
from	IN	O
this	DT	O
gene	NN	O
were	VBD	O
detected	VBN	O
at	IN	O
approximately	RB	O
1.6	CD	O
kb	NNS	O
and	CC	O
0.7	CD	O
kb	NN	O
.	.	O
Both	DT	O
sizes	NNS	O
of	IN	O
transcript	NN	O
were	VBD	O
expressed	VBN	O
in	IN	O
all	DT	O
normal	JJ	O
adult	NN	O
tissues	NNS	O
examined	VBN	O
.	.	O
However	RB	O
,	,	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
0.7	CD	O
kb	NN	O
transcript	NN	O
was	VBD	O
significantly	RB	O
reduced	VBN	O
in	IN	O
brain	NN	O
and	CC	O
was	VBD	O
of	IN	O
higher	JJR	O
levels	NNS	O
in	IN	O
heart	NN	O
,	,	O
skeletal	JJ	O
muscle	NN	O
and	CC	O
testicle	NN	O
than	IN	O
in	IN	O
other	JJ	O
tissues	NNS	O
examined	VBN	O
.	.	O
For	IN	O
further	JJ	O
examination	NN	O
of	IN	O
these	DT	O
two	CD	O
transcripts	NNS	O
,	,	O
eleven	RB	O
cDNA	JJ	O
clones	NNS	O
were	VBD	O
isolated	VBN	O
from	IN	O
a	DT	O
testis	NN	O
cDNA	NN	O
library	NN	O
and	CC	O
their	PRP$	O
DNA	NN	O
sequences	NNS	O
were	VBD	O
determined	VBN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
in	IN	O
six	CD	O
clones	NNS	O
,	,	O
the	DT	O
sequences	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
in	IN	O
agreement	NN	O
with	IN	O
that	DT	O
of	IN	O
the	DT	O
0.7	CD	O
kb	NN	O
transcript	NN	O
,	,	O
with	IN	O
a	DT	O
poly	NN	O
(	(	O
A	DT	O
)	)	O
sequence	NN	O
starting	VBG	O
at	IN	O
around	IN	O
the	DT	O
600th	JJ	O
nucleotide	NN	O
,	,	O
namely	RB	O
at	IN	O
the	DT	O
598th	CD	O
nucleotide	RB	O
in	IN	O
two	CD	O
of	IN	O
the	DT	O
six	CD	O
clones	NNS	O
,	,	O
at	IN	O
the	DT	O
606th	CD	O
nucleotide	NN	O
in	IN	O
three	CD	O
clones	NNS	O
,	,	O
and	CC	O
at	IN	O
the	DT	O
613th	CD	O
nucleotide	NN	O
in	IN	O
one	CD	O
clone	NN	O
.	.	O
In	IN	O
these	DT	O
six	CD	O
clones	NNS	O
,	,	O
the	DT	O
“	NNP	O
TATAAA	NNP	O
”	NNP	O
sequence	NN	O
was	VBD	O
recognized	VBN	O
at	IN	O
nucleotides	NNS	O
583-588	JJ	O
as	IN	O
a	DT	O
probable	JJ	O
poly	NN	O
(	(	O
A	DT	O
)	)	O
signal	NN	O
.	.	O
The	DT	O
upstream	JJ	O
poly	NN	O
(	(	O
A	DT	O
)	)	O
signal	NN	O
“	NN	O
TATAAA	NNP	O
”	NN	O
of	IN	O
this	DT	O
gene	NN	O
was	VBD	O
recognized	VBN	O
as	IN	O
little	JJ	O
influencing	NN	O
in	IN	O
brain	NN	O
and	CC	O
more	RBR	O
effective	JJ	O
in	IN	O
the	DT	O
three	CD	O
tissues	NNS	O
mentioned	VBN	O
above	IN	O
than	IN	O
in	IN	O
other	JJ	O
tissues	NNS	O
.	.	O
The	DT	O
possibility	NN	O
was	VBD	O
considered	VBN	O
that	IN	O
the	DT	O
stability	NN	O
of	IN	O
each	DT	O
transcript	NN	O
vary	VBP	O
from	IN	O
tissue	NN	O
to	TO	O
tissue	NN	O
.	.	O
Results	NNS	O
of	IN	O
zoo	NN	O
blot	NN	O
analysis	NN	O
indicated	VBD	O
that	IN	O
this	DT	O
gene	NN	O
is	VBZ	O
well	RB	O
conserved	VBN	O
also	RB	O
in	IN	O
other	JJ	O
vertebrates	NNS	O
.	.	O
Since	IN	O
this	DT	O
gene	NN	O
is	VBZ	O
expressed	VBN	O
ubiquitously	RB	O
in	IN	O
normal	JJ	O
adult	NN	O
tissues	NNS	O
and	CC	O
conserved	VBN	O
among	IN	O
a	DT	O
wide	JJ	O
range	NN	O
of	IN	O
species	NNS	O
,	,	O
the	DT	O
gene	NN	O
product	NN	O
is	VBZ	O
likely	JJ	O
to	TO	O
play	VB	O
an	DT	O
important	JJ	O
physiological	JJ	O
role	NN	O
.	.	O
The	DT	O
evidence	NN	O
that	IN	O
yeasts	VBZ	O
lacking	VBG	O
in	IN	O
NHP2	NNP	O
are	VBP	O
nonviable	JJ	O
suggests	NNS	O
that	IN	O
the	DT	O
human	JJ	O
homolog	NN	O
may	MD	O
also	RB	O
be	VB	O
essential	JJ	O
to	TO	O
cell	VB	O
viability	NN	O
.	.	O
(	(	O
3	CD	O
)	)	O
Chromosomal	NNP	O
Localization	NNP	O
of	IN	O
OTK27	NNP	O
by	IN	O
Direct	NNP	O
R-Banding	NNP	O
FISH	NNP	O
One	NNP	O
cosmid	NN	O
clone	NN	O
corresponding	VBG	O
to	TO	O
the	DT	O
cDNA	NN	O
OTK27	NNP	O
was	VBD	O
isolated	VBN	O
from	IN	O
a	DT	O
total	JJ	O
human	JJ	O
genomic	NN	O
cosmid	NN	O
library	JJ	O
(	(	O
5-genome	JJ	O
equivalent	NN	O
)	)	O
using	VBG	O
the	DT	O
OTK27	NNP	O
cDNA	NN	O
insert	NN	O
as	IN	O
a	DT	O
probe	NN	O
and	CC	O
subjected	VBN	O
to	TO	O
FISH	NNP	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
3	CD	O
)	)	O
for	IN	O
chromosomal	JJ	O
localization	NN	O
of	IN	O
OTK27	NNP	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
two	CD	O
distinct	JJ	O
spots	NNS	O
were	VBD	O
observed	VBN	O
on	IN	O
the	DT	O
chromosome	NN	O
band	NN	O
12q24.3	CD	O
.	.	O
The	DT	O
OTK27	NNP	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
causing	VBG	O
expression	NN	O
thereof	NN	O
and	CC	O
detecting	VBG	O
the	DT	O
OTK27	NNP	O
protein	NN	O
,	,	O
a	DT	O
human	JJ	O
nucleoprotein	NN	O
,	,	O
and	CC	O
thus	RB	O
can	MD	O
be	VB	O
utilized	VBN	O
in	IN	O
the	DT	O
diagnosis	NN	O
and	CC	O
pathologic	JJ	O
studies	NNS	O
of	IN	O
various	JJ	O
diseases	NNS	O
in	IN	O
which	WDT	O
said	VBD	O
protein	NN	O
is	VBZ	O
involved	VBN	O
and	CC	O
,	,	O
because	IN	O
of	IN	O
its	PRP$	O
involvement	NN	O
in	IN	O
cell	NN	O
proliferation	NN	O
and	CC	O
differentiation	NN	O
,	,	O
in	IN	O
screening	VBG	O
out	RP	O
and	CC	O
evaluating	VBG	O
therapeutic	JJ	O
and	CC	O
preventive	JJ	O
drugs	NNS	O
for	IN	O
cancer	NN	O
.	.	O
Example	RB	O
4	CD	O
OTK18	NNP	O
Gene	NNP	O
(	(	O
1	CD	O
)	)	O
OTK18	NNP	O
Gene	NNP	O
Cloning	NNP	O
and	CC	O
DNA	NNP	O
Sequencing	NNP	O
Zinc	NNP	O
finger	NN	O
proteins	NNS	O
are	VBP	O
defined	VBN	O
as	IN	O
constituing	VBG	O
a	DT	O
large	JJ	O
family	NN	O
of	IN	O
transcription-regulating	JJ	O
proteins	NNS	O
in	IN	O
eukaryotes	NNS	O
and	CC	O
carry	VBP	O
evolutionally	RB	O
conserved	VBN	O
structural	JJ	O
motifs	NNS	O
[	VBP	O
Kadonaga	NNP	B
,	,	I
J.	NNP	I
T.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
51	CD	I
,	,	I
1079-1090	CD	I
(	(	I
1987	CD	I
)	)	I
;	:	O
Klung	NNP	B
,	,	I
A.	NNP	I
and	CC	I
Rhodes	NNP	I
,	,	I
D.	NNP	I
,	,	I
Trends	NNP	I
Biol	NNP	I
.	.	I
Sci.	NNP	I
,	,	I
12	CD	I
,	,	I
464-469	CD	I
(	(	I
1987	CD	I
)	)	I
;	:	O
Evans	NNP	B
,	,	I
R.	NNP	I
M.	NNP	I
and	CC	I
Hollenberg	NNP	I
,	,	I
S.	NNP	I
M.	NNP	I
,	,	I
Cell	NNP	I
,	,	I
52	CD	I
,	,	I
1-3	CD	I
(	(	I
1988	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
zinc	NN	O
finger	NN	O
,	,	O
a	DT	O
loop-like	JJ	O
motif	NN	O
formed	VBN	O
by	IN	O
the	DT	O
interaction	NN	O
between	IN	O
the	DT	O
zinc	NN	O
ion	NN	O
and	CC	O
two	CD	O
residues	NNS	O
,	,	O
cysteine	NN	O
and	CC	O
histidine	NN	O
residues	NNS	O
,	,	O
is	VBZ	O
involved	VBN	O
in	IN	O
the	DT	O
sequence-specific	JJ	O
binding	NN	O
of	IN	O
a	DT	O
protein	NN	O
to	TO	O
RNA	NNP	O
or	CC	O
DNA	NNP	O
.	.	O
The	DT	O
zinc	NN	O
finger	NN	O
motif	NN	O
was	VBD	O
first	RB	O
identified	VBN	O
within	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
Xenopus	NNP	O
transcription	NN	O
factor	NN	O
IIIA	NNP	O
[	NNP	O
Miller	NNP	B
,	,	I
J.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
EMBO	NNP	I
J.	NNP	I
,	,	I
4	CD	I
,	,	I
1609-1614	CD	I
(	(	I
1986	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
C2H2	NNP	O
finger	NN	O
motif	NN	O
is	VBZ	O
in	IN	O
general	JJ	O
tandemly	NN	O
repeated	VBN	O
and	CC	O
contains	VBZ	O
an	DT	O
evolutionally	RB	O
conserved	VBN	O
intervening	VBG	O
sequence	NN	O
of	IN	O
7	CD	O
or	CC	O
8	CD	O
amino	JJ	O
acids	NNS	O
.	.	O
This	DT	O
intervening	NN	O
stretch	NN	O
was	VBD	O
first	RB	O
identified	VBN	O
in	IN	O
the	DT	O
Kruppel	NNP	O
segmentation	NN	O
gene	NN	O
of	IN	O
Drosophila	NNP	O
[	NNP	O
Rosenberg	NNP	B
,	,	I
U	NNP	I
.	.	I
B.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
319	CD	I
,	,	I
336-339	CD	I
(	(	I
1986	CD	I
)	)	I
]	NN	O
.	.	O
Since	IN	O
then	RB	O
,	,	O
hundreds	NNS	O
of	IN	O
C2H2	NNP	O
zinc	NNP	O
finger	VBD	O
protein-encoding	JJ	O
genes	NNS	O
have	VBP	O
been	VBN	O
found	VBN	O
invertebrate	JJ	O
genomes	NNS	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
sequence	NN	O
analysis	NN	O
of	IN	O
cDNA	NN	O
clones	NNS	O
arbitrarily	RB	O
selected	VBN	O
from	IN	O
a	DT	O
human	JJ	O
fetal	NN	O
brain	NN	O
cDNA	NN	O
library	NN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
and	CC	O
database	NN	O
searching	NN	O
,	,	O
several	JJ	O
zinc	CD	O
finger	JJR	O
structure-containing	JJ	O
clones	NNS	O
were	VBD	O
identified	VBN	O
and	CC	O
,	,	O
further	RB	O
,	,	O
a	DT	O
clone	NN	O
having	VBG	O
a	DT	O
zinc	NN	O
finger	NN	O
structure	NN	O
of	IN	O
the	DT	O
Kruppel	NNP	O
type	NN	O
was	VBD	O
found	VBN	O
.	.	O
Since	IN	O
this	DT	O
clone	NN	O
lacked	VBD	O
the	DT	O
5′	CD	O
portion	NN	O
of	IN	O
the	DT	O
transcript	NN	O
,	,	O
plaque	JJ	O
hybridization	NN	O
was	VBD	O
performed	VBN	O
with	IN	O
a	DT	O
fetal	JJ	O
brain	NN	O
cDNA	NN	O
library	JJ	O
using	VBG	O
,	,	O
as	IN	O
a	DT	O
probe	NN	O
,	,	O
an	DT	O
approximately	RB	O
1.8	CD	O
kb	NNS	O
insert	NN	O
in	IN	O
the	DT	O
cDNA	NN	O
clone	NN	O
,	,	O
whereby	WRB	O
three	CD	O
clones	NNS	O
were	VBD	O
isolated	VBN	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequences	NNS	O
of	IN	O
these	DT	O
were	VBD	O
determined	VBN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
.	.	O
Among	IN	O
the	DT	O
three	CD	O
clones	NNS	O
,	,	O
the	DT	O
one	CD	O
having	VBG	O
the	DT	O
largest	JJS	O
insert	NN	O
spans	VBZ	O
3,754	CD	O
nucleotides	NNS	O
including	VBG	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
2,133	CD	O
nucleotides	NNS	O
coding	VBG	O
for	IN	O
711	CD	O
amino	JJ	O
acids	NNS	O
.	.	O
It	PRP	O
was	VBD	O
found	VBN	O
that	IN	O
said	VBD	O
clone	NN	O
contains	VBZ	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
coding	VBG	O
for	IN	O
a	DT	O
peptide	NN	O
highly	RB	O
homologous	JJ	O
in	IN	O
the	DT	O
zinc	NN	O
finger	NN	O
domain	NN	O
to	TO	O
those	DT	O
encoded	VBN	O
by	IN	O
human	JJ	O
ZNF41	NNP	O
and	CC	O
the	DT	O
Drosophila	NNP	O
Kruppel	NNP	O
gene	NN	O
.	.	O
This	DT	O
gene	NN	O
was	VBD	O
named	VBN	O
OTK18	NNP	O
gene	NN	O
(	(	O
derived	VBN	O
from	IN	O
the	DT	O
clone	NN	O
GEN-076C09	NNP	O
)	)	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
cDNA	NN	O
clone	NN	O
of	IN	O
the	DT	O
OTK18	NNP	O
gene	NN	O
is	VBZ	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:12	NNP	O
,	,	O
the	DT	O
coding	VBG	O
region-containing	JJ	O
nucleotide	JJ	O
sequence	NN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:11	NNP	O
,	,	O
and	CC	O
the	DT	O
predicted	VBN	O
amino	NN	O
acid	JJ	O
sequence	NN	O
encoded	VBN	O
by	IN	O
said	VBD	O
OTK18	NNP	O
gene	NN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:10	NNP	O
.	.	O
It	PRP	O
was	VBD	O
found	VBN	O
that	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
OTK18	NNP	O
as	IN	O
deduced	VBN	O
from	IN	O
SEQ	NNP	O
ID	NNP	O
NO:12	NNP	O
contains	VBZ	O
13	CD	O
finger	NN	O
motifs	NNS	O
on	IN	O
its	PRP$	O
carboxy	JJ	O
side	NN	O
.	.	O
(	(	O
2	CD	O
)	)	O
Comparison	NN	O
with	IN	O
Other	JJ	O
Zinc	NNP	O
Finger	NNP	O
Motif-Containing	NNP	O
Genes	NNP	O
Comparison	NNP	O
among	IN	O
OTK18	NNP	O
,	,	O
human	JJ	O
ZNF41	NNP	O
and	CC	O
the	DT	O
Drosophila	NNP	O
Kruppel	NNP	O
gene	NN	O
revealed	VBD	O
that	IN	O
each	DT	O
finger	NN	O
motif	NN	O
is	VBZ	O
for	IN	O
the	DT	O
most	JJS	O
part	NN	O
conserved	VBN	O
in	IN	O
the	DT	O
consensus	NN	O
sequence	NN	O
CXECGKAFXQKSXLX2HQRXH	NNP	O
.	.	O
Comparison	NNP	O
of	IN	O
the	DT	O
consensus	NN	O
sequence	NN	O
of	IN	O
the	DT	O
zinc	NN	O
finger	NN	O
motifs	NNS	O
of	IN	O
OTK18	NNP	O
with	IN	O
those	DT	O
of	IN	O
human	JJ	O
ZNF41	NNP	O
and	CC	O
the	DT	O
Drosophila	NNP	O
Kruppel	NNP	O
gene	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
Kruppel	NNP	O
type	NN	O
motif	NN	O
is	VBZ	O
well	RB	O
conserved	VBN	O
in	IN	O
the	DT	O
OTK18-encoded	JJ	O
protein	NN	O
.	.	O
However	RB	O
,	,	O
the	DT	O
sequence	NN	O
similarities	NNS	O
were	VBD	O
limited	VBN	O
to	TO	O
zinc	VB	O
finger	NN	O
domains	NNS	O
and	CC	O
no	DT	O
significant	JJ	O
homologies	NNS	O
were	VBD	O
found	VBN	O
with	IN	O
regard	NN	O
to	TO	O
other	JJ	O
regions	NNS	O
.	.	O
The	DT	O
zinc	NN	O
finger	NN	O
domain	NN	O
interacts	NNS	O
specifically	RB	O
with	IN	O
the	DT	O
target	NN	O
DNA	NNP	O
,	,	O
recognizing	VBG	O
an	DT	O
about	IN	O
5	CD	O
by	IN	O
sequence	NN	O
to	TO	O
thereby	VB	O
bind	VB	O
to	TO	O
the	DT	O
DNA	NNP	O
helix	NN	O
[	NNP	O
Rhodes	NNP	B
,	,	I
D.	NNP	I
and	CC	I
Klug	NNP	I
,	,	I
A.	NNP	I
,	,	I
Cell	NNP	I
,	,	I
46	CD	I
,	,	I
123-132	CD	I
(	(	I
1986	CD	I
)	)	I
]	NN	O
.	.	O
Based	VBN	O
on	IN	O
the	DT	O
idea	NN	O
that	IN	O
,	,	O
in	IN	O
view	NN	O
of	IN	O
the	DT	O
above	NN	O
,	,	O
the	DT	O
multiple	JJ	O
module	NN	O
(	(	O
tandem	JJ	O
repetitions	NNS	O
of	IN	O
zinc	NNP	O
finger	NN	O
)	)	O
can	MD	O
interact	VB	O
with	IN	O
long	JJ	O
stretches	NNS	O
of	IN	O
DNA	NNP	O
,	,	O
it	PRP	O
is	VBZ	O
presumable	JJ	O
that	IN	O
the	DT	O
target	NN	O
DNA	NN	O
of	IN	O
this	DT	O
gene	NN	O
product	NN	O
containing	VBG	O
13	CD	O
repeated	VBN	O
zinc	NN	O
finger	NN	O
units	NNS	O
would	MD	O
be	VB	O
a	DT	O
DNA	NNP	O
fragment	NN	O
with	IN	O
a	DT	O
length	NN	O
of	IN	O
approximately	RB	O
65	CD	O
bp	NN	O
.	.	O
(	(	O
3	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
was	VBD	O
performed	VBN	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
2	CD	O
)	)	O
for	IN	O
checking	VBG	O
normal	JJ	O
human	JJ	O
tissues	NNS	O
for	IN	O
expression	NN	O
of	IN	O
the	DT	O
human	JJ	O
OTK18	NNP	O
mRNA	NN	O
therein	NN	O
by	IN	O
amplifying	VBG	O
the	DT	O
insert	NN	O
of	IN	O
the	DT	O
OTK18	NNP	O
cDNA	NN	O
by	IN	O
PCR	NNP	O
,	,	O
purifying	VBG	O
the	DT	O
PCR	NNP	O
product	NN	O
,	,	O
labeling	VBG	O
the	DT	O
same	JJ	O
with	IN	O
[	JJ	O
32P	CD	O
]	JJ	O
-dCTP	NNP	O
(	(	O
random-primed	JJ	O
DNA	NNP	O
labeling	VBG	O
kit	NN	O
,	,	O
Boehringer	NNP	O
Mannheim	NNP	O
)	)	O
and	CC	O
using	VBG	O
an	DT	O
MTN	NNP	O
blot	NN	O
with	IN	O
the	DT	O
labeled	JJ	O
product	NN	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O
The	DT	O
results	NNS	O
of	IN	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
transcript	NN	O
of	IN	O
OTK18	NNP	O
is	VBZ	O
approximately	RB	O
4.3	JJ	O
kb	NNS	O
long	JJ	O
and	CC	O
is	VBZ	O
expressed	VBN	O
ubiquitously	RB	O
in	IN	O
various	JJ	O
normal	JJ	O
adult	NN	O
tissues	NNS	O
.	.	O
However	RB	O
,	,	O
the	DT	O
expression	NN	O
level	NN	O
in	IN	O
the	DT	O
liver	NN	O
and	CC	O
in	IN	O
peripheral	JJ	O
blood	NN	O
lymphocytes	NNS	O
seemed	VBD	O
to	TO	O
be	VB	O
lower	JJR	O
than	IN	O
in	IN	O
other	JJ	O
organs	NNS	O
tested	VBN	O
.	.	O
(	(	O
4	CD	O
)	)	O
Cosmid	NNP	O
Cloning	NNP	O
and	CC	O
Chromosomal	NNP	O
Localization	NNP	O
by	IN	O
Direct	NNP	O
R-Banding	NNP	O
FISH	NNP	O
Chromosomal	NNP	O
localization	NN	O
of	IN	O
OTK18	NNP	O
was	VBD	O
carried	VBN	O
out	RP	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
3	CD	O
)	)	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
complete	JJ	O
twin	JJ	O
spots	NNS	O
were	VBD	O
identified	VBN	O
with	IN	O
8	CD	O
samples	NNS	O
while	IN	O
23	CD	O
samples	NNS	O
showed	VBD	O
an	DT	O
incomplete	JJ	O
signal	NN	O
or	CC	O
twin	JJ	O
spots	NNS	O
on	IN	O
either	DT	O
or	CC	O
both	DT	O
homologs	NNS	O
.	.	O
All	DT	O
signals	NNS	O
appeared	VBD	O
at	IN	O
the	DT	O
q13.4	JJ	O
band	NN	O
of	IN	O
chromosome	NN	O
19	CD	O
.	.	O
No	DT	O
twin	JJ	O
spots	NNS	O
were	VBD	O
observed	VBN	O
on	IN	O
any	DT	O
other	JJ	O
chromosomes	NNS	O
.	.	O
The	DT	O
results	NNS	O
of	IN	O
FISH	NNP	O
thus	RB	O
revealed	VBD	O
that	IN	O
this	DT	O
gene	NN	O
is	VBZ	O
localized	VBN	O
on	IN	O
chromosomal	JJ	O
band	NN	O
19q13.4	CD	O
.	.	O
This	DT	O
region	NN	O
is	VBZ	O
known	VBN	O
to	TO	O
contain	VB	O
many	JJ	O
DNA	NNP	O
segments	NNS	O
that	WDT	O
hybridize	VBP	O
with	IN	O
oligonucleotides	NNS	O
corresponding	VBG	O
to	TO	O
zinc	VB	O
finger	NN	O
domains	NNS	O
[	JJ	O
Hoovers	NNP	B
,	,	I
J.	NNP	I
M.	NNP	I
N.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Genomics	NNP	I
,	,	I
12	CD	I
,	,	I
254-263	CD	I
(	(	I
1992	CD	I
)	)	I
]	NN	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
at	IN	O
least	JJS	O
one	CD	O
other	JJ	O
gene	NN	O
coding	VBG	O
for	IN	O
a	DT	O
zinc	NN	O
finger	NN	O
domain	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
in	IN	O
this	DT	O
region	NN	O
[	FW	O
Marine	NNP	B
,	,	I
J.-C.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Genomics	NNP	I
,	,	I
21	CD	I
,	,	I
285-286	CD	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
.	.	O
Hence	NNP	O
,	,	O
the	DT	O
chromosome	NN	O
19q13	CD	O
is	VBZ	O
presumably	RB	O
a	DT	O
site	NN	O
of	IN	O
grouping	NN	O
of	IN	O
multiple	JJ	O
genes	NNS	O
coding	VBG	O
for	IN	O
transcription-regulating	JJ	O
proteins	NNS	O
.	.	O
When	WRB	O
the	DT	O
novel	JJ	O
human	JJ	O
OTK18	NNP	O
gene	NN	O
provided	VBN	O
by	IN	O
this	DT	O
example	NN	O
is	VBZ	O
used	VBN	O
,	,	O
it	PRP	O
becomes	VBZ	O
possible	JJ	O
to	TO	O
detect	VB	O
expression	NN	O
of	IN	O
said	VBD	O
gene	NN	O
in	IN	O
various	JJ	O
tissues	NNS	O
and	CC	O
produce	VB	O
the	DT	O
human	JJ	O
OTK18	NNP	O
protein	NN	O
in	IN	O
the	DT	O
manner	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
.	.	O
Through	IN	O
these	DT	O
,	,	O
it	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
analyze	VB	O
the	DT	O
functions	NNS	O
of	IN	O
the	DT	O
human	JJ	O
transcription	NN	O
regulating	VBG	O
protein	JJ	O
gene	NN	O
system	NN	O
or	CC	O
human	JJ	O
transcription	NN	O
regulating	NN	O
proteins	NNS	O
,	,	O
which	WDT	O
are	VBP	O
deeply	RB	O
involved	VBN	O
in	IN	O
diverse	JJ	O
activities	NNS	O
fundamental	VBP	O
to	TO	O
cells	NNS	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
to	TO	O
diagnose	VB	O
various	JJ	O
diseases	NNS	O
with	IN	O
which	WDT	O
said	VBD	O
gene	NN	O
is	VBZ	O
associated	VBN	O
,	,	O
for	IN	O
example	NN	O
malformation	NN	O
or	CC	O
cancer	NN	O
resulting	VBG	O
from	IN	O
a	DT	O
developmental	NN	O
or	CC	O
differentiation	NN	O
anomaly	NN	O
,	,	O
and	CC	O
mental	JJ	O
or	CC	O
nervous	JJ	O
disorder	NN	O
resulting	VBG	O
from	IN	O
a	DT	O
developmental	JJ	O
anomaly	NN	O
in	IN	O
the	DT	O
nervous	JJ	O
system	NN	O
,	,	O
and	CC	O
further	RB	O
to	TO	O
screen	VB	O
out	RP	O
and	CC	O
evaluate	VB	O
therapeutic	JJ	O
or	CC	O
prophylactic	JJ	O
drugs	NNS	O
for	IN	O
these	DT	O
diseases	NNS	O
.	.	O
Example	JJ	O
5	CD	O
Genes	NNPS	O
Encoding	NNP	O
Human	NNP	O
26S	CD	O
Proteasome	NNP	O
Constituent	NNP	O
P42	NNP	O
Protein	NNP	O
and	CC	O
P27	NNP	O
Protein	NNP	O
(	(	O
1	CD	O
)	)	O
Cloning	NN	O
and	CC	O
DNA	NNP	O
Sequencing	NNP	O
of	IN	O
Genes	NNP	O
Respectively	NNP	O
Encoding	NNP	O
Human	NNP	O
26S	CD	O
Proteasome	NNP	O
Constituent	NNP	O
P42	NNP	O
Protein	NNP	O
and	CC	O
P27	NNP	O
Protein	NNP	O
Proteasome	NNP	O
,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
multifunctional	JJ	O
protease	NN	O
,	,	O
is	VBZ	O
an	DT	O
enzyme	JJ	O
occurring	VBG	O
widely	RB	O
in	IN	O
eukaryotes	NNS	O
from	IN	O
yeasts	NNS	O
to	TO	O
humans	NNS	O
and	CC	O
decomposing	VBG	O
ubiquitin-binding	JJ	O
proteins	NNS	O
in	IN	O
cells	NNS	O
in	IN	O
an	DT	O
energy-dependent	JJ	O
manner	NN	O
.	.	O
Structurally	RB	O
,	,	O
said	VBD	O
proteasome	NN	O
is	VBZ	O
constituted	VBN	O
of	IN	O
20S	CD	O
proteasome	NN	O
composed	VBN	O
of	IN	O
various	JJ	O
constituents	NNS	O
with	IN	O
a	DT	O
molecular	JJ	O
weight	NN	O
of	IN	O
21	CD	O
to	TO	O
31	CD	O
kilodaltons	NNS	O
and	CC	O
a	DT	O
group	NN	O
of	IN	O
PA700	NNP	O
regulatory	JJ	O
proteins	NNS	O
composed	VBN	O
of	IN	O
various	JJ	O
constituents	NNS	O
with	IN	O
a	DT	O
molecular	JJ	O
weight	NN	O
of	IN	O
30	CD	O
to	TO	O
112	CD	O
kilodaltons	NNS	O
and	CC	O
showing	VBG	O
a	DT	O
sedimentation	NN	O
coefficient	NN	O
of	IN	O
22S	CD	O
and	CC	O
,	,	O
as	IN	O
a	DT	O
whole	NN	O
,	,	O
occurs	VBZ	O
as	IN	O
a	DT	O
macromolecule	NN	O
with	IN	O
a	DT	O
molecular	JJ	O
weight	NN	O
of	IN	O
about	IN	O
2	CD	O
million	CD	O
daltons	NNS	O
and	CC	O
a	DT	O
sedimentation	NN	O
coefficient	NN	O
of	IN	O
26S	CD	O
[	JJ	O
Rechsteiner	NNP	B
,	,	I
M.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
268	CD	I
,	,	I
6065-6068	CD	I
(	(	I
1993	CD	I
)	)	I
;	:	O
Yoshimura	NNP	B
,	,	I
T.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
J.	NNP	I
Struct	NNP	I
.	.	I
Biol.	NNP	I
,	,	I
111	CD	I
,	,	I
200-211	CD	I
(	(	I
1993	CD	I
)	)	I
;	:	O
Tanaka	NNP	B
,	,	I
K.	NNP	I
,	,	I
et	FW	I
al.	RB	I
,	,	I
New	NNP	I
Biologist	NNP	I
,	,	I
4	CD	I
,	,	I
173-187	CD	I
(	(	I
1992	CD	I
)	)	I
]	NN	O
.	.	O
Despite	IN	O
structural	JJ	O
and	CC	O
mechanical	JJ	O
analyses	NNS	O
thereof	NN	O
,	,	O
the	DT	O
whole	JJ	O
picture	NN	O
of	IN	O
proteasome	NN	O
is	VBZ	O
not	RB	O
yet	RB	O
fully	RB	O
clear	JJ	O
.	.	O
However	RB	O
,	,	O
according	VBG	O
to	TO	O
studies	NNS	O
using	VBG	O
yeasts	NNS	O
and	CC	O
mice	NN	O
in	IN	O
the	DT	O
main	JJ	O
,	,	O
it	PRP	O
reportedly	RB	O
has	VBZ	O
the	DT	O
functions	NNS	O
mentioned	VBN	O
below	IN	O
and	CC	O
its	PRP$	O
functions	NNS	O
are	VBP	O
becoming	VBG	O
more	JJR	O
and	CC	O
more	RBR	O
elucidated	JJ	O
.	.	O
The	DT	O
mechanism	NN	O
of	IN	O
energy-dependent	JJ	O
proteolysis	NN	O
in	IN	O
cells	NNS	O
starts	NNS	O
with	IN	O
selection	NN	O
of	IN	O
proteins	NNS	O
by	IN	O
ubiquitin	JJ	O
binding	NN	O
.	.	O
It	PRP	O
is	VBZ	O
not	RB	O
20S	CD	O
proteasome	NN	O
but	CC	O
26S	CD	O
proteasome	NN	O
that	WDT	O
has	VBZ	O
ubiquitin-conjugated	JJ	O
protein	NNS	O
decomposing	VBG	O
activity	NN	O
which	WDT	O
is	VBZ	O
ATP-dependent	JJ	O
[	JJ	O
Chu-Ping	NNP	B
et	NN	I
al.	NN	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
269	CD	I
,	,	I
3539-3547	CD	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
.	.	O
Hence	NNP	O
,	,	O
human	JJ	O
26S	CD	O
proteasome	NN	O
is	VBZ	O
considered	VBN	O
to	TO	O
be	VB	O
useful	JJ	O
in	IN	O
elucidating	VBG	O
the	DT	O
mechanism	NN	O
of	IN	O
energy-dependent	JJ	O
proteolysis	NN	O
.	.	O
Factors	NNS	O
involved	VBN	O
in	IN	O
the	DT	O
cell	NN	O
cycle	NN	O
regulation	NN	O
are	VBP	O
generally	RB	O
short	JJ	O
in	IN	O
half-life	JJ	O
and	CC	O
in	IN	O
many	JJ	O
cases	NNS	O
they	PRP	O
are	VBP	O
subject	JJ	O
to	TO	O
strict	VB	O
quantitative	JJ	O
control	NN	O
.	.	O
In	IN	O
fact	NN	O
,	,	O
it	PRP	O
has	VBZ	O
been	VBN	O
made	VBN	O
clear	JJ	O
that	IN	O
the	DT	O
oncogene	NN	O
products	NNS	O
Mos	NNP	O
,	,	O
Myc	NNP	O
,	,	O
Fos	NNP	O
and	CC	O
so	RB	O
forth	JJ	O
can	MD	O
be	VB	O
decomposed	VBN	O
by	IN	O
26S	CD	O
proteasome	NN	O
in	IN	O
an	DT	O
energy-	JJ	O
and	CC	O
ubiquitin-dependent	JJ	O
manner	NN	O
[	NNP	O
Ishida	NNP	B
,	,	I
N.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
FEBS	NNP	I
Lett.	NNP	I
,	,	I
324	CD	I
,	,	I
345-348	CD	I
(	(	I
1993	CD	I
)	)	I
;	:	O
Hershko	NNP	B
,	,	I
A.	NNP	I
and	CC	I
Ciechanover	NNP	I
,	,	I
A.	NNP	I
,	,	I
Annu	NNP	I
.	.	I
Rev	NNP	I
.	.	I
Biochem.	NNP	I
,	,	I
61	CD	I
,	,	I
761-807	CD	I
(	(	I
1992	CD	I
)	)	I
]	NN	O
and	CC	O
the	DT	O
importance	NN	O
of	IN	O
proteasone	NN	O
in	IN	O
cell	NN	O
cycle	NN	O
control	NN	O
is	VBZ	O
being	VBG	O
recognized	VBN	O
.	.	O
Its	PRP$	O
importance	NN	O
in	IN	O
the	DT	O
immune	NN	O
system	NN	O
has	VBZ	O
also	RB	O
been	VBN	O
pointed	VBN	O
out	RP	O
.	.	O
It	PRP	O
is	VBZ	O
suggested	VBN	O
that	IN	O
proteasome	NN	O
is	VBZ	O
positively	RB	O
involved	VBN	O
in	IN	O
class	NN	O
I	PRP	O
major	JJ	O
histocompatible	JJ	O
complex	JJ	O
antigen	NN	O
presentation	NN	O
[	NNP	O
Michalek	NNP	B
,	,	I
M.	NNP	I
T.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
363	CD	I
,	,	I
552-554	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
and	CC	O
it	PRP	O
is	VBZ	O
further	RBR	O
suggested	VBD	O
that	IN	O
proteasome	NN	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
Alzheimer	NNP	O
disease	NN	O
,	,	O
since	IN	O
the	DT	O
phenomena	NN	O
of	IN	O
abnormal	JJ	O
accumulation	NN	O
of	IN	O
ubiquitin-conjugated	JJ	O
proteins	NNS	O
in	IN	O
the	DT	O
brain	NN	O
of	IN	O
patients	NNS	O
with	IN	O
Alzheimer	NNP	O
disease	NN	O
[	NNP	O
Kitaguchi	NNP	B
,	,	I
N.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
361	CD	I
,	,	I
530-532	CD	I
(	(	I
1988	CD	I
)	)	I
]	NN	O
.	.	O
Because	IN	O
of	IN	O
its	PRP$	O
diverse	JJ	O
functions	NNS	O
such	JJ	O
as	IN	O
those	DT	O
mentioned	VBN	O
above	IN	O
,	,	O
proteasome	JJ	O
attracts	NNS	O
attention	NN	O
from	IN	O
the	DT	O
viewpoint	NN	O
of	IN	O
its	PRP$	O
utility	NN	O
in	IN	O
the	DT	O
diagnosis	NN	O
and	CC	O
treatment	NN	O
of	IN	O
various	JJ	O
diseases	NNS	O
.	.	O
A	DT	O
main	JJ	O
function	NN	O
of	IN	O
26S	CD	O
proteasome	NN	O
is	VBZ	O
ubiquitin-conjugated	JJ	O
protein	JJ	O
decomposing	NN	O
activity	NN	O
.	.	O
In	IN	O
particular	JJ	O
,	,	O
it	PRP	O
is	VBZ	O
known	VBN	O
that	IN	O
cell	NN	O
cycle-related	JJ	O
gene	NN	O
products	NNS	O
such	JJ	O
as	IN	O
oncogene	NN	O
products	NNS	O
and	CC	O
cyclins	NNS	O
,	,	O
typically	RB	O
c-Myc	JJ	O
,	,	O
are	VBP	O
degraded	VBN	O
via	IN	O
ubiquitin-dependent	JJ	O
pathways	NNS	O
.	.	O
It	PRP	O
has	VBZ	O
also	RB	O
been	VBN	O
observed	VBN	O
that	IN	O
the	DT	O
proteasome	JJ	O
gene	NN	O
is	VBZ	O
expressed	VBN	O
abnormally	RB	O
in	IN	O
liver	NN	O
cancer	NN	O
cells	NNS	O
,	,	O
renal	JJ	O
cancer	NN	O
cells	NNS	O
,	,	O
leukemia	NN	O
cells	NNS	O
and	CC	O
the	DT	O
like	JJ	O
as	IN	O
compared	VBN	O
with	IN	O
normal	JJ	O
cells	NNS	O
[	JJ	O
Kanayama	NNP	B
,	,	I
H.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cancer	NNP	I
Res.	NNP	I
,	,	I
51	CD	I
,	,	I
6677-6685	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
and	CC	O
that	DT	O
proteasome	NN	O
is	VBZ	O
abnormally	RB	O
accumulated	VBN	O
in	IN	O
tumor	NN	O
cell	NN	O
nuclei	NN	O
.	.	O
Hence	NNP	O
,	,	O
constituents	NNS	O
of	IN	O
proteasome	NN	O
are	VBP	O
expected	VBN	O
to	TO	O
be	VB	O
useful	JJ	O
in	IN	O
studying	VBG	O
the	DT	O
mechanism	NN	O
of	IN	O
such	JJ	O
canceration	NN	O
and	CC	O
in	IN	O
the	DT	O
diagnosis	NN	O
or	CC	O
treatment	NN	O
of	IN	O
cancer	NN	O
.	.	O
Also	RB	O
,	,	O
it	PRP	O
is	VBZ	O
known	VBN	O
that	IN	O
the	DT	O
expression	NN	O
of	IN	O
proteasome	NN	O
is	VBZ	O
induced	VBN	O
by	IN	O
interferon	NN	O
γ	NN	O
and	CC	O
so	RB	O
on	IN	O
and	CC	O
is	VBZ	O
deeply	RB	O
involved	VBN	O
in	IN	O
antigen	NN	O
presentation	NN	O
in	IN	O
cells	NNS	O
[	JJ	O
Aki	NNP	B
,	,	I
M.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
J	NNP	I
.	.	I
Biochem.	NNP	I
,	,	I
115	CD	I
,	,	I
257-269	CD	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
.	.	O
Hence	NNP	O
,	,	O
constituents	NNS	O
of	IN	O
human	JJ	O
proteasome	NN	O
are	VBP	O
expected	VBN	O
to	TO	O
be	VB	O
useful	JJ	O
in	IN	O
studying	VBG	O
the	DT	O
mechanism	NN	O
of	IN	O
antigen	NN	O
presentation	NN	O
in	IN	O
the	DT	O
immune	NN	O
system	NN	O
and	CC	O
in	IN	O
developing	VBG	O
immunoregulating	VBG	O
drugs	NNS	O
.	.	O
Furthermore	RB	O
,	,	O
proteasome	NN	O
is	VBZ	O
considered	VBN	O
to	TO	O
be	VB	O
deeply	RB	O
associated	VBN	O
with	IN	O
ubiquitin	JJ	O
abnormally	RB	O
accumulated	VBN	O
in	IN	O
the	DT	O
brain	NN	O
of	IN	O
patients	NNS	O
with	IN	O
Alzheimer	NNP	O
disease	NN	O
.	.	O
Hence	RB	O
,	,	O
it	PRP	O
is	VBZ	O
suggested	VBN	O
that	IN	O
constituents	NNS	O
of	IN	O
human	JJ	O
proteasome	NN	O
should	MD	O
be	VB	O
useful	JJ	O
in	IN	O
studying	VBG	O
the	DT	O
cause	NN	O
of	IN	O
Alzheimer	NNP	O
disease	NN	O
and	CC	O
in	IN	O
the	DT	O
treatment	NN	O
of	IN	O
said	VBD	O
disease	NN	O
.	.	O
In	IN	O
addition	NN	O
to	TO	O
the	DT	O
utilization	NN	O
of	IN	O
expectedly	JJ	O
multifunctional	JJ	O
proteasome	NN	O
as	IN	O
such	JJ	O
in	IN	O
the	DT	O
above	JJ	O
manner	NN	O
,	,	O
it	PRP	O
is	VBZ	O
probably	RB	O
possible	JJ	O
to	TO	O
produce	VB	O
antibodies	NNS	O
using	VBG	O
constituents	NNS	O
of	IN	O
proteasome	NN	O
as	IN	O
antigens	NNS	O
and	CC	O
use	VB	O
such	JJ	O
antibodies	NNS	O
in	IN	O
diagnosing	VBG	O
various	JJ	O
diseases	NNS	O
by	IN	O
immunoassay	NN	O
.	.	O
Its	PRP$	O
utility	NN	O
in	IN	O
this	DT	O
field	NN	O
of	IN	O
diagnosis	NN	O
is	VBZ	O
thus	RB	O
also	RB	O
a	DT	O
focus	NN	O
of	IN	O
interest	NN	O
.	.	O
Meanwhile	RB	O
,	,	O
a	DT	O
protein	NN	O
having	VBG	O
the	DT	O
characteristics	NNS	O
of	IN	O
human	JJ	O
26S	CD	O
proteasome	NN	O
is	VBZ	O
disclosed	VBN	O
,	,	O
for	IN	O
example	NN	O
in	IN	O
Japanese	JJ	O
Unexamined	JJ	O
Patent	NNP	O
Publication	NNP	O
No	NNP	O
.	.	O
292964/1993	CD	O
and	CC	O
rat	VB	O
proteasome	JJ	O
constituents	NNS	O
are	VBP	O
disclosed	VBN	O
in	IN	O
Japanese	JJ	O
Unexamined	JJ	O
Patent	NNP	O
Publication	NNP	O
Nos	NNP	O
.	.	O
268957/1993	CD	O
and	CC	O
317059/1993	CD	O
.	.	O
However	RB	O
,	,	O
no	DT	O
human	JJ	O
26S	CD	O
proteasome	NN	O
constituents	NNS	O
are	VBP	O
known	VBN	O
.	.	O
Therefore	RB	O
,	,	O
the	DT	O
present	JJ	O
inventors	NNS	O
made	VBD	O
a	DT	O
further	JJ	O
search	NN	O
for	IN	O
human	JJ	O
26S	CD	O
proteasome	NN	O
constituents	NNS	O
and	CC	O
successfully	RB	O
obtained	VBN	O
two	CD	O
novel	JJ	O
human	JJ	O
26S	CD	O
proteasome	NN	O
constituents	NNS	O
,	,	O
namely	RB	O
human	JJ	O
26S	CD	O
proteasome	JJ	O
constituent	NN	O
P42	NNP	O
protein	NN	O
and	CC	O
human	JJ	O
S26	NNP	O
proteasome	NN	O
constituent	NN	O
P27	NNP	O
protein	NN	O
,	,	O
and	CC	O
performed	VBD	O
cloning	NN	O
and	CC	O
DNA	NNP	O
sequencing	NN	O
of	IN	O
the	DT	O
corresponding	JJ	O
genes	NNS	O
in	IN	O
the	DT	O
following	JJ	O
manner	NN	O
.	.	O
(	(	O
1	CD	O
)	)	O
Purification	NN	O
of	IN	O
Human	NNP	O
26S	CD	O
Proteasome	NNP	O
Constituents	NNP	O
P42	NNP	O
Protein	NNP	O
and	CC	O
P27	NNP	O
Protein	NNP	O
Human	NNP	O
proteasome	NN	O
was	VBD	O
purified	VBN	O
using	VBG	O
about	IN	O
100	CD	O
g	NNS	O
of	IN	O
fresh	JJ	O
human	JJ	O
kidney	NN	O
and	CC	O
following	VBG	O
the	DT	O
method	NN	O
of	IN	O
purifying	VBG	O
human	JJ	O
proteasome	NN	O
as	IN	O
described	VBN	O
in	IN	O
Japanese	JJ	O
Unexamined	JJ	O
Patent	NNP	O
Publication	NNP	O
No	NNP	O
.	.	O
292964/1993	CD	O
,	,	O
namely	RB	O
by	IN	O
column	NN	O
chromatography	NN	O
using	VBG	O
BioGel	NNP	O
A-1.5	NNP	O
m	NN	O
(	(	O
5×90	CD	O
cm	NN	O
,	,	O
Bio-Rad	NNP	O
)	)	O
,	,	O
hydroxyapatite	JJ	O
(	(	O
1.5×15	CD	O
cm	NN	O
,	,	O
Bio-Rad	NNP	O
)	)	O
and	CC	O
Q-Sepharose	NNP	O
(	(	O
1.5×15	CD	O
cm	NN	O
,	,	O
Pharmacia	NNP	O
)	)	O
and	CC	O
glycerol	JJ	O
density	NN	O
gradient	NN	O
centrifugation	NN	O
.	.	O
The	DT	O
thus-obtained	JJ	O
human	JJ	O
proteasome	NN	O
was	VBD	O
subjected	VBN	O
to	TO	O
reversed	VBN	O
phase	NN	O
high	JJ	O
performance	NN	O
liquid	NN	O
chromatography	NN	O
(	(	O
HPLC	NNP	O
)	)	O
using	VBG	O
a	DT	O
Hitachi	NNP	O
model	NN	O
L6200	NNP	O
HPLC	NNP	O
system	NN	O
.	.	O
A	DT	O
Shodex	NNP	O
RS	NNP	O
Pak	NNP	O
D4-613	NNP	O
(	(	O
0.6×15	CD	O
cm	NN	O
,	,	O
Showa	NNP	O
Denko	NNP	O
)	)	O
was	VBD	O
used	VBN	O
and	CC	O
gradient	JJ	O
elution	NN	O
was	VBD	O
performed	VBN	O
with	IN	O
the	DT	O
following	VBG	O
two	CD	O
solutions	NNS	O
:	:	O
First	JJ	O
solution	NN	O
:	:	O
0.06	CD	O
%	NN	O
trifluoroacetic	JJ	O
acid	NN	O
;	:	O
Second	JJ	O
solution	NN	O
:	:	O
0.05	CD	O
%	NN	O
trifluoroacetic	JJ	O
acid	NN	O
,	,	O
70	CD	O
%	NN	O
acetonitrile	NN	O
.	.	O
An	DT	O
aliquot	NN	O
of	IN	O
each	DT	O
eluate	NN	O
fraction	NN	O
was	VBD	O
subjected	VBN	O
to	TO	O
8.5	CD	O
%	NN	O
SDS-polyacrylamide	JJ	O
electrophoresis	NN	O
under	IN	O
conditions	NNS	O
of	IN	O
reduction	NN	O
with	IN	O
dithiothreitol	NN	O
.	.	O
The	DT	O
P42	NNP	O
protein	NN	O
and	CC	O
P27	NNP	O
protein	VBP	O
thus	RB	O
detected	VBN	O
were	VBD	O
isolated	VBN	O
and	CC	O
purified	VBN	O
.	.	O
The	DT	O
purified	JJ	O
P42	NNP	O
and	CC	O
P27	NNP	O
proteins	NNS	O
were	VBD	O
respectively	RB	O
digested	VBN	O
with	IN	O
1	CD	O
μg	NNS	O
of	IN	O
trypsin	NN	O
in	IN	O
0.1	CD	O
M	NNP	O
Tris	NNP	O
buffer	NN	O
(	(	O
pH	JJ	O
7.8	CD	O
)	)	O
containing	VBG	O
2	CD	O
M	NNP	O
urea	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
for	IN	O
8	CD	O
hours	NNS	O
and	CC	O
the	DT	O
partial	JJ	O
peptide	NN	O
fragments	NNS	O
obtained	VBN	O
were	VBD	O
separated	VBN	O
by	IN	O
reversed	JJ	O
phase	NN	O
HPLC	NNP	O
and	CC	O
their	PRP$	O
sequences	NNS	O
were	VBD	O
determined	VBN	O
by	IN	O
Edman	NNP	O
degradation	NN	O
.	.	O
The	DT	O
results	NNS	O
obtained	VBN	O
are	VBP	O
as	IN	O
shown	VBN	O
below	IN	O
in	IN	O
Table	JJ	O
2	CD	O
.	.	O
(	(	O
2	CD	O
)	)	O
cDNA	NN	O
Library	NNP	O
Screening	NNP	O
,	,	O
Clone	NNP	O
Isolation	NNP	O
and	CC	O
cDNA	NN	O
Nucleotide	NNP	O
Sequence	NNP	O
Determination	NNP	O
As	IN	O
mentioned	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
,	,	O
the	DT	O
present	JJ	O
inventors	NNS	O
have	VBP	O
a	DT	O
database	NN	O
comprising	VBG	O
about	IN	O
30,000	CD	O
cDNA	NN	O
data	NNS	O
as	IN	O
constructed	VBN	O
based	VBN	O
on	IN	O
large-scale	JJ	O
DNA	NNP	O
sequencing	VBG	O
using	VBG	O
human	JJ	O
fetal	JJ	O
brain	NN	O
,	,	O
arterial	JJ	O
blood	NN	O
vessel	NN	O
and	CC	O
placenta	NN	O
cDNA	NN	O
libraries	NNS	O
.	.	O
Based	VBN	O
on	IN	O
the	DT	O
amino	NN	O
acid	NN	O
sequences	NNS	O
obtained	VBD	O
as	IN	O
mentioned	VBN	O
above	IN	O
in	IN	O
(	(	O
1	CD	O
)	)	O
,	,	O
computer	NN	O
searching	NN	O
was	VBD	O
performed	VBN	O
with	IN	O
the	DT	O
FASTA	NNP	O
program	NN	O
(	(	O
search	NN	O
for	IN	O
homology	NN	O
between	IN	O
said	VBD	O
amino	NN	O
acid	NN	O
sequences	NNS	O
and	CC	O
the	DT	O
amino	NN	O
acid	NN	O
sequences	NNS	O
estimated	VBN	O
from	IN	O
the	DT	O
database	NN	O
)	)	O
.	.	O
As	IN	O
regards	NNS	O
P42	NNP	O
,	,	O
a	DT	O
clone	NN	O
(	(	O
GEN-331G07	NNP	O
)	)	O
showing	VBG	O
identity	NN	O
with	IN	O
regard	NN	O
to	TO	O
two	CD	O
amino	NN	O
acid	NN	O
sequences	NNS	O
[	NNP	O
(	(	O
2	CD	O
)	)	O
and	CC	O
(	(	O
7	CD	O
)	)	O
shown	VBN	O
in	IN	O
table	JJ	O
2	CD	O
]	NN	O
was	VBD	O
screened	VBN	O
out	RP	O
and	CC	O
,	,	O
as	IN	O
regards	NNS	O
P27	NNP	O
,	,	O
a	DT	O
clone	NN	O
(	(	O
GEN-163D09	NNP	O
)	)	O
showing	VBG	O
identity	NN	O
with	IN	O
regard	NN	O
to	TO	O
two	CD	O
amino	NN	O
acid	NN	O
sequences	NNS	O
[	NNP	O
(	(	O
1	CD	O
)	)	O
and	CC	O
(	(	O
8	CD	O
)	)	O
shown	VBN	O
in	IN	O
Table	JJ	O
2	CD	O
]	NN	O
was	VBD	O
found	VBN	O
.	.	O
For	IN	O
each	DT	O
of	IN	O
these	DT	O
clones	NNS	O
,	,	O
the	DT	O
5′	CD	O
side	NN	O
sequence	NN	O
was	VBD	O
determined	VBN	O
by	IN	O
5′	CD	O
RACE	NNP	O
and	CC	O
the	DT	O
whole	JJ	O
sequence	NN	O
was	VBD	O
determined	VBN	O
,	,	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
2	CD	O
(	(	O
2	CD	O
)	)	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
it	PRP	O
was	VBD	O
revealed	VBN	O
that	IN	O
the	DT	O
above-mentioned	JJ	O
P42	NNP	O
clone	NN	O
GEN-331G07	NNP	O
comprises	VBZ	O
a	DT	O
1,566-nucleotide	JJ	O
sequence	NN	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:15	NNP	O
,	,	O
inclusive	NN	O
of	IN	O
a	DT	O
1,167-nucleotide	JJ	O
open	JJ	O
reading	NN	O
frame	NN	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:14	NNP	O
,	,	O
and	CC	O
that	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
encoded	VBD	O
thereby	RB	O
is	VBZ	O
the	DT	O
one	CD	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:13	NNP	O
and	CC	O
comprises	VBZ	O
389	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
.	.	O
The	DT	O
results	NNS	O
of	IN	O
computer	NN	O
homology	NN	O
search	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
P42	NNP	O
protein	NN	O
is	VBZ	O
significantly	RB	O
homologous	JJ	O
to	TO	O
the	DT	O
AAA	NNP	O
(	(	O
ATPase	NNP	O
associated	VBN	O
with	IN	O
a	DT	O
variety	NN	O
of	IN	O
cellular	JJ	O
activities	NNS	O
)	)	O
protein	VBP	O
family	NN	O
(	(	O
e.g	NN	O
.	.	O
P45	NNP	O
,	,	O
TBP1	NNP	O
,	,	O
TBP7	NNP	O
,	,	O
S4	NNP	O
,	,	O
MSS1	NNP	O
,	,	O
etc	FW	O
.	.	O
)	)	O
.	.	O
It	PRP	O
was	VBD	O
thus	RB	O
suggested	VBN	O
that	IN	O
it	PRP	O
is	VBZ	O
a	DT	O
new	JJ	O
member	NN	O
of	IN	O
the	DT	O
AAA	NNP	O
protein	NN	O
family	NN	O
.	.	O
As	IN	O
for	IN	O
the	DT	O
P27	NNP	O
clone	NN	O
GEN-163D09	NNP	O
,	,	O
it	PRP	O
was	VBD	O
revealed	VBN	O
that	IN	O
it	PRP	O
comprises	VBZ	O
a	DT	O
1,128-nucleotide	JJ	O
sequence	NN	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:18	NNP	O
,	,	O
including	VBG	O
a	DT	O
669-nucleotide	JJ	O
open	JJ	O
reading	NN	O
frame	NN	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:17	NNP	O
and	CC	O
that	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
encoded	VBD	O
thereby	RB	O
is	VBZ	O
the	DT	O
one	CD	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:16	NNP	O
and	CC	O
comprises	VBZ	O
223	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
.	.	O
As	IN	O
regards	NNS	O
the	DT	O
P27	NNP	O
protein	NN	O
,	,	O
homology	NN	O
search	NN	O
using	VBG	O
a	DT	O
computer	NN	O
failed	VBD	O
to	TO	O
reveal	VB	O
any	DT	O
homologous	JJ	O
gene	NN	O
among	IN	O
public	JJ	O
databases	NNS	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
gene	NN	O
in	IN	O
question	NN	O
is	VBZ	O
presumably	RB	O
a	DT	O
novel	JJ	O
gene	NN	O
having	VBG	O
an	DT	O
unknown	JJ	O
function	NN	O
.	.	O
Originally	RB	O
,	,	O
the	DT	O
above-mentioned	JJ	O
P42	NNP	O
and	CC	O
P27	NNP	O
gene	NN	O
products	NNS	O
were	VBD	O
both	DT	O
purified	VBN	O
as	IN	O
regulatory	JJ	O
subunit	JJ	O
components	NNS	O
of	IN	O
proteasome	NN	O
complex	NN	O
.	.	O
Therefore	RB	O
,	,	O
these	DT	O
are	VBP	O
expected	VBN	O
to	TO	O
play	VB	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
various	JJ	O
biological	JJ	O
functions	NNS	O
through	IN	O
proteolysis	NN	O
,	,	O
for	IN	O
example	NN	O
a	DT	O
role	NN	O
in	IN	O
energy	NN	O
supply	NN	O
through	IN	O
decomposition	NN	O
of	IN	O
ATP	NNP	O
and	CC	O
,	,	O
hence	RB	O
,	,	O
they	PRP	O
are	VBP	O
presumably	RB	O
useful	JJ	O
not	RB	O
only	RB	O
in	IN	O
studying	VBG	O
the	DT	O
function	NN	O
of	IN	O
human	JJ	O
26S	CD	O
proteasome	NN	O
but	CC	O
also	RB	O
in	IN	O
the	DT	O
diagnosis	NN	O
and	CC	O
treatment	NN	O
of	IN	O
various	JJ	O
diseases	NNS	O
caused	VBN	O
by	IN	O
lowering	VBG	O
of	IN	O
said	VBD	O
biological	JJ	O
functions	NNS	O
,	,	O
among	IN	O
others	NNS	O
.	.	O
Example	RB	O
6	CD	O
BNAP	NNP	O
Gene	NNP	O
(	(	O
1	CD	O
)	)	O
BNAP	NNP	O
Gene	NNP	O
Cloning	NNP	O
and	CC	O
DNA	NNP	O
Sequencing	VBG	O
The	DT	O
nucleosome	NN	O
composed	VBD	O
of	IN	O
DNA	NNP	O
and	CC	O
histone	NN	O
is	VBZ	O
a	DT	O
fundamental	JJ	O
structure	NN	O
constituting	VBG	O
chromosomes	NNS	O
in	IN	O
eukaryotic	JJ	O
cells	NNS	O
and	CC	O
is	VBZ	O
well	RB	O
conserved	VBN	O
over	IN	O
borders	NNS	O
among	IN	O
species	NNS	O
.	.	O
This	DT	O
structure	NN	O
is	VBZ	O
closely	RB	O
associated	VBN	O
with	IN	O
the	DT	O
processes	NNS	O
of	IN	O
replication	NN	O
and	CC	O
transcription	NN	O
of	IN	O
DNA	NNP	O
.	.	O
However	RB	O
,	,	O
the	DT	O
nucleosome	JJ	O
formation	NN	O
is	VBZ	O
not	RB	O
fully	RB	O
understood	JJ	O
as	IN	O
yet	RB	O
.	.	O
Only	RB	O
certain	JJ	O
specific	JJ	O
factors	NNS	O
involved	VBN	O
in	IN	O
nucleosome	JJ	O
assembly	NN	O
(	(	O
NAPs	NNP	O
)	)	O
have	VBP	O
been	VBN	O
identified	VBN	O
.	.	O
Thus	RB	O
,	,	O
two	CD	O
acidic	JJ	O
proteins	NNS	O
,	,	O
nucleoplasmin	NNS	O
and	CC	O
N1	NNP	O
,	,	O
are	VBP	O
already	RB	O
known	VBN	O
to	TO	O
facilitate	VB	O
nucleosome	JJ	O
construction	NN	O
[	NNP	O
Kleinschmidt	NNP	B
,	,	I
J	NNP	I
.	.	I
A.	NN	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
260	CD	I
,	,	I
1166-1176	CD	I
(	(	I
1985	CD	I
)	)	I
;	:	O
Dilworth	NNP	B
,	,	I
S.	NNP	I
M.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
51	CD	I
,	,	I
1009-1018	CD	I
(	(	I
1987	CD	I
)	)	I
]	NN	O
.	.	O
A	DT	O
yeast	JJ	O
gene	NN	O
,	,	O
NAP-I	NNP	O
,	,	O
was	VBD	O
isolated	VBN	O
using	VBG	O
a	DT	O
mono-clonal	JJ	O
antibody	NN	O
and	CC	O
recombinant	JJ	O
proteins	NNS	O
derived	VBN	O
therefrom	NNS	O
were	VBD	O
tested	VBN	O
as	IN	O
to	TO	O
whether	IN	O
they	PRP	O
have	VBP	O
nucleosome	JJ	O
assembling	NN	O
activity	NN	O
in	IN	O
vivo	NN	O
.	.	O
More	RBR	O
recently	RB	O
,	,	O
a	DT	O
mouse	NN	O
NAP-I	JJ	O
gene	NN	O
,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
mammalian	JJ	O
homolog	NN	O
of	IN	O
the	DT	O
yeast	JJ	O
NAP-I	JJ	O
gene	NN	O
was	VBD	O
cloned	VBN	O
(	(	O
Okuda	NNP	O
,	,	O
A.	NNP	O
;	:	O
registered	VBN	O
in	IN	O
database	NN	O
under	IN	O
the	DT	O
accession	NN	O
number	NN	O
D12618	NNP	O
)	)	O
.	.	O
Also	RB	O
cloned	VBN	O
were	VBD	O
a	DT	O
mouse	NN	O
gene	NN	O
,	,	O
DN38	NNP	O
[	NNP	O
Kato	NNP	B
,	,	I
K.	NNP	I
,	,	I
Eur	NNP	I
.	.	I
J	NNP	I
.	.	I
Neurosci.	NNP	I
,	,	I
2	CD	I
,	,	I
704-711	CD	I
(	(	I
1990	CD	I
)	)	I
]	NN	O
and	CC	O
a	DT	O
human	JJ	O
nucleosome	NN	O
assembly	NN	O
protein	NN	O
(	(	O
hNRP	NN	O
)	)	O
[	NN	O
Simon	NNP	B
,	,	I
H.	NNP	I
U.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Biochem	NNP	I
.	.	I
J.	NNP	I
,	,	I
297	CD	I
,	,	I
389-397	CD	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
.	.	O
It	PRP	O
was	VBD	O
shown	VBN	O
that	IN	O
the	DT	O
hNRP	NN	O
gene	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
many	JJ	O
tissues	NNS	O
and	CC	O
is	VBZ	O
associated	VBN	O
with	IN	O
T	NNP	O
lymphocyte	JJ	O
proliferation	NN	O
.	.	O
The	DT	O
present	JJ	O
inventors	NNS	O
performed	VBD	O
sequence	JJ	O
analysis	NN	O
of	IN	O
cDNA	NN	O
clones	NNS	O
arbitrarily	RB	O
chosen	VBN	O
from	IN	O
a	DT	O
human	JJ	O
fetal	NN	O
brain	NN	O
cDNA	NN	O
library	NN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
,	,	O
followed	VBN	O
by	IN	O
searches	NNS	O
among	IN	O
databases	NNS	O
and	CC	O
,	,	O
as	IN	O
a	DT	O
result	NN	O
,	,	O
made	VBD	O
it	PRP	O
clear	JJ	O
that	IN	O
a	DT	O
1,125-nucleotide	JJ	O
cDNA	NN	O
clone	NN	O
(	(	O
free	JJ	O
of	IN	O
poly	NN	O
(	(	O
A	NNP	O
)	)	O
)	)	O
,	,	O
GEN-078D05	NNP	O
,	,	O
is	VBZ	O
significantly	RB	O
homologous	JJ	O
to	TO	O
the	DT	O
mouse	NN	O
NAP-I	NNP	O
gene	NN	O
,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
gene	NN	O
for	IN	O
a	DT	O
nucleosome	JJ	O
assembly	NN	O
protein	NN	O
(	(	O
NAP	NNP	O
)	)	O
involved	VBN	O
in	IN	O
nucleosome	JJ	O
construction	NN	O
,	,	O
a	DT	O
mouse	NN	O
partial	JJ	O
cDNA	NN	O
clone	NN	O
,	,	O
DN38	NNP	O
,	,	O
and	CC	O
hNRP	NN	O
.	.	O
Since	IN	O
said	VBD	O
clone	NN	O
GEN-078D05	NNP	O
was	VBD	O
lacking	VBG	O
in	IN	O
the	DT	O
5′	CD	O
region	NN	O
,	,	O
5′	CD	O
RACE	NNP	O
was	VBD	O
performed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
2	CD	O
(	(	O
2	CD	O
)	)	O
to	TO	O
obtain	VB	O
the	DT	O
whole	JJ	O
coding	NN	O
region	NN	O
.	.	O
For	IN	O
this	DT	O
5′	CD	O
RACE	NNP	O
,	,	O
primers	NNS	O
P1	NNP	O
and	CC	O
P2	NNP	O
respectively	RB	O
having	VBG	O
the	DT	O
nucleotide	JJ	O
sequences	NNS	O
shown	VBN	O
below	IN	O
in	IN	O
Table	JJ	O
3	CD	O
.	.	O
After	IN	O
the	DT	O
first	JJ	O
5′	CD	O
RACE	NNP	O
,	,	O
a	DT	O
single	JJ	O
band	NN	O
corresponding	VBG	O
to	TO	O
a	DT	O
sequence	NN	O
length	NN	O
of	IN	O
1,300	CD	O
nucleotides	NNS	O
was	VBD	O
obtained	VBN	O
.	.	O
This	DT	O
product	NN	O
was	VBD	O
inserted	VBN	O
into	IN	O
pT7Blue	NN	O
(	(	O
R	NNP	O
)	)	O
T-Vector	NNP	O
and	CC	O
several	JJ	O
clones	NNS	O
appropriate	VBP	O
in	IN	O
insert	JJ	O
size	NN	O
were	VBD	O
selected	VBN	O
.	.	O
Ten	CD	O
5′	CD	O
RACE	NNP	O
clones	NNS	O
obtained	VBN	O
from	IN	O
two	CD	O
independent	JJ	O
PCR	NNP	O
reactions	NNS	O
were	VBD	O
sequenced	VBN	O
and	CC	O
the	DT	O
longest	JJS	O
clone	NN	O
GEN-078D05TA13	NNP	O
(	(	O
about	IN	O
1,300	CD	O
nucleotides	NNS	O
long	RB	O
)	)	O
was	VBD	O
further	JJ	O
analyzed	VBN	O
.	.	O
Both	DT	O
strands	NNS	O
of	IN	O
the	DT	O
two	CD	O
overlapping	VBG	O
cDNA	NN	O
clones	NNS	O
GEN-078D05	NNP	O
and	CC	O
GEN-078D05TA13	NNP	O
were	VBD	O
sequenced	VBN	O
,	,	O
whereby	WRB	O
it	PRP	O
was	VBD	O
confirmed	VBN	O
that	IN	O
the	DT	O
two	CD	O
clones	NNS	O
did	VBD	O
not	RB	O
yet	RB	O
cover	VB	O
the	DT	O
whole	JJ	O
coding	NN	O
region	NN	O
.	.	O
Therefore	RB	O
,	,	O
a	DT	O
further	JJ	O
second	JJ	O
5′	CD	O
RACE	NNP	O
was	VBD	O
carried	VBN	O
out	RP	O
.	.	O
For	IN	O
the	DT	O
second	JJ	O
5′	CD	O
RACE	NNP	O
,	,	O
two	CD	O
primers	NNS	O
,	,	O
P3	NNP	O
and	CC	O
P4	NNP	O
,	,	O
respectively	RB	O
having	VBG	O
the	DT	O
sequences	NNS	O
shown	VBN	O
below	IN	O
in	IN	O
Table	JJ	O
4	CD	O
were	VBD	O
used	VBN	O
.	.	O
A	DT	O
clone	NN	O
,	,	O
GEN-078D0508	NNP	O
,	,	O
obtained	VBN	O
by	IN	O
the	DT	O
second	JJ	O
5′	CD	O
RACE	NNP	O
was	VBD	O
300	CD	O
nucleotides	NNS	O
long	RB	O
.	.	O
This	DT	O
clone	NN	O
contained	VBD	O
an	DT	O
estimable	JJ	O
initiation	NN	O
codon	NN	O
and	CC	O
three	CD	O
preceding	VBG	O
in-frame	JJ	O
termination	NN	O
codons	NNS	O
.	.	O
From	IN	O
these	DT	O
three	CD	O
overlapping	VBG	O
clones	NNS	O
,	,	O
it	PRP	O
became	VBD	O
clear	JJ	O
that	IN	O
the	DT	O
whole	JJ	O
coding	NN	O
region	NN	O
comprises	VBZ	O
2,636	CD	O
nucleotides	NNS	O
.	.	O
This	DT	O
gene	NN	O
was	VBD	O
named	VBN	O
brain-specific	JJ	O
nucleosome	NN	O
assembly	NN	O
protein	NN	O
(	(	O
BNAP	NNP	O
)	)	O
gene	NN	O
.	.	O
The	DT	O
BNAP	NNP	O
gene	NN	O
contains	VBZ	O
a	DT	O
1,518-nucleotide	JJ	O
open	JJ	O
reading	NN	O
frame	NN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:20	NNP	O
.	.	O
The	DT	O
amino	NN	O
acid	NN	O
encoded	VBD	O
thereby	RB	O
comprises	VBZ	O
506	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:19	NNP	O
,	,	O
and	CC	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
whole	JJ	O
cDNA	NN	O
clone	NN	O
of	IN	O
BNAP	NNP	O
is	VBZ	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:21	NNP	O
.	.	O
As	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
:	:	O
21	CD	O
,	,	O
the	DT	O
5′	CD	O
noncoding	JJ	O
region	NN	O
of	IN	O
said	VBD	O
gene	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
generally	RB	O
rich	JJ	O
in	IN	O
GC	NNP	O
.	.	O
Candidate	NNP	O
initiation	NN	O
codon	NN	O
sequences	NNS	O
were	VBD	O
found	VBN	O
at	IN	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
266-268	JJ	O
,	,	O
287-289	JJ	O
and	CC	O
329-331	JJ	O
.	.	O
These	DT	O
three	CD	O
sequences	NNS	O
all	DT	O
had	VBD	O
well	RB	O
conserved	VBN	O
sequences	NNS	O
in	IN	O
the	DT	O
vicinity	NN	O
of	IN	O
the	DT	O
initiation	NN	O
codons	NNS	O
[	VBP	O
Kozak	NNP	B
,	,	I
M.	NNP	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
266	CD	I
,	,	I
19867-19870	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
.	.	O
According	VBG	O
to	TO	O
the	DT	O
scanning	VBG	O
model	NN	O
,	,	O
the	DT	O
first	JJ	O
ATG	NNP	O
(	(	O
nucleotides	JJ	O
Nos	NNP	O
.	.	O
266-268	JJ	O
)	)	O
of	IN	O
the	DT	O
cDNA	NN	O
clone	NN	O
may	MD	O
be	VB	O
the	DT	O
initiation	NN	O
codon	NN	O
.	.	O
The	DT	O
termination	NN	O
codon	NN	O
was	VBD	O
located	VBN	O
at	IN	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
1784-1786	JJ	O
.	.	O
The	DT	O
3′	CD	O
noncoding	JJ	O
redion	NN	O
was	VBD	O
generally	RB	O
rich	JJ	O
in	IN	O
AT	NNP	O
and	CC	O
two	CD	O
polyadenylation	NN	O
signals	NNS	O
(	(	O
AATAAA	NNP	O
)	)	O
were	VBD	O
located	VBN	O
at	IN	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
2606-2611	JJ	O
and	CC	O
2610-2615	JJ	O
,	,	O
respectively	RB	O
.	.	O
The	DT	O
longest	JJS	O
open	JJ	O
reading	NN	O
frame	NN	O
comprised	VBD	O
1,518	CD	O
nucleotides	NNS	O
coding	VBG	O
for	IN	O
506	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
and	CC	O
the	DT	O
calculated	JJ	O
molecular	JJ	O
weight	NN	O
of	IN	O
the	DT	O
BNAP	NNP	O
gene	NN	O
product	NN	O
was	VBD	O
57,600	CD	O
daltons	NNS	O
.	.	O
Hydrophilic	NNP	O
plots	NNS	O
indicated	VBD	O
that	IN	O
BNAP	NNP	O
is	VBZ	O
very	RB	O
hydrophilic	JJ	O
,	,	O
like	IN	O
other	JJ	O
NAPs	NNP	O
.	.	O
For	IN	O
recombinant	JJ	O
BNAP	NNP	O
expression	NN	O
and	CC	O
purification	NN	O
and	CC	O
for	IN	O
eliminating	VBG	O
the	DT	O
possibility	NN	O
that	IN	O
the	DT	O
BNAP	NNP	O
gene	NN	O
sequence	NN	O
might	MD	O
give	VB	O
three	CD	O
chimera	NN	O
clones	NNS	O
in	IN	O
the	DT	O
step	NN	O
of	IN	O
5′	CD	O
RACE	NNP	O
,	,	O
RT-PCR	NNP	O
was	VBD	O
performed	VBN	O
using	VBG	O
a	DT	O
sequence	NN	O
comprising	VBG	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
326-356	JJ	O
as	IN	O
a	DT	O
sense	NN	O
primer	NN	O
and	CC	O
a	DT	O
sequence	NN	O
comprising	VBG	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
1758-1786	JJ	O
as	IN	O
an	DT	O
antisenses	VBZ	O
primer	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
a	DT	O
single	JJ	O
product	NN	O
of	IN	O
about	IN	O
1,500	CD	O
by	IN	O
was	VBD	O
obtained	VBN	O
and	CC	O
it	PRP	O
was	VBD	O
thus	RB	O
confirmed	VBN	O
that	IN	O
said	VBD	O
sequence	NN	O
is	VBZ	O
not	RB	O
a	DT	O
chimera	NN	O
but	CC	O
a	DT	O
single	JJ	O
transcript	NN	O
.	.	O
(	(	O
2	CD	O
)	)	O
Comparison	NNP	O
between	IN	O
BNAP	NNP	O
and	CC	O
NAPs	NNP	O
The	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
deduced	VBD	O
from	IN	O
BNAP	NNP	O
showed	VBD	O
46	CD	O
%	NN	O
identity	NN	O
and	CC	O
65	CD	O
%	NN	O
similarity	NN	O
to	TO	O
hNRP	VB	O
.	.	O
The	DT	O
deduced	JJ	O
BNAP	NNP	O
gene	NN	O
product	NN	O
had	VBD	O
motifs	VBN	O
characteristic	NN	O
of	IN	O
the	DT	O
NAPs	NNP	O
already	RB	O
reported	VBD	O
and	CC	O
of	IN	O
BNAP	NNP	O
.	.	O
In	IN	O
general	JJ	O
,	,	O
half	NN	O
of	IN	O
the	DT	O
C	NNP	O
terminus	NN	O
was	VBD	O
well	RB	O
conserved	VBN	O
in	IN	O
humans	NNS	O
and	CC	O
yeasts	NNS	O
.	.	O
The	DT	O
first	JJ	O
motif	NN	O
(	(	O
domain	VB	O
I	PRP	O
)	)	O
is	VBZ	O
KGIPDYWLI	NNP	O
(	(	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
309-317	JJ	O
)	)	O
.	.	O
This	DT	O
was	VBD	O
observed	VBN	O
also	RB	O
in	IN	O
hNRP	NN	O
(	(	O
KGIPSFWLT	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:75	NNP	O
)	)	O
)	)	O
and	CC	O
in	IN	O
yeast	JJ	O
NAP-I	NNP	O
(	(	O
KGIPEFWLT	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:76	NNP	O
)	)	O
)	)	O
.	.	O
The	DT	O
second	JJ	O
motif	NN	O
(	(	O
domain	VB	O
II	NNP	O
)	)	O
is	VBZ	O
ASFFNFFSPP	NNP	O
(	(	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
437-446	JJ	O
)	)	O
and	CC	O
this	DT	O
was	VBD	O
expressed	VBN	O
as	IN	O
DSFFNFFAPP	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:77	NNP	O
)	)	O
in	IN	O
hNRP	NN	O
and	CC	O
as	IN	O
ESFFNFFSP	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:78	NNP	O
)	)	O
in	IN	O
yeast	JJ	O
NAP-I	NNP	O
.	.	O
These	DT	O
two	CD	O
motifs	NNS	O
were	VBD	O
also	RB	O
conserved	VBN	O
in	IN	O
the	DT	O
deduced	JJ	O
mouse	NN	O
NAP-I	NNP	O
and	CC	O
DN38	NNP	O
peptides	NNS	O
.	.	O
Both	DT	O
conserved	VBD	O
motifs	NNS	O
were	VBD	O
each	DT	O
a	DT	O
hydrophilic	JJ	O
cluster	NN	O
,	,	O
and	CC	O
the	DT	O
Cys	NNP	O
in	IN	O
position	NN	O
402	CD	O
was	VBD	O
also	RB	O
found	VBN	O
conserved	VBD	O
.	.	O
Half	NN	O
of	IN	O
the	DT	O
N	NNP	O
terminus	NN	O
had	VBD	O
no	DT	O
motifs	NNS	O
strictly	RB	O
conserved	VBN	O
from	IN	O
yeasts	NNS	O
to	TO	O
mammalian	JJ	O
species	NNS	O
,	,	O
while	IN	O
motifs	NNS	O
conserved	VBN	O
among	IN	O
mammalian	JJ	O
species	NNS	O
were	VBD	O
found	VBN	O
.	.	O
For	IN	O
instance	NN	O
,	,	O
HDLERKYA	NNP	O
(	(	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
130	CD	O
to	TO	O
137	CD	O
)	)	O
and	CC	O
IINAEYEPTEEECEW	NNP	O
(	(	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
150-164	JJ	O
)	)	O
,	,	O
which	WDT	O
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
mammal-specific	JJ	O
functions	NNS	O
,	,	O
were	VBD	O
found	VBN	O
strictly	RB	O
conserved	VBN	O
.	.	O
NAPs	NNP	O
had	VBD	O
acidic	JJ	O
stretches	NNS	O
,	,	O
which	WDT	O
are	VBP	O
believed	VBN	O
to	TO	O
be	VB	O
readily	RB	O
capable	JJ	O
of	IN	O
binding	VBG	O
to	TO	O
histone	VB	O
or	CC	O
other	JJ	O
basic	JJ	O
proteins	NNS	O
.	.	O
All	DT	O
NAPs	NNP	O
had	VBD	O
three	CD	O
acidic	JJ	O
stretches	NNS	O
but	CC	O
the	DT	O
locations	NNS	O
thereof	WDT	O
were	VBD	O
not	RB	O
conserved	VBN	O
.	.	O
BNAP	NNP	O
has	VBZ	O
no	DT	O
such	JJ	O
three	CD	O
acidic	JJ	O
stretches	NNS	O
but	CC	O
,	,	O
instead	RB	O
,	,	O
three	CD	O
repeated	VBN	O
sequences	NNS	O
(	(	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
194-207	JJ	O
,	,	O
208-221	JJ	O
and	CC	O
222-235	JJ	O
)	)	O
with	IN	O
a	DT	O
long	JJ	O
acidic	JJ	O
cluster	NN	O
,	,	O
inclusive	NN	O
of	IN	O
41	CD	O
amino	NN	O
acid	NN	O
residues	VBZ	O
out	IN	O
of	IN	O
98	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
,	,	O
the	DT	O
consensus	NN	O
sequence	NN	O
being	VBG	O
ExxKExPEVKxEEK	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:79	NNP	O
)	)	O
(	(	O
each	DT	O
x	NN	O
being	VBG	O
a	DT	O
nonconserved	VBN	O
,	,	O
mostly	RB	O
hydrophobic	JJ	O
,	,	O
residue	JJ	O
)	)	O
.	.	O
Furthermore	RB	O
,	,	O
it	PRP	O
was	VBD	O
revealed	VBN	O
that	IN	O
the	DT	O
BNAP	NNP	O
sequence	NN	O
had	VBD	O
several	JJ	O
BNAP-specific	NNP	O
motifs	NNS	O
.	.	O
Thus	RB	O
,	,	O
an	DT	O
extremely	RB	O
serine-rich	JJ	O
doamin	NN	O
(	(	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
24-72	JJ	O
)	)	O
with	IN	O
33	CD	O
(	(	O
67	CD	O
%	NN	O
)	)	O
of	IN	O
49	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
being	VBG	O
serine	JJ	O
residues	NNS	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
N-terminus	NNP	O
portion	NN	O
.	.	O
On	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
level	NN	O
,	,	O
they	PRP	O
were	VBD	O
reflected	VBN	O
as	IN	O
incomplete	JJ	O
repetitions	NNS	O
of	IN	O
AGC	NNP	O
.	.	O
Following	VBG	O
this	DT	O
serine-rich	JJ	O
region	NN	O
,	,	O
there	EX	O
appeared	VBD	O
a	DT	O
basic	JJ	O
domain	NN	O
(	(	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
71-89	CD	O
)	)	O
comprising	VBG	O
10	CD	O
basic	JJ	O
amino	NN	O
acid	NN	O
residues	NNS	O
among	IN	O
19	CD	O
residues	NNS	O
.	.	O
BNAP	NNP	O
is	VBZ	O
supposed	VBN	O
to	TO	O
be	VB	O
localized	VBN	O
in	IN	O
the	DT	O
nucleus	NN	O
.	.	O
Two	CD	O
possible	JJ	O
signals	NNS	O
localized	VBN	O
in	IN	O
the	DT	O
nucleus	NN	O
were	VBD	O
observed	VBN	O
(	(	O
NLSs	NNP	O
)	)	O
.	.	O
The	DT	O
first	JJ	O
signal	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
basic	JJ	O
domain	NN	O
of	IN	O
BNAP	NNP	O
and	CC	O
its	PRP$	O
sequence	NN	O
YRKKR	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:96	NNP	O
)	)	O
(	(	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
75-79	JJ	O
)	)	O
was	VBD	O
similar	JJ	O
to	TO	O
NLS	NNP	O
(	(	O
GRKKR	NNP	O
)	)	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:80	NNP	O
)	)	O
of	IN	O
Tat	NNP	O
of	IN	O
HIV-1	NNP	O
.	.	O
The	DT	O
second	JJ	O
signal	NN	O
was	VBD	O
located	VBN	O
in	IN	O
the	DT	O
C	NNP	O
terminus	NN	O
and	CC	O
its	PRP$	O
sequence	NN	O
KKYRK	NNP	O
(	(	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
502-506	JJ	O
)	)	O
was	VBD	O
similar	JJ	O
to	TO	O
NLS	NNP	O
(	(	O
KKKRK	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:81	NNP	O
)	)	O
)	)	O
of	IN	O
the	DT	O
large	JJ	O
T	NNP	O
antigen	NN	O
of	IN	O
SV40	NNP	O
.	.	O
The	DT	O
presence	NN	O
of	IN	O
these	DT	O
two	CD	O
presumable	JJ	O
NLSs	NNP	O
suggested	VBD	O
the	DT	O
localization	NN	O
of	IN	O
BNAP	NNP	O
in	IN	O
the	DT	O
nucleus	NN	O
.	.	O
However	RB	O
the	DT	O
possibility	NN	O
that	IN	O
other	JJ	O
basic	JJ	O
clusters	NNS	O
might	MD	O
act	VB	O
as	IN	O
NLSs	NNP	O
could	MD	O
not	RB	O
be	VB	O
excluded	VBN	O
.	.	O
BNAP	NNP	O
has	VBZ	O
several	JJ	O
phosphorylation	NN	O
sites	NNS	O
and	CC	O
the	DT	O
activity	NN	O
of	IN	O
BNAP	NNP	O
may	MD	O
be	VB	O
controlled	VBN	O
through	IN	O
phosphorylation	NN	O
thereof	NN	O
.	.	O
(	(	O
3	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
was	VBD	O
performed	VBN	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
2	CD	O
)	)	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
clone	NN	O
GEN-078D05TA13	NNP	O
(	(	O
corresponding	VBG	O
to	TO	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
323	CD	O
to	TO	O
1558	CD	O
in	IN	O
the	DT	O
BNAP	NNP	O
gene	NN	O
sequence	NN	O
)	)	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
,	,	O
the	DT	O
PCR	NNP	O
product	NN	O
was	VBD	O
purified	VBN	O
and	CC	O
labeled	VBN	O
with	IN	O
[	JJ	O
32P	CD	O
]	JJ	O
-dCTP	NNP	O
(	(	O
random-primed	JJ	O
DNA	NNP	O
labeling	VBG	O
kit	NN	O
,	,	O
Boehringer	NNP	O
Mannheim	NNP	O
)	)	O
,	,	O
and	CC	O
the	DT	O
expression	NN	O
of	IN	O
BNAP	NNP	O
mRNA	NN	O
in	IN	O
normal	JJ	O
human	JJ	O
tissues	NNS	O
was	VBD	O
examined	VBN	O
using	VBG	O
an	DT	O
MTN	NNP	O
blot	NN	O
with	IN	O
the	DT	O
labeled	JJ	O
product	NN	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
,	,	O
a	DT	O
3.0	CD	O
kb	NN	O
transcript	NN	O
of	IN	O
BNAP	NNP	O
was	VBD	O
detected	VBN	O
(	(	O
8-hour	JJ	O
exposure	NN	O
)	)	O
in	IN	O
the	DT	O
brain	NN	O
among	IN	O
eight	CD	O
human	NNS	O
adult	NN	O
tissues	NNS	O
tested	VBN	O
,	,	O
namely	RB	O
heart	NN	O
,	,	O
brain	NN	O
,	,	O
placenta	NN	O
,	,	O
lung	NN	O
,	,	O
liver	NN	O
,	,	O
skeletal	JJ	O
muscle	NN	O
,	,	O
kidney	NN	O
and	CC	O
pancreas	NNS	O
and	CC	O
,	,	O
after	IN	O
longer	JJR	O
exposure	NN	O
(	(	O
24	CD	O
hours	NNS	O
)	)	O
,	,	O
a	DT	O
dim	JJ	O
band	NN	O
of	IN	O
the	DT	O
same	JJ	O
size	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
heart	NN	O
.	.	O
BNAP	NNP	O
was	VBD	O
found	VBN	O
equally	RB	O
expressed	VBN	O
in	IN	O
several	JJ	O
sites	NNS	O
of	IN	O
brain	NN	O
tested	VBN	O
whereas	NNS	O
,	,	O
in	IN	O
other	JJ	O
tissues	NNS	O
,	,	O
no	DT	O
signal	NN	O
was	VBD	O
detected	VBN	O
at	IN	O
all	DT	O
even	RB	O
after	IN	O
72	CD	O
hours	NNS	O
of	IN	O
exposure	NN	O
.	.	O
hNRP	NN	O
mRNA	NN	O
was	VBD	O
found	VBN	O
expressed	VBN	O
everywhere	RB	O
in	IN	O
the	DT	O
human	JJ	O
tissues	NNS	O
tested	VBN	O
whereas	IN	O
the	DT	O
expression	NN	O
of	IN	O
BNAP	NNP	O
mRNA	NN	O
was	VBD	O
tissue-specific	JJ	O
.	.	O
(	(	O
4	CD	O
)	)	O
Radiation	NNP	O
Hybrid	NNP	O
Mapping	NNP	O
Chromosomal	NNP	O
mapping	NN	O
of	IN	O
the	DT	O
BNAP	NNP	O
clone	NN	O
was	VBD	O
performed	VBN	O
by	IN	O
means	NNS	O
of	IN	O
radiation	NN	O
hybrid	JJ	O
mapping	NN	O
[	NN	O
Cox	NNP	B
,	,	I
D.	NNP	I
R.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Science	NNP	I
,	,	I
250	CD	I
,	,	I
245-250	CD	I
(	(	I
1990	CD	I
)	)	I
]	NN	O
.	.	O
Thus	RB	O
,	,	O
a	DT	O
total	JJ	O
human	JJ	O
genome	NN	O
radiation	NN	O
hybrid	JJ	O
clone	NN	O
(	(	O
G3RH	NNP	O
)	)	O
panel	NN	O
was	VBD	O
purchased	VBN	O
from	IN	O
Research	NNP	O
Genetics	NNP	O
,	,	O
Inc.	NNP	O
,	,	O
AL	NNP	O
,	,	O
USA	NNP	O
and	CC	O
PCR	NNP	O
was	VBD	O
carried	VBN	O
out	RP	O
for	IN	O
chromosomal	JJ	O
mapping	NN	O
analysis	NN	O
according	VBG	O
to	TO	O
the	DT	O
product	NN	O
manual	JJ	O
using	VBG	O
two	CD	O
primers	NNS	O
,	,	O
A1	NNP	O
and	CC	O
A2	NNP	O
,	,	O
respectively	RB	O
having	VBG	O
the	DT	O
nucleotide	JJ	O
sequences	NNS	O
shown	VBN	O
in	IN	O
Table	JJ	O
5	CD	O
.	.	O
The	DT	O
results	NNS	O
obtained	VBN	O
were	VBD	O
analyzed	VBN	O
utilizing	JJ	O
softwares	NNS	O
usable	JJ	O
on	IN	O
the	DT	O
Internet	NNP	O
[	NNP	O
Boehnke	NNP	B
,	,	I
M.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Am	NNP	I
.	.	I
J.	NNP	I
Hum	NNP	I
.	.	I
Genet.	NNP	I
,	,	I
46	CD	I
,	,	I
581-586	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
the	DT	O
BNAP	NNP	O
gene	NN	O
was	VBD	O
found	VBN	O
strongly	RB	O
linked	VBN	O
to	TO	O
the	DT	O
marker	NN	O
DXS990	NNP	O
(	(	O
LOD=1000	NNP	O
,	,	O
cR8000=−0.00	NN	O
)	)	O
.	.	O
Since	IN	O
DXS990	NNP	O
is	VBZ	O
a	DT	O
marker	NN	O
localized	VBN	O
on	IN	O
the	DT	O
chromosome	NN	O
Xq21.3-q22	NN	O
,	,	O
it	PRP	O
was	VBD	O
established	VBN	O
that	IN	O
BNAP	NNP	O
is	VBZ	O
localized	VBN	O
to	TO	O
the	DT	O
chromosomal	JJ	O
locus	NN	O
Xq21.3-q22	NNP	O
where	WRB	O
genes	NNS	O
involved	VBN	O
in	IN	O
several	JJ	O
signs	NNS	O
or	CC	O
symptoms	NNS	O
of	IN	O
X-chromosome-associated	JJ	O
mental	JJ	O
retardation	NN	O
are	VBP	O
localized	VBN	O
.	.	O
The	DT	O
nucleosome	NN	O
is	VBZ	O
not	RB	O
only	RB	O
a	DT	O
fundamental	JJ	O
chromosomal	JJ	O
structural	JJ	O
unit	NN	O
characteristic	NN	O
of	IN	O
eukaryotes	NNS	O
but	CC	O
also	RB	O
a	DT	O
gene	NN	O
expression	NN	O
regulating	VBG	O
unit	NN	O
.	.	O
Several	JJ	O
results	NNS	O
indicate	VBP	O
that	IN	O
genes	NNS	O
with	IN	O
high	JJ	O
transcription	NN	O
activity	NN	O
are	VBP	O
sensitive	JJ	O
to	TO	O
nuclease	VB	O
treatment	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
chromosome	NN	O
structure	NN	O
changes	NNS	O
with	IN	O
the	DT	O
transcription	NN	O
activity	NN	O
[	NNP	O
Elgin	NNP	B
,	,	I
S.	NNP	I
C.	NNP	I
R.	NNP	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
263	CD	I
,	,	I
19259-19262	CD	I
(	(	I
1988	CD	I
)	)	I
]	NN	O
.	.	O
NAP-I	NNP	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
in	IN	O
yeast	NN	O
,	,	O
mouse	NN	O
and	CC	O
human	JJ	O
and	CC	O
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
factors	NNS	O
capable	JJ	O
of	IN	O
promoting	VBG	O
nucleosome	JJ	O
construction	NN	O
in	IN	O
vivo	NN	O
.	.	O
In	IN	O
a	DT	O
study	NN	O
performed	VBN	O
on	IN	O
their	PRP$	O
sequences	NNS	O
,	,	O
NAPs	NNP	O
containing	VBG	O
the	DT	O
epitope	NN	O
of	IN	O
the	DT	O
specific	JJ	O
antibody	NN	O
4A8	CD	O
were	VBD	O
detected	VBN	O
in	IN	O
human	JJ	O
,	,	O
mouse	NN	O
,	,	O
frog	NN	O
,	,	O
Drosophila	NNP	O
and	CC	O
yeast	NNP	O
(	(	O
Saccharomyces	NNP	O
cerevisiae	NN	O
)	)	O
[	NN	O
Ishimi	NNP	B
,	,	I
Y.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Eur	NNP	I
.	.	I
J	NNP	I
.	.	I
Biochem.	NNP	I
,	,	I
162	CD	I
,	,	I
19-24	CD	I
(	(	I
1987	CD	I
)	)	I
]	NN	O
.	.	O
In	IN	O
these	DT	O
experiments	NNS	O
,	,	O
NAPs	NNP	O
,	,	O
upon	IN	O
SDS-PAGE	NNP	O
analysis	NN	O
,	,	O
electrophoretically	RB	O
migrated	VBN	O
to	TO	O
positions	NNS	O
corresponding	VBG	O
to	TO	O
a	DT	O
molecular	JJ	O
weight	NN	O
between	IN	O
50	CD	O
and	CC	O
60	CD	O
kDa	NN	O
,	,	O
whereas	IN	O
the	DT	O
recombinant	JJ	O
BNAP	NNP	O
slowly	RB	O
migrated	VBD	O
to	TO	O
a	DT	O
position	NN	O
of	IN	O
about	IN	O
80	CD	O
kDa	NNS	O
.	.	O
The	DT	O
epitope	NN	O
of	IN	O
4A8	CD	O
was	VBD	O
shown	VBN	O
to	TO	O
be	VB	O
localized	VBN	O
in	IN	O
the	DT	O
second	JJ	O
,	,	O
well-conserved	JJ	O
,	,	O
hydrophobic	JJ	O
motif	NN	O
.	.	O
And	CC	O
,	,	O
it	PRP	O
was	VBD	O
simultaneously	RB	O
shown	VBN	O
that	IN	O
the	DT	O
triplet	NN	O
FNF	NNP	O
is	VBZ	O
important	JJ	O
as	IN	O
a	DT	O
part	NN	O
of	IN	O
the	DT	O
epitope	NN	O
[	NNP	O
Fujii-Nakata	NNP	B
,	,	I
T.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
267	CD	I
,	,	I
20980-20986	CD	I
(	(	I
1992	CD	I
)	)	I
]	NN	O
.	.	O
BNAP	NNP	O
also	RB	O
contained	VBD	O
this	DT	O
consensus	NN	O
motif	NN	O
in	IN	O
domain	NN	O
II	NNP	O
.	.	O
The	DT	O
fact	NN	O
that	IN	O
domain	NN	O
II	NNP	O
is	VBZ	O
markedly	RB	O
hydrophobic	JJ	O
and	CC	O
the	DT	O
fact	NN	O
that	IN	O
domain	NN	O
II	NNP	O
can	MD	O
be	VB	O
recognized	VBN	O
by	IN	O
the	DT	O
immune	NN	O
system	NN	O
suggest	VBP	O
that	IN	O
it	PRP	O
is	VBZ	O
probably	RB	O
presented	VBN	O
on	IN	O
the	DT	O
BNAP	NNP	O
surface	NN	O
and	CC	O
is	VBZ	O
possibly	RB	O
involved	VBN	O
in	IN	O
protein-protein	JJ	O
interactions	NNS	O
.	.	O
Domain	NN	O
I	PRP	O
,	,	O
too	RB	O
,	,	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
protein-protein	JJ	O
interactions	NNS	O
.	.	O
Considering	VBG	O
that	IN	O
these	DT	O
are	VBP	O
conserved	VBN	O
generally	RB	O
among	IN	O
NAPs	NNP	O
,	,	O
though	RB	O
to	TO	O
a	DT	O
relatively	RB	O
low	JJ	O
extent	NN	O
,	,	O
it	PRP	O
is	VBZ	O
conceivable	JJ	O
that	IN	O
they	PRP	O
must	MD	O
be	VB	O
essential	JJ	O
for	IN	O
nucleosome	JJ	O
construction	NN	O
,	,	O
although	IN	O
the	DT	O
functional	JJ	O
meaning	NN	O
of	IN	O
the	DT	O
conserved	JJ	O
domains	NNS	O
is	VBZ	O
still	RB	O
unknown	JJ	O
.	.	O
The	DT	O
hNRP	NN	O
gene	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
thyroid	NN	O
gland	NN	O
,	,	O
stomach	NN	O
,	,	O
kidney	NN	O
,	,	O
intestine	NN	O
,	,	O
leukemia	NN	O
,	,	O
lung	NN	O
cancer	NN	O
,	,	O
mammary	JJ	O
cancer	NN	O
and	CC	O
so	RB	O
on	IN	O
[	NN	O
Simon	NNP	B
,	,	I
H.	NNP	I
U.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Biochem	NNP	I
.	.	I
J.	NNP	I
,	,	I
297	CD	I
,	,	I
389-397	CD	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
.	.	O
Like	IN	O
that	DT	O
,	,	O
NAPs	NNP	O
are	VBP	O
expressed	VBN	O
everywhere	RB	O
and	CC	O
are	VBP	O
thought	VBN	O
to	TO	O
be	VB	O
playing	VBG	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
fundamental	JJ	O
nucleosome	JJ	O
formation	NN	O
.	.	O
BNAP	NNP	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
brain-specific	JJ	O
nucleosome	JJ	O
formation	NN	O
and	CC	O
an	DT	O
insufficiency	NN	O
thereof	NN	O
may	MD	O
cause	VB	O
neurological	JJ	O
diseases	NNS	O
or	CC	O
mental	JJ	O
retardation	NN	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
deviated	JJ	O
functions	NNS	O
of	IN	O
neurons	NNS	O
.	.	O
BNAP	NNP	O
was	VBD	O
found	VBN	O
strongly	RB	O
linked	VBN	O
to	TO	O
a	DT	O
marker	NN	O
on	IN	O
the	DT	O
X-chromosome	JJ	O
q21.3-q22	NN	O
where	WRB	O
sequences	NNS	O
involved	VBN	O
in	IN	O
several	JJ	O
symptoms	NNS	O
of	IN	O
X-chromosome-associated	JJ	O
mental	JJ	O
retardation	NN	O
are	VBP	O
localized	VBN	O
.	.	O
This	DT	O
center-surrounding	JJ	O
region	NN	O
of	IN	O
X-chromosome	NNP	O
was	VBD	O
rich	JJ	O
in	IN	O
genes	NNS	O
responsible	JJ	O
for	IN	O
α-thalassemia	JJ	O
,	,	O
mental	JJ	O
retardation	NN	O
(	(	O
ATR-X	NNP	O
)	)	O
or	CC	O
some	DT	O
other	JJ	O
forms	NNS	O
of	IN	O
mental	JJ	O
retardation	NN	O
[	NNP	O
Gibbons	NNP	B
,	,	I
R.	NNP	I
J.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
80	CD	I
,	,	I
837-845	CD	I
(	(	I
1995	CD	I
)	)	I
]	NN	O
.	.	O
Like	IN	O
the	DT	O
analysis	NN	O
of	IN	O
the	DT	O
ATR-X	NNP	O
gene	NN	O
which	WDT	O
seems	VBZ	O
to	TO	O
regulate	VB	O
the	DT	O
nucleosome	JJ	O
structure	NN	O
,	,	O
the	DT	O
present	JJ	O
inventors	NNS	O
suppose	VBP	O
that	IN	O
BNAP	NNP	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
a	DT	O
certain	JJ	O
type	NN	O
of	IN	O
X-chromosome-linked	JJ	O
mental	JJ	O
retardation	NN	O
.	.	O
According	VBG	O
to	TO	O
this	DT	O
example	NN	O
,	,	O
the	DT	O
novel	NN	O
BNAP	NNP	O
gene	NN	O
is	VBZ	O
provided	VBN	O
and	CC	O
,	,	O
when	WRB	O
said	VBD	O
gene	NN	O
is	VBZ	O
used	VBN	O
,	,	O
it	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
detect	VB	O
the	DT	O
expression	NN	O
of	IN	O
said	VBD	O
gene	NN	O
in	IN	O
various	JJ	O
tissues	NNS	O
and	CC	O
to	TO	O
produce	VB	O
the	DT	O
BNAP	NNP	O
protein	NN	O
by	IN	O
the	DT	O
technology	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
.	.	O
Through	IN	O
these	DT	O
,	,	O
it	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
study	VB	O
the	DT	O
brain	NN	O
nucleosome	JJ	O
formation	NN	O
deeply	RB	O
involved	JJ	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
in	IN	O
variegated	JJ	O
activities	NNS	O
essential	JJ	O
to	TO	O
cells	NNS	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
functions	NNS	O
of	IN	O
cranial	JJ	O
nerve	NN	O
cells	NNS	O
and	CC	O
to	TO	O
diagnose	VB	O
various	JJ	O
neurological	JJ	O
diseases	NNS	O
or	CC	O
mental	JJ	O
retardation	NN	O
in	IN	O
which	WDT	O
these	DT	O
are	VBP	O
involved	VBN	O
and	CC	O
screen	VBN	O
out	RP	O
and	CC	O
evaluate	VB	O
drugs	NNS	O
for	IN	O
the	DT	O
treatment	NN	O
or	CC	O
prevention	NN	O
of	IN	O
such	JJ	O
diseases	NNS	O
.	.	O
Example	JJ	O
7	CD	O
Human	NNP	O
Skeletal	NNP	O
Muscle-Specific	NNP	O
Ubiquitin-Conjugating	NNP	O
Enzyme	NNP	O
Gene	NNP	O
(	(	O
UBE2G	NNP	O
Gene	NNP	O
)	)	O
The	DT	O
ubiquitin	JJ	O
system	NN	O
is	VBZ	O
a	DT	O
group	NN	O
of	IN	O
enzymes	NNS	O
essential	JJ	O
for	IN	O
cellular	JJ	O
processes	NNS	O
and	CC	O
is	VBZ	O
conserved	VBN	O
from	IN	O
yeast	NN	O
to	TO	O
human	JJ	O
.	.	O
Said	NNP	O
system	NN	O
is	VBZ	O
composed	VBN	O
of	IN	O
ubiquitin-activating	JJ	O
enzymes	NNS	O
(	(	O
UBAs	NNP	O
)	)	O
,	,	O
ubiquitin-conjugating	JJ	O
enzymes	NNS	O
(	(	O
UBCs	NNP	O
)	)	O
,	,	O
ubiquitin	JJ	O
protein	NN	O
ligases	NNS	O
(	(	O
UBRs	NNP	O
)	)	O
and	CC	O
26S	CD	O
proteasome	NN	O
particles	NNS	O
.	.	O
Ubiquitin	NNP	O
is	VBZ	O
transferred	VBN	O
from	IN	O
the	DT	O
above-mentioned	JJ	O
UBAs	NNP	O
to	TO	O
several	JJ	O
UBCs	NNP	O
,	,	O
whereby	NN	O
it	PRP	O
is	VBZ	O
activated	VBN	O
.	.	O
UBCs	NNP	O
transfer	NN	O
ubiquitins	VBZ	O
to	TO	O
target	VB	O
proteins	NNS	O
with	IN	O
or	CC	O
without	IN	O
the	DT	O
participation	NN	O
of	IN	O
UBRs	NNP	O
.	.	O
These	DT	O
ubiquitin-conjugated	JJ	O
target	NN	O
proteins	NNS	O
are	VBP	O
said	VBD	O
to	TO	O
induce	VB	O
a	DT	O
number	NN	O
of	IN	O
cellular	JJ	O
responses	NNS	O
,	,	O
such	JJ	O
as	IN	O
protein	JJ	O
degradation	NN	O
,	,	O
protein	NN	O
modification	NN	O
,	,	O
protein	JJ	O
translocation	NN	O
,	,	O
DNA	NNP	O
repair	NN	O
,	,	O
cell	NN	O
cycle	NN	O
control	NN	O
,	,	O
transcription	NN	O
control	NN	O
,	,	O
stress	NN	O
responses	NNS	O
,	,	O
etc	FW	O
.	.	O
and	CC	O
immunological	JJ	O
responses	NNS	O
[	VBP	O
Jentsch	NNP	B
,	,	I
S.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Biochim	NNP	I
.	.	I
Biophys	NNP	I
.	.	I
Acta	NNP	I
,	,	I
1089	CD	I
,	,	I
127-139	CD	I
(	(	I
1991	CD	I
)	)	I
;	:	O
Hershko	NNP	B
,	,	I
A.	NNP	I
and	CC	I
Ciechanover	NNP	I
,	,	I
A.	NNP	I
,	,	I
Annu	NNP	I
.	.	I
Rev	NNP	I
.	.	I
Biochem.	NNP	I
,	,	I
61	CD	I
,	,	I
761-807	CD	I
(	(	I
1992	CD	I
)	)	I
;	:	O
Jentsch	NNP	B
,	,	I
S.	NNP	I
,	,	I
Annu	NNP	I
.	.	I
Rev	NNP	I
.	.	I
Genet.	NNP	I
,	,	I
26	CD	I
,	,	I
179-207	CD	I
(	(	I
1992	CD	I
)	)	I
;	:	O
Ciechanover	NNP	B
,	,	I
A.	NNP	I
,	,	I
Cell	NNP	I
,	,	I
79	CD	I
,	,	I
13-21	CD	I
(	(	I
1994	CD	I
)	)	I
]	NN	O
.	.	O
UBCs	NNS	O
are	VBP	O
key	JJ	O
components	NNS	O
of	IN	O
this	DT	O
system	NN	O
and	CC	O
seem	VBP	O
to	TO	O
have	VB	O
distinct	JJ	O
substrate	NN	O
specificities	NNS	O
and	CC	O
modulate	VB	O
different	JJ	O
functions	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
Saccharomyces	NNP	O
cerevisiae	NN	O
UBC7	NNP	O
is	VBZ	O
induced	VBN	O
by	IN	O
cadmium	NN	O
and	CC	O
involved	VBN	O
in	IN	O
resistance	NN	O
to	TO	O
cadmium	VB	O
poisoning	VBG	O
[	NNP	O
Jungmann	NNP	B
,	,	I
J.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
361	CD	I
,	,	I
369-371	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
.	.	O
Degradation	NN	O
of	IN	O
MAT-α2	NNP	O
is	VBZ	O
also	RB	O
executed	VBN	O
by	IN	O
UBC7	NNP	O
and	CC	O
UBC6	NNP	O
[	NNP	O
Chen	NNP	B
,	,	I
P.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
74	CD	I
,	,	I
357-369	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
novel	JJ	O
gene	NN	O
obtained	VBN	O
in	IN	O
this	DT	O
example	NN	O
is	VBZ	O
UBC7-like	JJ	O
gene	NN	O
strongly	RB	O
expressed	VBN	O
in	IN	O
human	JJ	O
skeletal	JJ	O
muscle	NN	O
.	.	O
In	IN	O
the	DT	O
following	NN	O
,	,	O
cloning	VBG	O
and	CC	O
DNA	NNP	O
sequencing	VBG	O
thereof	NNS	O
are	VBP	O
described	VBN	O
.	.	O
(	(	O
1	CD	O
)	)	O
Cloning	NN	O
and	CC	O
DNA	NNP	O
Sequencing	NNP	O
of	IN	O
Human	NNP	O
Skeletal	NNP	O
Muscle-Specific	NNP	O
Ubiquitin-Conjugating	NNP	O
Enzyme	NNP	O
Gene	NNP	O
(	(	O
Ube2G	NNP	O
Gene	NNP	O
)	)	O
Following	VBG	O
the	DT	O
same	JJ	O
procedure	NN	O
as	IN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
,	,	O
cDNA	JJ	O
clones	NNS	O
were	VBD	O
arbitrarily	RB	O
selected	VBN	O
from	IN	O
a	DT	O
human	JJ	O
fetal	NN	O
brain	NN	O
cDNA	NN	O
library	NN	O
and	CC	O
subjected	VBN	O
to	TO	O
sequence	VB	O
analysis	NN	O
,	,	O
and	CC	O
database	NN	O
searches	NNS	O
were	VBD	O
performed	VBN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
a	DT	O
cDNA	NN	O
clone	NN	O
,	,	O
GEN-423A12	NNP	O
,	,	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
significantly	RB	O
high	JJ	O
level	NN	O
of	IN	O
homology	NN	O
to	TO	O
the	DT	O
genes	NNS	O
coding	VBG	O
for	IN	O
ubiquitin-conjugating	JJ	O
enzymes	NNS	O
(	(	O
UBCs	NNP	O
)	)	O
in	IN	O
various	JJ	O
species	NNS	O
.	.	O
Since	IN	O
said	VBD	O
GEN-423A12	NNP	O
clone	NN	O
was	VBD	O
lacking	VBG	O
in	IN	O
the	DT	O
5′	CD	O
side	NN	O
,	,	O
5′	CD	O
RACE	NNP	O
was	VBD	O
performed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
2	CD	O
(	(	O
2	CD	O
)	)	O
to	TO	O
obtain	VB	O
an	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
.	.	O
For	IN	O
said	VBD	O
5′	CD	O
RACE	NNP	O
,	,	O
two	CD	O
primers	NNS	O
,	,	O
P1	NNP	O
and	CC	O
P2	NNP	O
,	,	O
respectively	RB	O
having	VBG	O
the	DT	O
nucleotide	JJ	O
sequences	NNS	O
shown	VBN	O
in	IN	O
Table	JJ	O
6	CD	O
were	VBD	O
used	VBN	O
.	.	O
The	DT	O
5′	CD	O
RACE	NNP	O
product	NN	O
was	VBD	O
inserted	VBN	O
into	IN	O
pT7Blue	NN	O
(	(	O
R	NNP	O
)	)	O
T-Vector	NN	O
and	CC	O
clones	NNS	O
with	IN	O
an	DT	O
insert	JJ	O
proper	NN	O
in	IN	O
size	NN	O
were	VBD	O
selected	VBN	O
.	.	O
Four	CD	O
of	IN	O
the	DT	O
5′	CD	O
RACE	NNP	O
clones	NNS	O
obtained	VBN	O
from	IN	O
two	CD	O
independent	JJ	O
PCR	NNP	O
reactions	NNS	O
contained	VBD	O
the	DT	O
same	JJ	O
sequence	NN	O
but	CC	O
were	VBD	O
different	JJ	O
in	IN	O
length	NN	O
.	.	O
By	IN	O
sequencing	VBG	O
the	DT	O
above	JJ	O
clones	NNS	O
,	,	O
the	DT	O
coding	VBG	O
sequence	NN	O
and	CC	O
adjacent	JJ	O
5′-	JJ	O
and	CC	O
3′-flanking	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
novel	JJ	O
gene	NN	O
were	VBD	O
determined	VBN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
it	PRP	O
was	VBD	O
revealed	VBN	O
that	IN	O
the	DT	O
novel	JJ	O
gene	NN	O
has	VBZ	O
a	DT	O
total	JJ	O
length	NN	O
of	IN	O
617	CD	O
nucleotides	NNS	O
.	.	O
This	DT	O
gene	NN	O
was	VBD	O
named	VBN	O
human	JJ	O
skeletal	JJ	O
muscle-specific	JJ	O
ubiquitin-conjugating	JJ	O
enzyme	NN	O
gene	NN	O
(	(	O
UBE2G	NNP	O
gene	NN	O
)	)	O
.	.	O
To	TO	O
exclude	VB	O
the	DT	O
conceivable	JJ	O
possibility	NN	O
that	IN	O
this	DT	O
sequence	NN	O
was	VBD	O
a	DT	O
chimera	NN	O
clone	NN	O
,	,	O
RT-PCR	NNP	O
was	VBD	O
performed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
6	CD	O
(	(	O
1	CD	O
)	)	O
using	VBG	O
the	DT	O
sense	NN	O
primer	NN	O
to	TO	O
amplify	VB	O
said	VBD	O
sequence	NN	O
from	IN	O
the	DT	O
human	JJ	O
fetal	JJ	O
brain	NN	O
cDNA	NN	O
library	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
a	DT	O
single	JJ	O
PCR	NNP	O
product	NN	O
was	VBD	O
obtained	VBN	O
,	,	O
whereby	WRB	O
it	PRP	O
was	VBD	O
confirmed	VBN	O
that	IN	O
said	VBD	O
sequence	NN	O
is	VBZ	O
not	RB	O
a	DT	O
chimera	NN	O
one	CD	O
.	.	O
The	DT	O
UBE2G	NNP	O
gene	NN	O
contains	VBZ	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
510	CD	O
nucleotides	NNS	O
,	,	O
which	WDT	O
is	VBZ	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:23	NNP	O
,	,	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
encoded	VBD	O
thereby	RB	O
comprises	VBZ	O
170	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:22	NNP	O
,	,	O
and	CC	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
entire	JJ	O
UBE2G	NNP	O
cDNA	NN	O
is	VBZ	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:24	NNP	O
.	.	O
As	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:24	NNP	O
,	,	O
the	DT	O
estimable	JJ	O
initiation	NN	O
codon	NN	O
was	VBD	O
located	VBN	O
at	IN	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
19-21	JJ	O
,	,	O
corresponding	VBG	O
to	TO	O
the	DT	O
first	JJ	O
ATG	NNP	O
triplet	NN	O
of	IN	O
the	DT	O
cDNA	NN	O
clone	NN	O
.	.	O
Since	IN	O
no	DT	O
preceding	VBG	O
in-frame	JJ	O
termination	NN	O
codon	NN	O
was	VBD	O
found	VBN	O
,	,	O
it	PRP	O
was	VBD	O
deduced	VBN	O
that	IN	O
this	DT	O
clone	NN	O
contains	VBZ	O
the	DT	O
entire	JJ	O
open	JJ	O
reading	NN	O
frame	NN	O
on	IN	O
the	DT	O
following	JJ	O
grounds	NNS	O
.	.	O
Thus	RB	O
,	,	O
(	(	O
a	DT	O
)	)	O
the	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
is	VBZ	O
highly	RB	O
homologous	JJ	O
to	TO	O
S.	NNP	O
cerevisiae	NN	O
UBC7	NNP	O
and	CC	O
said	VBD	O
initiation	NN	O
codon	NN	O
agrees	VBZ	O
with	IN	O
that	DT	O
of	IN	O
yeast	NN	O
UBC7	NNP	O
,	,	O
supporting	VBG	O
said	VBD	O
ATG	NNP	O
as	IN	O
such	JJ	O
.	.	O
(	(	O
b	NN	O
)	)	O
The	DT	O
sequence	NN	O
AGGATGA	NNP	O
is	VBZ	O
similar	JJ	O
to	TO	O
the	DT	O
consensus	NN	O
sequence	NN	O
(	(	O
A/G	NNP	O
)	)	O
CCATGG	NNP	O
around	IN	O
the	DT	O
initiation	NN	O
codon	NN	O
[	NNP	O
Kozak	NNP	B
,	,	I
M.	NNP	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
266	CD	I
,	,	I
19867-19870	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
.	.	O
(	(	O
2	CD	O
)	)	O
Comparison	NNP	O
in	IN	O
Amino	NNP	O
Acid	NNP	O
Sequence	NNP	O
Between	NNP	O
UBE2G	NNP	O
and	CC	O
UBCs	NNP	O
Comparison	NNP	O
in	IN	O
amino	NN	O
acid	NN	O
sequence	NN	O
between	IN	O
UBE2G	NNP	O
and	CC	O
UBCs	NNP	O
suggested	VBD	O
that	IN	O
the	DT	O
active	JJ	O
site	NN	O
cystein	NN	O
capable	JJ	O
of	IN	O
binding	VBG	O
to	TO	O
ubiquitin	VB	O
should	MD	O
be	VB	O
the	DT	O
90th	CD	O
residue	JJ	O
cystein	NN	O
.	.	O
The	DT	O
peptides	NNS	O
encoded	VBN	O
by	IN	O
these	DT	O
genes	NNS	O
seem	VBP	O
to	TO	O
belong	VB	O
to	TO	O
the	DT	O
same	JJ	O
family	NN	O
.	.	O
(	(	O
3	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
2	CD	O
)	)	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
entire	JJ	O
sequence	NN	O
of	IN	O
UBE2G	NNP	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
,	,	O
the	DT	O
PCR	NNP	O
product	NN	O
was	VBD	O
purified	VBN	O
and	CC	O
labeled	VBN	O
with	IN	O
[	JJ	O
32P	CD	O
]	JJ	O
-dCTP	NNP	O
(	(	O
random-primed	JJ	O
DNA	NNP	O
labeling	VBG	O
kit	NN	O
,	,	O
Boehringer	NNP	O
Mannheim	NNP	O
)	)	O
and	CC	O
the	DT	O
expression	NN	O
of	IN	O
UBE2G	NNP	O
mRNA	NN	O
in	IN	O
normal	JJ	O
human	JJ	O
tissues	NNS	O
using	VBG	O
the	DT	O
labeled	JJ	O
product	NN	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O
The	DT	O
membrane	NN	O
used	VBN	O
was	VBD	O
an	DT	O
MTN	NNP	O
blot	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
the	DT	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
,	,	O
4.4	CD	O
kb	NN	O
,	,	O
2.4	CD	O
kb	NN	O
and	CC	O
1.6	CD	O
kb	NN	O
transcripts	NNS	O
could	MD	O
be	VB	O
detected	VBN	O
in	IN	O
all	DT	O
16	CD	O
human	JJ	O
adult	NN	O
tissues	NNS	O
,	,	O
namely	RB	O
heart	NN	O
,	,	O
brain	NN	O
,	,	O
placenta	NN	O
,	,	O
lung	NN	O
,	,	O
liver	NN	O
,	,	O
skeletal	JJ	O
muscle	NN	O
,	,	O
kidney	NN	O
,	,	O
pancreas	NNS	O
,	,	O
spleen	NN	O
,	,	O
thyroid	JJ	O
gland	NN	O
,	,	O
urinary	JJ	O
bladder	NN	O
,	,	O
testis	NN	O
,	,	O
ovary	JJ	O
,	,	O
small	JJ	O
intestine	NN	O
,	,	O
large	JJ	O
intestine	NN	O
and	CC	O
peripheral	JJ	O
blood	NN	O
leukocye	NN	O
,	,	O
after	IN	O
18	CD	O
hours	NNS	O
of	IN	O
exposure	NN	O
.	.	O
Strong	JJ	O
expression	NN	O
of	IN	O
these	DT	O
transcripts	NNS	O
was	VBD	O
observed	VBN	O
in	IN	O
skeletal	JJ	O
muscle	NN	O
.	.	O
(	(	O
4	CD	O
)	)	O
Radiation	NNP	O
Hybrid	NNP	O
Mapping	NNP	O
Chromosomal	NNP	O
mapping	NN	O
of	IN	O
the	DT	O
UBE2G	NNP	O
clone	NN	O
was	VBD	O
performed	VBN	O
by	IN	O
radiation	NN	O
hybrid	JJ	O
mapping	NN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
6	CD	O
(	(	O
4	CD	O
)	)	O
.	.	O
The	DT	O
primers	NNS	O
C1	NNP	O
and	CC	O
C4	NNP	O
used	VBD	O
in	IN	O
PCR	NNP	O
for	IN	O
chromosomal	JJ	O
mapping	NN	O
analysis	NN	O
respectively	RB	O
correspond	NN	O
to	TO	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
415-435	JJ	O
and	CC	O
nucleotides	JJ	O
Nos	NNP	O
.	.	O
509-528	JJ	O
in	IN	O
the	DT	O
sequence	NN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:24	NNP	O
and	CC	O
their	PRP$	O
nucleotide	JJ	O
sequences	NNS	O
are	VBP	O
as	IN	O
shown	VBN	O
below	IN	O
in	IN	O
Table	JJ	O
7	CD	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
the	DT	O
UBE2G	NNP	O
gene	NN	O
was	VBD	O
found	VBN	O
linked	VBN	O
to	TO	O
the	DT	O
markers	NNS	O
D1S446	NNP	O
(	(	O
LOD=12.52	NNP	O
,	,	O
cR8000=8.60	NN	O
)	)	O
and	CC	O
D1S235	NNP	O
(	(	O
LOD=9.14	NNP	O
,	,	O
cR8000=22.46	NN	O
)	)	O
.	.	O
These	DT	O
markers	NNS	O
are	VBP	O
localized	VBN	O
to	TO	O
the	DT	O
chromosome	NN	O
bands	VBZ	O
1q42.13-q42.3	JJ	O
.	.	O
UBE2G	NNP	O
was	VBD	O
expressed	VBN	O
strongly	RB	O
in	IN	O
skeletal	JJ	O
muscle	NN	O
and	CC	O
very	RB	O
weakly	RB	O
in	IN	O
all	DT	O
other	JJ	O
tissues	NNS	O
examined	VBN	O
.	.	O
All	DT	O
other	JJ	O
UBCs	NNP	O
are	VBP	O
involved	VBN	O
in	IN	O
essential	JJ	O
cellular	JJ	O
functions	NNS	O
,	,	O
such	JJ	O
as	IN	O
cell	NN	O
cycle	NN	O
control	NN	O
,	,	O
and	CC	O
those	DT	O
UBCs	NNP	O
are	VBP	O
expressed	VBN	O
ubiquitously	RB	O
.	.	O
However	RB	O
,	,	O
the	DT	O
expression	NN	O
pattern	NN	O
of	IN	O
UBE2G	NNP	O
might	MD	O
suggest	VB	O
a	DT	O
muscle-specific	JJ	O
role	NN	O
thereof	NN	O
.	.	O
While	IN	O
the	DT	O
three	CD	O
transcripts	NNS	O
differing	VBG	O
in	IN	O
size	NN	O
were	VBD	O
detected	VBN	O
,	,	O
attempts	NNS	O
failed	VBD	O
to	TO	O
identify	VB	O
which	WDT	O
corresponds	VBZ	O
to	TO	O
the	DT	O
cDNA	NN	O
clone	NN	O
.	.	O
The	DT	O
primary	JJ	O
structure	NN	O
of	IN	O
the	DT	O
UBE2G	NNP	O
product	NN	O
showed	VBD	O
an	DT	O
extreme	JJ	O
homology	NN	O
to	TO	O
yeast	VB	O
UBC7	NNP	O
.	.	O
On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
nematode	NN	O
UBC7	NNP	O
showed	VBD	O
strong	JJ	O
homology	NN	O
to	TO	O
yeast	VB	O
UBC7	NNP	O
.	.	O
It	PRP	O
is	VBZ	O
involved	VBN	O
in	IN	O
degradation	NN	O
of	IN	O
the	DT	O
repressor	NN	O
and	CC	O
further	JJ	O
confers	NNS	O
resistance	NN	O
to	TO	O
cadmium	VB	O
in	IN	O
yeasts	NNS	O
.	.	O
The	DT	O
similarities	NNS	O
among	IN	O
these	DT	O
proteins	NNS	O
suggest	VBP	O
that	IN	O
they	PRP	O
belong	VBP	O
to	TO	O
the	DT	O
same	JJ	O
family	NN	O
.	.	O
It	PRP	O
is	VBZ	O
speculated	VBN	O
that	IN	O
UBE2G	NNP	O
is	VBZ	O
involved	VBN	O
in	IN	O
degradation	NN	O
of	IN	O
muscle-specific	JJ	O
proteins	NNS	O
and	CC	O
that	IN	O
a	DT	O
defect	NN	O
in	IN	O
said	VBD	O
gene	NN	O
could	MD	O
lead	VB	O
to	TO	O
such	JJ	O
diseases	NNS	O
as	IN	O
muscular	JJ	O
dystrophy	NN	O
.	.	O
Recently	RB	O
,	,	O
another	DT	O
proteolytic	JJ	O
enzyme	NN	O
,	,	O
calpain	VBP	O
3	CD	O
,	,	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
responsible	JJ	O
for	IN	O
limb-girdle	JJ	O
muscular	JJ	O
dystrophy	NN	O
type	NN	O
2A	CD	O
[	NNP	O
Richard	NNP	B
,	,	I
I.	NNP	I
,	,	I
et	NN	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
81	CD	I
,	,	I
27-40	CD	I
(	(	I
1995	CD	I
)	)	I
]	NN	O
.	.	O
At	IN	O
the	DT	O
present	JJ	O
,	,	O
the	DT	O
chromosomal	JJ	O
location	NN	O
of	IN	O
UBE2G	NNP	O
suggests	VBZ	O
no	DT	O
significant	JJ	O
relationship	NN	O
with	IN	O
any	DT	O
hereditary	JJ	O
muscular	JJ	O
disease	NN	O
but	CC	O
it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
a	DT	O
relation	NN	O
to	TO	O
the	DT	O
gene	NN	O
will	MD	O
be	VB	O
unearthed	VBN	O
by	IN	O
linkage	NN	O
analysis	NN	O
in	IN	O
future	JJ	O
.	.	O
In	IN	O
accordance	NN	O
with	IN	O
this	DT	O
example	NN	O
,	,	O
the	DT	O
novel	JJ	O
UBE2G	NNP	O
gene	NN	O
is	VBZ	O
provided	VBN	O
and	CC	O
the	DT	O
use	NN	O
of	IN	O
said	VBD	O
gene	NN	O
enables	NNS	O
detection	NN	O
of	IN	O
its	PRP$	O
expression	NN	O
in	IN	O
various	JJ	O
tissues	NNS	O
and	CC	O
production	NN	O
of	IN	O
the	DT	O
UBE2G	NNP	O
protein	NN	O
by	IN	O
the	DT	O
technology	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
.	.	O
Through	IN	O
these	DT	O
,	,	O
it	PRP	O
becomes	VBZ	O
possible	JJ	O
to	TO	O
study	VB	O
the	DT	O
degradation	NN	O
of	IN	O
muscle-specific	JJ	O
proteins	NNS	O
deeply	RB	O
involved	VBN	O
in	IN	O
basic	JJ	O
activities	NNS	O
variegated	VBN	O
and	CC	O
essential	JJ	O
to	TO	O
cells	NNS	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
and	CC	O
the	DT	O
functions	NNS	O
of	IN	O
skeletal	JJ	O
muscle	NN	O
,	,	O
to	TO	O
diagnose	VB	O
various	JJ	O
muscular	JJ	O
diseases	NNS	O
in	IN	O
which	WDT	O
these	DT	O
are	VBP	O
involved	VBN	O
and	CC	O
further	RBR	O
to	TO	O
screen	VB	O
out	RP	O
and	CC	O
evaluate	VB	O
drugs	NNS	O
for	IN	O
the	DT	O
treatment	NN	O
and	CC	O
prevention	NN	O
of	IN	O
such	JJ	O
diseases	NNS	O
.	.	O
Example	JJ	O
8	CD	O
TMP-2	JJ	O
Gene	NNP	O
(	(	O
1	CD	O
)	)	O
TMP-2	NNP	O
Gene	NNP	O
Cloning	NNP	O
and	CC	O
DNA	NNP	O
Sequencing	NNP	O
Following	VBG	O
the	DT	O
procedure	NN	O
of	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
,	,	O
cDNA	JJ	O
clones	NNS	O
were	VBD	O
arbitrarily	RB	O
selected	VBN	O
from	IN	O
a	DT	O
human	JJ	O
fetal	NN	O
brain	NN	O
cDNA	NN	O
library	NN	O
and	CC	O
subjected	VBN	O
to	TO	O
sequence	VB	O
analysis	NN	O
,	,	O
and	CC	O
database	NN	O
searches	NNS	O
were	VBD	O
performed	VBN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
a	DT	O
clone	NN	O
(	(	O
GEN-092E10	NNP	O
)	)	O
having	VBG	O
a	DT	O
cDNA	NN	O
sequence	NN	O
highly	RB	O
homologous	JJ	O
to	TO	O
a	DT	O
transmembrane	NN	O
protein	NN	O
gene	NN	O
(	(	O
accession	JJ	O
No	DT	O
.	.	O
:	:	O
U19878	NN	O
)	)	O
was	VBD	O
found	VBN	O
out	RP	O
.	.	O
Membrane	NNP	O
protein	NN	O
genes	NNS	O
have	VBP	O
so	RB	O
far	RB	O
been	VBN	O
cloned	VBN	O
in	IN	O
frog	NN	O
(	(	O
Xenopus	NNP	O
laevis	NN	O
)	)	O
and	CC	O
human	JJ	O
.	.	O
These	DT	O
are	VBP	O
considered	VBN	O
to	TO	O
be	VB	O
a	DT	O
gene	NN	O
for	IN	O
a	DT	O
transmembrane	NN	O
type	NN	O
protein	NN	O
having	VBG	O
a	DT	O
follistatin	NN	O
module	NN	O
and	CC	O
an	DT	O
epidermal	JJ	O
growth	NN	O
factor	NN	O
(	(	O
EGF	NNP	O
)	)	O
domain	NN	O
(	(	O
accession	NN	O
No	NNP	O
.	.	O
:	:	O
U19878	NN	O
)	)	O
.	.	O
The	DT	O
sequence	NN	O
information	NN	O
of	IN	O
the	DT	O
above	JJ	O
protein	NN	O
gene	NN	O
indicated	VBD	O
that	IN	O
the	DT	O
GEN-092E10	NNP	O
clone	NN	O
was	VBD	O
lacking	VBG	O
in	IN	O
the	DT	O
5′	CD	O
region	NN	O
,	,	O
so	IN	O
that	IN	O
the	DT	O
λgt10	NNP	O
cDNA	NN	O
library	NN	O
(	(	O
human	JJ	O
fetal	NN	O
brain	NN	O
5′-STRETCH	JJ	O
PLUS	NNP	O
cDNA	NN	O
;	:	O
Clontech	NNP	O
)	)	O
was	VBD	O
screened	VBN	O
using	VBG	O
the	DT	O
GEN-092E10	NNP	O
clone	NN	O
as	IN	O
a	DT	O
probe	NN	O
,	,	O
whereby	WRB	O
a	DT	O
cDNA	NN	O
clone	NN	O
containing	VBG	O
a	DT	O
further	JJ	O
5′	CD	O
upstream	JJ	O
region	NN	O
was	VBD	O
isolated	VBN	O
.	.	O
Both	DT	O
strands	NNS	O
of	IN	O
this	DT	O
cDNA	NN	O
clone	NN	O
were	VBD	O
sequenced	VBN	O
,	,	O
whereby	WRB	O
the	DT	O
sequence	NN	O
covering	VBG	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
became	VBD	O
clear	JJ	O
.	.	O
This	DT	O
gene	NN	O
was	VBD	O
named	VBN	O
TMP-2	NNP	O
gene	NN	O
.	.	O
The	DT	O
TMP-2	NNP	O
gene	NN	O
was	VBD	O
found	VBN	O
to	TO	O
contain	VB	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
1,122	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:26	NNP	O
,	,	O
encoding	VBG	O
an	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
374	CD	O
residues	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:25	NNP	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
entire	JJ	O
TMP-2	NNP	O
cDNA	NN	O
clone	NN	O
comprises	VBZ	O
1,721	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:27	NNP	O
.	.	O
As	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
:	:	O
27	CD	O
,	,	O
the	DT	O
5′	CD	O
noncoding	JJ	O
region	NN	O
was	VBD	O
generally	RB	O
rich	JJ	O
in	IN	O
GC	NNP	O
.	.	O
Several	JJ	O
candidates	NNS	O
for	IN	O
the	DT	O
initiation	NN	O
codon	NN	O
were	VBD	O
found	VBN	O
but	CC	O
,	,	O
according	VBG	O
to	TO	O
the	DT	O
scanning	VBG	O
model	NN	O
,	,	O
the	DT	O
5th	CD	O
ATG	NNP	O
of	IN	O
the	DT	O
cDNA	NN	O
clone	NN	O
(	(	O
bases	NNS	O
Nos	NNP	O
.	.	O
368-370	JJ	O
)	)	O
was	VBD	O
estimated	VBN	O
as	IN	O
the	DT	O
initiation	NN	O
codon	NN	O
.	.	O
The	DT	O
termination	NN	O
codon	NN	O
was	VBD	O
located	VBN	O
at	IN	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
1490-1492	JJ	O
.	.	O
The	DT	O
polyadenylation	NN	O
signal	NN	O
(	(	O
AATAAA	NNP	O
)	)	O
was	VBD	O
located	VBN	O
at	IN	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
1703-1708	JJ	O
.	.	O
The	DT	O
calculated	JJ	O
molecular	JJ	O
weight	NN	O
of	IN	O
the	DT	O
TMP-2	NNP	O
gene	NN	O
product	NN	O
was	VBD	O
41,400	CD	O
daltons	NNS	O
.	.	O
As	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
the	DT	O
transmembrane	NN	O
genes	NNS	O
have	VBP	O
a	DT	O
follistatin	NN	O
module	NN	O
and	CC	O
an	DT	O
EGF	NNP	O
domain	NN	O
.	.	O
These	DT	O
motifs	NNS	O
were	VBD	O
also	RB	O
found	VBN	O
conserved	VBN	O
in	IN	O
the	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
.	.	O
The	DT	O
TMP-2	NNP	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
presumably	RB	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
cell	NN	O
proliferation	NN	O
or	CC	O
intercellular	JJ	O
communication	NN	O
,	,	O
since	IN	O
,	,	O
on	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
level	NN	O
,	,	O
said	VBD	O
gene	NN	O
shows	NNS	O
homology	NN	O
,	,	O
across	IN	O
the	DT	O
EGF	NNP	O
domain	NN	O
,	,	O
to	TO	O
TGF-α	NNP	O
(	(	O
transforming	VBG	O
growth	NN	O
factor-α	NN	O
;	:	O
Derynck	NNP	B
,	,	I
R.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
38	CD	I
,	,	I
287-297	CD	I
(	(	I
1984	CD	I
)	)	I
]	NN	O
,	,	O
beta-cellulin	JJ	O
[	NNP	O
Igarashi	NNP	B
,	,	I
K.	NNP	I
and	CC	I
Folkman	NNP	I
,	,	I
J.	NNP	I
,	,	I
Science	NNP	I
,	,	I
259	CD	I
,	,	I
1604-1607	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
,	,	O
heparin-binding	JJ	O
EGF-like	JJ	O
growth	NN	O
factor	NN	O
[	NNP	O
Higashiyama	NNP	B
,	,	I
S.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Science	NNP	I
,	,	I
251	CD	I
,	,	I
936-939	CD	I
(	(	I
1991	CD	I
)	)	I
]	NN	O
and	CC	O
schwannoma-derived	JJ	O
growth	NN	O
factor	NN	O
[	NNP	O
Kimura	NNP	B
,	,	I
H.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
,	,	I
348	CD	I
,	,	I
257-260	CD	I
(	(	I
1990	CD	I
)	)	I
]	NN	O
.	.	O
(	(	O
2	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
2	CD	O
)	)	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
clone	NN	O
GEN-092E10	NNP	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
,	,	O
the	DT	O
PCR	NNP	O
product	NN	O
was	VBD	O
purified	VBN	O
and	CC	O
labeled	VBN	O
with	IN	O
[	JJ	O
32P	CD	O
]	JJ	O
-dCTP	NNP	O
(	(	O
random-primed	JJ	O
DNA	NNP	O
labeling	VBG	O
kit	NN	O
,	,	O
Boehringer	NNP	O
Mannheim	NNP	O
)	)	O
,	,	O
and	CC	O
the	DT	O
expression	NN	O
of	IN	O
TMP-2	NNP	O
mRNA	NN	O
in	IN	O
normal	JJ	O
human	JJ	O
tissues	NNS	O
was	VBD	O
examined	VBN	O
using	VBG	O
an	DT	O
MTN	NNP	O
blot	NN	O
with	IN	O
the	DT	O
labeled	JJ	O
product	NN	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
high	JJ	O
levels	NNS	O
of	IN	O
expression	NN	O
were	VBD	O
detected	VBN	O
in	IN	O
brain	NN	O
and	CC	O
prostate	NN	O
gland	NN	O
.	.	O
Said	NNP	O
TMP-2	NNP	O
gene	NN	O
mRNA	NN	O
was	VBD	O
about	IN	O
2	CD	O
kb	NNS	O
in	IN	O
size	NN	O
.	.	O
According	VBG	O
to	TO	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
the	DT	O
novel	JJ	O
human	JJ	O
TMP-2	NNP	O
gene	NN	O
is	VBZ	O
provided	VBN	O
and	CC	O
the	DT	O
use	NN	O
of	IN	O
said	VBD	O
gene	NN	O
makes	VBZ	O
it	PRP	O
possible	JJ	O
to	TO	O
detect	VB	O
the	DT	O
expression	NN	O
of	IN	O
said	VBD	O
gene	NN	O
in	IN	O
various	JJ	O
tissues	NNS	O
or	CC	O
produce	VB	O
the	DT	O
human	JJ	O
TMP-2	NNP	O
protein	NN	O
by	IN	O
the	DT	O
technology	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
and	CC	O
,	,	O
through	IN	O
these	DT	O
,	,	O
it	PRP	O
becomes	VBZ	O
possible	JJ	O
to	TO	O
study	VB	O
brain	NN	O
tumor	NN	O
and	CC	O
prostatic	JJ	O
cancer	NN	O
,	,	O
which	WDT	O
are	VBP	O
closely	RB	O
associated	VBN	O
with	IN	O
cell	NN	O
proliferation	NN	O
or	CC	O
intercellular	JJ	O
communication	NN	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
to	TO	O
diagnose	VB	O
these	DT	O
diseases	NNS	O
and	CC	O
to	TO	O
screen	VB	O
out	RP	O
and	CC	O
evaluate	VB	O
drugs	NNS	O
for	IN	O
the	DT	O
treatment	NN	O
and	CC	O
prevention	NN	O
of	IN	O
such	JJ	O
diseases	NNS	O
.	.	O
Example	JJ	O
9	CD	O
Human	NNP	O
NPIK	NNP	O
Gene	NNP	O
(	(	O
1	CD	O
)	)	O
Human	NNP	O
NPIK	NNP	O
Gene	NNP	O
Cloning	NNP	O
and	CC	O
DNA	NNP	O
Sequencing	NNP	O
Following	VBG	O
the	DT	O
procedures	NNS	O
of	IN	O
Example	NNP	O
1	CD	O
and	CC	O
Example	NNP	O
2	CD	O
,	,	O
cDNA	NN	O
clones	NNS	O
were	VBD	O
arbitrarily	RB	O
selected	VBN	O
from	IN	O
a	DT	O
human	JJ	O
fetal	NN	O
brain	NN	O
cDNA	NN	O
library	NN	O
and	CC	O
subjected	VBN	O
to	TO	O
sequence	VB	O
analysis	NN	O
,	,	O
and	CC	O
database	NN	O
searches	NNS	O
were	VBD	O
performed	VBN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
two	CD	O
cDNA	NN	O
clones	NNS	O
highly	RB	O
homologous	JJ	O
to	TO	O
the	DT	O
gene	NN	O
coding	VBG	O
for	IN	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
conserved	VBN	O
in	IN	O
phosphatidylinositol	NN	O
3	CD	O
and	CC	O
4	CD	O
kinases	NNS	O
[	JJ	O
Kunz	NNP	B
,	,	I
J.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
73	CD	I
,	,	I
585-596	CD	I
(	(	I
1993	CD	I
)	)	I
]	NN	O
were	VBD	O
obtained	VBN	O
.	.	O
These	DT	O
were	VBD	O
named	VBN	O
GEN-428B12c1	NNP	O
and	CC	O
GEN-428B12c2	NNP	O
and	CC	O
the	DT	O
entire	JJ	O
sequences	NNS	O
of	IN	O
these	DT	O
were	VBD	O
determined	VBN	O
as	IN	O
in	IN	O
the	DT	O
foregoing	NN	O
examples	NNS	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
the	DT	O
GEN-428B12c1	NNP	O
cDNA	NN	O
clone	NN	O
and	CC	O
the	DT	O
GEN-428B12c2	NNP	O
clone	NN	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
coding	VBG	O
sequences	NNS	O
differing	VBG	O
by	IN	O
12	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
at	IN	O
the	DT	O
5′	CD	O
terminus	NN	O
,	,	O
the	DT	O
GEN-428B12c1	NNP	O
cDNA	NN	O
clone	NN	O
being	VBG	O
longer	JJR	O
by	IN	O
12	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
.	.	O
The	DT	O
GEN-428B12c1	NNP	O
cDNA	NN	O
sequence	NN	O
of	IN	O
the	DT	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
contained	VBD	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
2,487	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:32	NNP	O
,	,	O
encoding	VBG	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
comprising	VBG	O
829	CD	O
amino	JJ	O
acid	NN	O
residues	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:31	NNP	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
full-length	JJ	O
cDNA	NN	O
clone	NN	O
comprised	VBD	O
3,324	CD	O
nucleotides	NNS	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:33	NNP	O
.	.	O
The	DT	O
estimated	VBN	O
initiation	NN	O
codon	NN	O
was	VBD	O
located	VBN	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:33	NNP	O
,	,	O
at	IN	O
nucleotides	JJ	O
Nos	NNP	O
.	.	O
115-117	JJ	O
corresponding	NN	O
to	TO	O
the	DT	O
second	JJ	O
ATG	NNP	O
triplet	NN	O
of	IN	O
the	DT	O
cDNA	NN	O
clone	NN	O
.	.	O
The	DT	O
termination	NN	O
codon	NN	O
was	VBD	O
located	VBN	O
at	IN	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
2602-2604	JJ	O
and	CC	O
the	DT	O
polyadenylation	NN	O
signal	NN	O
(	(	O
AATAAA	NNP	O
)	)	O
at	IN	O
Nos	NNP	O
.	.	O
3305-3310	JJ	O
.	.	O
On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
the	DT	O
GEN-428B12c2	NNP	O
cDNA	NN	O
sequence	NN	O
of	IN	O
the	DT	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
contained	VBD	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
2,451	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:29	NNP	O
.	.	O
The	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
encoded	VBD	O
thereby	RB	O
comprised	VBN	O
817	CD	O
amino	JJ	O
acid	NN	O
residues	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:28	NNP	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
full-length	JJ	O
cDNA	NN	O
clone	NN	O
comprised	VBD	O
3,602	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:30	NNP	O
.	.	O
The	DT	O
estimated	VBN	O
initiation	NN	O
codon	NN	O
was	VBD	O
located	VBN	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:30	NNP	O
,	,	O
at	IN	O
nucleotides	JJ	O
Nos	NNP	O
.	.	O
429-431	JJ	O
corresponding	NN	O
to	TO	O
the	DT	O
7th	CD	O
ATG	NNP	O
triplet	NN	O
of	IN	O
the	DT	O
cDNA	NN	O
clone	NN	O
.	.	O
The	DT	O
termination	NN	O
codon	NN	O
was	VBD	O
located	VBN	O
at	IN	O
nucleotides	NNS	O
Nos	NNP	O
.	.	O
2880-2882	JJ	O
and	CC	O
the	DT	O
polyadenylation	NN	O
signal	NN	O
(	(	O
AATAAA	NNP	O
)	)	O
at	IN	O
Nos	NNP	O
.	.	O
3583-3588	JJ	O
.	.	O
(	(	O
2	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
2	CD	O
)	)	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
entire	JJ	O
sequence	NN	O
of	IN	O
human	JJ	O
NPIK	NNP	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
,	,	O
the	DT	O
PCR	NNP	O
product	NN	O
was	VBD	O
purified	VBN	O
and	CC	O
labeled	VBN	O
with	IN	O
[	JJ	O
32P	CD	O
]	JJ	O
-dCTP	NNP	O
(	(	O
random-primed	JJ	O
DNA	NNP	O
labeling	VBG	O
kit	NN	O
,	,	O
Boehringer	NNP	O
Mannheim	NNP	O
)	)	O
,	,	O
and	CC	O
normal	JJ	O
human	JJ	O
tissues	NNS	O
were	VBD	O
examined	VBN	O
for	IN	O
expression	NN	O
of	IN	O
the	DT	O
human	JJ	O
NPIK	NNP	O
mRNA	NN	O
using	VBG	O
the	DT	O
MTN	NNP	O
blot	NN	O
membrane	NN	O
with	IN	O
the	DT	O
labeled	JJ	O
product	NN	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
16	CD	O
various	JJ	O
human	JJ	O
adult	NN	O
tissues	NNS	O
examined	VBD	O
and	CC	O
an	DT	O
about	IN	O
3.8	CD	O
kb	NNS	O
transcript	NN	O
and	CC	O
an	DT	O
about	IN	O
5	CD	O
kb	NNS	O
one	CD	O
could	MD	O
be	VB	O
detected	VBN	O
.	.	O
Using	VBG	O
primer	NN	O
A	NNP	O
having	VBG	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
shown	VBN	O
below	IN	O
in	IN	O
Table	JJ	O
8	CD	O
and	CC	O
containing	VBG	O
the	DT	O
initiation	NN	O
codon	NN	O
of	IN	O
the	DT	O
GEN-428B12c2	NNP	O
cDNA	NN	O
and	CC	O
primer	NN	O
B	NNP	O
shown	VBN	O
in	IN	O
table	JJ	O
8	CD	O
and	CC	O
containing	VBG	O
the	DT	O
termination	NN	O
codon	NN	O
,	,	O
PCR	NNP	O
was	VBD	O
performed	VBN	O
with	IN	O
Human	NNP	O
Fetal	NNP	O
Brain	NNP	O
Marathon-Ready	JJ	O
cDNA	NN	O
(	(	O
Clontech	NNP	O
)	)	O
as	IN	O
a	DT	O
template	NN	O
,	,	O
and	CC	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
PCR	NNP	O
product	NN	O
was	VBD	O
determined	VBN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
it	PRP	O
was	VBD	O
found	VBN	O
that	IN	O
the	DT	O
human	JJ	O
NPIK	NNP	O
mRNA	NN	O
expressed	VBD	O
included	VBD	O
one	CD	O
lacking	NN	O
in	IN	O
nucleotides	JJ	O
Nos	NNP	O
.	.	O
1060-1104	CD	O
of	IN	O
the	DT	O
GEN-428B12c1	NNP	O
cDNA	NN	O
sequence	NN	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:33	NNP	O
)	)	O
(	(	O
amino	JJ	O
acids	NNS	O
Nos	NNP	O
.	.	O
316-330	CD	O
of	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:31	NNP	O
)	)	O
and	CC	O
one	CD	O
lacking	NN	O
in	IN	O
nucleotides	JJ	O
Nos	NNP	O
.	.	O
1897-1911	CD	O
of	IN	O
the	DT	O
GEN-428B12c1	NNP	O
cDNA	NN	O
sequence	NN	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:33	NNP	O
)	)	O
(	(	O
amino	JJ	O
acids	NNS	O
Nos	NNP	O
.	.	O
595-599	CD	O
of	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:31	NNP	O
)	)	O
.	.	O
It	PRP	O
was	VBD	O
further	RBR	O
revealed	VBD	O
that	IN	O
polymorphism	NN	O
existed	VBN	O
in	IN	O
this	DT	O
gene	NN	O
(	(	O
428B12c1.fasta	CD	O
)	)	O
,	,	O
as	IN	O
shown	VBN	O
below	IN	O
in	IN	O
Table	NNP	O
9	CD	O
,	,	O
in	IN	O
the	DT	O
region	NN	O
of	IN	O
bases	NNS	O
Nos	NNP	O
.	.	O
1941-1966	CD	O
of	IN	O
the	DT	O
GEN-428B12c1	NNP	O
cDNA	NN	O
sequence	NN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:33	NNP	O
,	,	O
whereby	WRB	O
a	DT	O
mutant	JJ	O
protein	NN	O
was	VBD	O
encoded	VBN	O
which	WDT	O
resulted	VBD	O
from	IN	O
the	DT	O
mutation	NN	O
of	IN	O
IQDSCEITT	NNP	O
(	(	O
amino	JJ	O
acid	NN	O
residues	NNS	O
Nos	NNP	O
.	.	O
610-618	JJ	O
in	IN	O
the	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:31	NNP	O
)	)	O
encoded	VBN	O
by	IN	O
GEN-428B12c1	NNP	O
)	)	O
into	IN	O
YKILVISA	NNP	O
.	.	O
(	(	O
3	CD	O
)	)	O
Chromosomal	NNP	O
Mapping	NNP	O
of	IN	O
Human	NNP	O
NPIK	NNP	O
Gene	NNP	O
by	IN	O
FISH	NNP	O
Chromosomal	NNP	O
mapping	NN	O
of	IN	O
the	DT	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
by	IN	O
FISH	NNP	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
3	CD	O
)	)	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
it	PRP	O
was	VBD	O
found	VBN	O
that	IN	O
the	DT	O
locus	NN	O
of	IN	O
the	DT	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
is	VBZ	O
in	IN	O
the	DT	O
chromosomal	JJ	O
position	NN	O
1q21.1-q21.3	NNS	O
.	.	O
The	DT	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
,	,	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
,	,	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
included	VBD	O
two	CD	O
cDNAs	NN	O
differing	VBG	O
in	IN	O
the	DT	O
5′	CD	O
region	NN	O
and	CC	O
capable	JJ	O
of	IN	O
encoding	VBG	O
829	CD	O
and	CC	O
817	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
.	.	O
In	IN	O
view	NN	O
of	IN	O
this	DT	O
and	CC	O
further	RBR	O
in	IN	O
view	NN	O
of	IN	O
the	DT	O
findings	NNS	O
that	IN	O
the	DT	O
mRNA	NN	O
corresponding	VBG	O
to	TO	O
this	DT	O
gene	NN	O
includes	VBZ	O
two	CD	O
deletable	JJ	O
sites	NNS	O
and	CC	O
there	EX	O
occurs	VBZ	O
polymorphism	NN	O
in	IN	O
a	DT	O
specific	JJ	O
region	NN	O
corresponding	VBG	O
to	TO	O
amino	VB	O
acid	JJ	O
residues	NNS	O
Nos	NNP	O
.	.	O
610-618	CD	O
of	IN	O
the	DT	O
GEN-428B12c1	NNP	O
amino	NN	O
acid	NN	O
sequence	NN	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:31	NNP	O
)	)	O
,	,	O
whereby	WRB	O
a	DT	O
mutant	JJ	O
protein	NN	O
is	VBZ	O
encoded	VBN	O
,	,	O
it	PRP	O
is	VBZ	O
conceivable	JJ	O
that	IN	O
human	JJ	O
NPIK	NNP	O
includes	VBZ	O
species	NNS	O
resulting	VBG	O
from	IN	O
a	DT	O
certain	JJ	O
number	NN	O
of	IN	O
combinations	NNS	O
,	,	O
namely	RB	O
human	JJ	O
NPIK	NNP	O
,	,	O
deletion-containing	JJ	O
human	JJ	O
NPIK	NNP	O
,	,	O
human	JJ	O
NPIK	NNP	O
mutant	NN	O
and/or	VBD	O
deletion-containing	JJ	O
human	JJ	O
NPIK	NNP	O
mutant	NN	O
.	.	O
Recently	RB	O
,	,	O
several	JJ	O
proteins	NNS	O
belonging	VBG	O
to	TO	O
the	DT	O
family	NN	O
including	VBG	O
the	DT	O
above-mentioned	JJ	O
PI3	NNP	O
and	CC	O
4	CD	O
kinases	NNS	O
have	VBP	O
protein	VBN	O
kinase	NN	O
activity	NN	O
[	NNP	O
Dhand	NNP	B
,	,	I
R.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
EMBO	NNP	I
J.	NNP	I
,	,	I
13	CD	I
,	,	I
522-533	CD	I
(	(	I
1994	CD	I
)	)	I
;	:	O
Stack	NNP	B
,	,	I
J.	NNP	I
H.	NNP	I
and	CC	I
Emr	NNP	I
,	,	I
S.	NNP	I
D.	NNP	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
269	CD	I
,	,	I
31552-31562	CD	I
(	(	I
1994	CD	I
)	)	I
;	:	O
Hartley	NNP	B
,	,	I
K.	NNP	I
O.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
82	CD	I
,	,	I
848-856	CD	I
(	(	I
1995	CD	I
)	)	I
]	NN	O
.	.	O
It	PRP	O
was	VBD	O
also	RB	O
revealed	VBN	O
that	IN	O
a	DT	O
protein	NN	O
belonging	VBG	O
to	TO	O
this	DT	O
family	NN	O
is	VBZ	O
involved	VBN	O
in	IN	O
DNA	NNP	O
repair	NN	O
[	NNP	O
Hartley	NNP	B
,	,	I
K.	NNP	I
O.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Cell	NNP	I
,	,	I
82	CD	I
,	,	I
849-856	CD	I
(	(	I
1995	CD	I
)	)	I
]	NN	O
and	CC	O
is	VBZ	O
a	DT	O
causative	JJ	O
gene	NN	O
of	IN	O
ataxia	JJ	O
[	NNP	O
Savitsky	NNP	B
,	,	I
K.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Science	NNP	I
,	,	I
268	CD	I
,	,	I
1749-1753	CD	I
(	(	I
1995	CD	I
)	)	I
]	NN	O
.	.	O
It	PRP	O
can	MD	O
be	VB	O
anticipated	VBN	O
that	IN	O
the	DT	O
human	JJ	O
NPIK	NNP	O
gene-encoded	JJ	O
protein	NN	O
highly	RB	O
homologous	JJ	O
to	TO	O
the	DT	O
family	NN	O
of	IN	O
these	DT	O
PI	NNP	O
kinases	NNS	O
is	VBZ	O
a	DT	O
novel	JJ	O
enzyme	NN	O
phosphorylating	VBG	O
lipids	NNS	O
or	CC	O
proteins	NNS	O
.	.	O
According	VBG	O
to	TO	O
this	DT	O
example	NN	O
,	,	O
the	DT	O
novel	JJ	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
is	VBZ	O
provided	VBN	O
.	.	O
The	DT	O
use	NN	O
of	IN	O
said	VBD	O
gene	NN	O
makes	VBZ	O
it	PRP	O
possible	JJ	O
to	TO	O
detect	VB	O
the	DT	O
expression	NN	O
of	IN	O
said	VBD	O
gene	NN	O
in	IN	O
various	JJ	O
tissues	NNS	O
and	CC	O
manufacture	VB	O
the	DT	O
human	JJ	O
NPIK	NNP	O
protein	NN	O
by	IN	O
the	DT	O
technology	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
and	CC	O
,	,	O
through	IN	O
these	DT	O
,	,	O
it	PRP	O
becomes	VBZ	O
possible	JJ	O
to	TO	O
study	VB	O
lipid-	JJ	O
or	CC	O
protein-phosphrylating	JJ	O
enzymes	NNS	O
such	JJ	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
study	VB	O
DNA	NNP	O
repairing	VBG	O
,	,	O
study	NN	O
or	CC	O
diagnose	JJ	O
diseases	NNS	O
in	IN	O
which	WDT	O
these	DT	O
are	VBP	O
involved	VBN	O
,	,	O
for	IN	O
example	NN	O
cancer	NN	O
,	,	O
and	CC	O
screen	NN	O
out	RB	O
and	CC	O
evaluate	VB	O
drugs	NNS	O
for	IN	O
the	DT	O
treatment	NN	O
or	CC	O
prevention	NN	O
thereof	NN	O
.	.	O
(	(	O
4	CD	O
)	)	O
Construction	NN	O
of	IN	O
an	DT	O
Expression	NNP	O
Vector	NNP	O
for	IN	O
Fusion	NNP	O
Protein	NNP	O
To	TO	O
subclone	VB	O
the	DT	O
coding	NN	O
region	NN	O
for	IN	O
a	DT	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
(	(	O
GEN-428B12c2	NNP	O
)	)	O
,	,	O
first	RB	O
of	IN	O
all	DT	O
,	,	O
two	CD	O
primers	NNS	O
,	,	O
C1	NNP	O
and	CC	O
C2	NNP	O
,	,	O
having	VBG	O
the	DT	O
sequences	NNS	O
shown	VBN	O
below	IN	O
in	IN	O
Table	JJ	O
10	CD	O
were	VBD	O
formed	VBN	O
based	VBN	O
on	IN	O
the	DT	O
information	NN	O
on	IN	O
the	DT	O
DNA	NN	O
sequences	NNS	O
obtained	VBN	O
above	IN	O
in	IN	O
(	(	O
1	CD	O
)	)	O
.	.	O
Both	DT	O
of	IN	O
the	DT	O
primers	NNS	O
C1	NNP	O
and	CC	O
C2	NNP	O
have	VBP	O
a	DT	O
BglII	NNP	O
site	NN	O
,	,	O
and	CC	O
primer	NN	O
C2	NNP	O
is	VBZ	O
an	DT	O
antisense	JJ	O
primer	NN	O
.	.	O
Using	VBG	O
these	DT	O
two	CD	O
primers	NNS	O
,	,	O
cDNA	NN	O
derived	VBD	O
from	IN	O
human	JJ	O
fetal	JJ	O
brain	NN	O
mRNA	NN	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
to	TO	O
provide	VB	O
a	DT	O
product	NN	O
having	VBG	O
a	DT	O
length	NN	O
of	IN	O
about	IN	O
2500	CD	O
bases	NNS	O
.	.	O
The	DT	O
amplified	JJ	O
cDNA	NN	O
was	VBD	O
precipitated	VBN	O
from	IN	O
ethanol	NN	O
and	CC	O
inserted	VBN	O
into	IN	O
pT7BlueT-Vector	NN	O
(	(	O
product	NN	O
of	IN	O
Novagen	NNP	O
)	)	O
and	CC	O
subcloning	NN	O
was	VBD	O
completed	VBN	O
.	.	O
The	DT	O
entire	JJ	O
sequence	NN	O
was	VBD	O
determined	VBN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
above	IN	O
in	IN	O
Examples	NNP	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
it	PRP	O
was	VBD	O
revealed	VBN	O
that	IN	O
this	DT	O
gene	NN	O
had	VBD	O
polymorphism	VBN	O
shown	VBN	O
above	IN	O
in	IN	O
Table	JJ	O
9	CD	O
.	.	O
The	DT	O
above	JJ	O
cDNA	NN	O
was	VBD	O
cleaved	VBN	O
by	IN	O
BglII	NNP	O
and	CC	O
subjected	VBN	O
to	TO	O
agarose	VB	O
gel	JJ	O
electrophoresis	NN	O
.	.	O
The	DT	O
cDNA	NN	O
was	VBD	O
then	RB	O
excised	VBN	O
from	IN	O
agarose	JJ	O
gel	NN	O
and	CC	O
collected	VBD	O
using	VBG	O
GENECLEAN	NNP	O
II	NNP	O
KIT	NNP	O
(	(	O
product	NN	O
of	IN	O
Bio	NNP	O
101	CD	O
)	)	O
.	.	O
The	DT	O
cDNA	NN	O
was	VBD	O
inserted	VBN	O
into	IN	O
pBlueBacHis2B-Vector	NN	O
(	(	O
product	NN	O
of	IN	O
Invitrogen	NNP	O
)	)	O
at	IN	O
the	DT	O
BglII	NNP	O
cleavage	NN	O
site	NN	O
and	CC	O
subcloning	NN	O
was	VBD	O
completed	VBN	O
.	.	O
The	DT	O
fusion	NN	O
vector	NN	O
thus	RB	O
obtained	VBN	O
had	VBD	O
a	DT	O
BglII	NNP	O
cleavage	NN	O
site	NN	O
and	CC	O
was	VBD	O
an	DT	O
expression	NN	O
vector	NN	O
for	IN	O
a	DT	O
fusion	NN	O
protein	NN	O
of	IN	O
the	DT	O
contemplated	JJ	O
gene	NN	O
product	NN	O
(	(	O
about	IN	O
91	CD	O
kd	NN	O
)	)	O
and	CC	O
38	CD	O
amino	NN	O
acids	NNS	O
derived	VBN	O
from	IN	O
pBlueBacHis2B-Vector	NN	O
and	CC	O
containing	VBG	O
a	DT	O
polyhistidine	JJ	O
region	NN	O
and	CC	O
an	DT	O
epitope	NN	O
recognizing	VBG	O
Anti-Xpress™	NNP	O
antibody	NN	O
(	(	O
product	NN	O
of	IN	O
Invitrogen	NNP	O
)	)	O
.	.	O
(	(	O
5	CD	O
)	)	O
Transfection	NN	O
into	IN	O
Insect	NNP	O
Cell	NNP	O
Sf-9	NNP	O
The	DT	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
was	VBD	O
expressed	VBN	O
according	VBG	O
to	TO	O
the	DT	O
Baculovirus	NNP	O
expression	NN	O
system	NN	O
.	.	O
Baculovirus	NNP	O
is	VBZ	O
a	DT	O
cyclic	JJ	O
double-stranded	JJ	O
insect-pathogenic	JJ	O
virus	NN	O
and	CC	O
can	MD	O
produce	VB	O
large	JJ	O
amounts	NNS	O
of	IN	O
inclusion	NN	O
bodies	NNS	O
named	VBN	O
polyhedrins	NNS	O
in	IN	O
the	DT	O
cells	NNS	O
of	IN	O
insects	NNS	O
.	.	O
Using	VBG	O
Bac-N-Blue™	NNP	O
Transfection	NNP	O
Kit	NNP	O
utilizing	VBG	O
this	DT	O
characteristic	NN	O
of	IN	O
Baculovirus	NNP	O
and	CC	O
developed	VBN	O
by	IN	O
Invitrogen	NNP	O
,	,	O
the	DT	O
Baculovirus	NNP	O
expression	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
.	.	O
Stated	VBN	O
more	RBR	O
specifically	RB	O
,	,	O
4	CD	O
μg	NN	O
of	IN	O
pBlueBacHis2B	NN	O
containing	VBG	O
the	DT	O
region	NN	O
of	IN	O
the	DT	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
and	CC	O
1	CD	O
μg	NN	O
of	IN	O
Bac-N-Blue™	NNP	O
DNA	NNP	O
(	(	O
product	NN	O
of	IN	O
Invitrogen	NNP	O
)	)	O
were	VBD	O
co-transfected	JJ	O
into	IN	O
Sf-9	NNP	O
cells	NNS	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
Insectin™	NNP	O
liposomes	NNS	O
(	(	O
product	NN	O
of	IN	O
Invitrogen	NNP	O
)	)	O
.	.	O
Prior	RB	O
to	TO	O
co-transfection	NN	O
,	,	O
LacZ	NNP	O
gene	NN	O
was	VBD	O
incorporated	VBN	O
into	IN	O
Bac-N-Blue™	NNP	O
DNA	NNP	O
,	,	O
so	IN	O
that	DT	O
LacZ	NNP	O
would	MD	O
be	VB	O
expressed	VBN	O
only	RB	O
when	WRB	O
homologous	JJ	O
recombination	NN	O
took	VBD	O
place	NN	O
between	IN	O
the	DT	O
Bac-N-Blue™	NNP	O
DNA	NNP	O
and	CC	O
pBlueBacHis2B	NN	O
.	.	O
Thus	RB	O
when	WRB	O
the	DT	O
co-transfected	JJ	O
Sf-9	JJ	O
cells	NNS	O
were	VBD	O
incubated	VBN	O
on	IN	O
agar	NN	O
medium	NN	O
,	,	O
the	DT	O
plaques	NNS	O
of	IN	O
the	DT	O
virus	NN	O
expressing	VBG	O
the	DT	O
contemplated	VBN	O
gene	NN	O
were	VBD	O
easily	RB	O
detected	VBN	O
as	IN	O
blue	JJ	O
plaques	NNS	O
.	.	O
The	DT	O
blue	NN	O
plaques	NNS	O
were	VBD	O
excised	VBN	O
from	IN	O
each	DT	O
agar	NN	O
and	CC	O
suspended	VBN	O
in	IN	O
400	CD	O
μl	NN	O
of	IN	O
medium	NN	O
to	TO	O
disperse	VB	O
the	DT	O
virus	NN	O
thereon	NN	O
.	.	O
The	DT	O
suspension	NN	O
was	VBD	O
subjected	VBN	O
to	TO	O
centrifugation	NN	O
to	TO	O
give	VB	O
a	DT	O
supernatant	NN	O
containing	VBG	O
the	DT	O
virus	NN	O
.	.	O
Sf-9	JJ	O
cells	NNS	O
were	VBD	O
infected	VBN	O
with	IN	O
the	DT	O
virus	NN	O
again	RB	O
to	TO	O
increase	VB	O
the	DT	O
titre	NN	O
and	CC	O
to	TO	O
obtain	VB	O
a	DT	O
large	JJ	O
amount	NN	O
of	IN	O
infective	JJ	O
virus	NN	O
solution	NN	O
.	.	O
(	(	O
6	CD	O
)	)	O
Preparation	NN	O
of	IN	O
Human	NNP	O
NPIK	NNP	O
The	DT	O
expression	NN	O
of	IN	O
the	DT	O
contemplated	JJ	O
human	JJ	O
NPIK	NNP	O
gene	NN	O
was	VBD	O
confirmed	VBN	O
three	CD	O
days	NNS	O
after	IN	O
infection	NN	O
with	IN	O
the	DT	O
virus	NN	O
as	IN	O
follows	VBZ	O
.	.	O
Sf-9	JJ	O
cells	NNS	O
were	VBD	O
collected	VBN	O
and	CC	O
washed	VBN	O
with	IN	O
PBS	NNP	O
.	.	O
The	DT	O
cells	NNS	O
were	VBD	O
boiled	VBN	O
with	IN	O
a	DT	O
SDS-PAGE	JJ	O
loading	NN	O
buffer	NN	O
for	IN	O
5	CD	O
minutes	NNS	O
and	CC	O
SDS-PAGE	NNP	O
was	VBD	O
performed	VBN	O
.	.	O
According	VBG	O
to	TO	O
the	DT	O
western	JJ	O
blot	NN	O
technique	NN	O
using	VBG	O
Anti-Xpress	NNP	O
as	IN	O
an	DT	O
antibody	NN	O
,	,	O
the	DT	O
contemplated	JJ	O
protein	NN	O
was	VBD	O
detected	VBN	O
at	IN	O
the	DT	O
position	NN	O
of	IN	O
its	PRP$	O
presumed	JJ	O
molecular	JJ	O
weight	NN	O
.	.	O
By	IN	O
contrast	NN	O
,	,	O
in	IN	O
the	DT	O
case	NN	O
of	IN	O
control	NN	O
cells	NNS	O
uninfected	VBN	O
with	IN	O
the	DT	O
virus	NN	O
,	,	O
no	DT	O
band	NN	O
corresponding	VBG	O
to	TO	O
human	JJ	O
NPIK	NNP	O
was	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
test	NN	O
.	.	O
Stated	VBN	O
more	RBR	O
specifically	RB	O
,	,	O
three	CD	O
days	NNS	O
after	IN	O
the	DT	O
infection	NN	O
of	IN	O
15	CD	O
flasks	NNS	O
(	(	O
175-cm2	JJ	O
,	,	O
FALCON	NNP	O
)	)	O
of	IN	O
semi-confluent	JJ	O
Sf-9	NNP	O
cells	NNS	O
,	,	O
the	DT	O
cells	NNS	O
were	VBD	O
harvested	VBN	O
and	CC	O
washed	VBN	O
with	IN	O
PBS	NNP	O
,	,	O
followed	VBN	O
by	IN	O
resuspension	NN	O
in	IN	O
a	DT	O
buffer	NN	O
(	(	O
20	CD	O
mM	NN	O
Tris/HCl	NNP	O
(	(	O
pH	VB	O
7.5	CD	O
)	)	O
,	,	O
1	CD	O
mM	NN	O
EDTA	NNP	O
and	CC	O
1	CD	O
mM	NNS	O
DTT	NNP	O
)	)	O
.	.	O
The	DT	O
suspended	JJ	O
cells	NNS	O
were	VBD	O
lysed	VBN	O
by	IN	O
4	CD	O
time-sonications	NNS	O
for	IN	O
30	CD	O
seconds	NNS	O
at	IN	O
4°	CD	O
C.	NNP	O
with	IN	O
30	CD	O
seconds	NNS	O
intervals	NNS	O
.	.	O
The	DT	O
sonicated	JJ	O
cells	NNS	O
were	VBD	O
subjected	VBN	O
to	TO	O
centrifugation	NN	O
and	CC	O
the	DT	O
supernatant	NN	O
was	VBD	O
collected	VBN	O
.	.	O
The	DT	O
protein	NN	O
in	IN	O
the	DT	O
supernatant	NN	O
was	VBD	O
immunoprecipitated	VBN	O
using	VBG	O
an	DT	O
Anti-Xpress	JJ	O
antibody	NN	O
and	CC	O
obtained	VBN	O
as	IN	O
a	DT	O
slurry	NN	O
of	IN	O
protein	JJ	O
A-Sepharose	JJ	O
beads	NNS	O
.	.	O
The	DT	O
slurry	NN	O
was	VBD	O
boiled	VBN	O
with	IN	O
a	DT	O
SDS-PAGE	JJ	O
loading	NN	O
buffer	NN	O
for	IN	O
5	CD	O
minutes	NNS	O
.	.	O
SDS-PAGE	NN	O
was	VBD	O
performed	VBN	O
for	IN	O
identification	NN	O
and	CC	O
quantification	NN	O
of	IN	O
NPIK	NNP	O
.	.	O
The	DT	O
slurry	NN	O
itself	PRP	O
was	VBD	O
subjected	VBN	O
to	TO	O
the	DT	O
following	VBG	O
assaying	NN	O
.	.	O
(	(	O
7	CD	O
)	)	O
Confirmation	NN	O
of	IN	O
PI4	NNP	O
Kinase	NNP	O
Activity	NNP	O
NPIK	NNP	O
was	VBD	O
expected	VBN	O
to	TO	O
have	VB	O
the	DT	O
activity	NN	O
of	IN	O
incorporation	NN	O
phosphoric	JJ	O
acid	NN	O
at	IN	O
the	DT	O
4-position	NN	O
of	IN	O
the	DT	O
inositol	JJ	O
ring	NN	O
of	IN	O
phosphatidylinositol	NN	O
(	(	O
PI	NNP	O
)	)	O
,	,	O
namely	RB	O
,	,	O
PI4	NNP	O
Kinase	NNP	O
activity	NN	O
.	.	O
PI4	NNP	O
Kinase	NNP	O
activity	NN	O
of	IN	O
NPIK	NNP	O
was	VBD	O
assayed	VBN	O
according	VBG	O
to	TO	O
the	DT	O
method	NN	O
of	IN	O
Takenawa	NNP	O
,	,	O
et	RB	O
al	NN	O
.	.	O
(	(	O
Yamakawa	UH	B
,	,	I
A.	NNP	I
and	CC	I
Takenawa	NNP	I
,	,	I
T.	NNP	I
,	,	I
J.	NNP	I
Biol	NNP	I
.	.	I
Chem.	NNP	I
,	,	I
263	CD	I
,	,	I
17555-17560	CD	I
(	(	I
1988	CD	I
)	)	I
)	)	O
as	IN	O
shown	VBN	O
below	IN	O
.	.	O
First	RB	O
prepared	VBN	O
was	VBD	O
a	DT	O
mixture	NN	O
of	IN	O
10	CD	O
μl	NN	O
of	IN	O
a	DT	O
NPIK	NNP	O
slurry	NN	O
(	(	O
20	CD	O
mM	NN	O
Tris/HCl	NNP	O
(	(	O
pH	VB	O
7.5	CD	O
)	)	O
,	,	O
1	CD	O
mM	NN	O
EDTA	NNP	O
,	,	O
1	CD	O
mM	NN	O
DTT	NNP	O
and	CC	O
50	CD	O
%	NN	O
protein	NN	O
A	NNP	O
beads	NN	O
)	)	O
,	,	O
10	CD	O
μl	NN	O
of	IN	O
a	DT	O
PI	NNP	O
solution	NN	O
(	(	O
prepared	VBN	O
by	IN	O
drying	VBG	O
5	CD	O
mg	NN	O
of	IN	O
a	DT	O
PI-containing	JJ	O
commercial	JJ	O
chloroform	NN	O
solution	NN	O
in	IN	O
a	DT	O
stream	NN	O
of	IN	O
nitrogen	NN	O
onto	IN	O
a	DT	O
glass	NN	O
tube	NN	O
wall	NN	O
,	,	O
adding	VBG	O
1	CD	O
ml	NN	O
of	IN	O
20	CD	O
mM	NNS	O
Tris/HCl	NNP	O
(	(	O
pH	VB	O
7.5	CD	O
)	)	O
buffer	NN	O
and	CC	O
forming	NN	O
micelles	NNS	O
by	IN	O
sonication	NN	O
)	)	O
,	,	O
10	CD	O
μl	NN	O
of	IN	O
an	DT	O
applied	JJ	O
buffer	NN	O
(	(	O
210	CD	O
mM	NN	O
Tris/HCl	NNP	O
(	(	O
pH	VB	O
7.5	CD	O
)	)	O
,	,	O
5	CD	O
mM	NN	O
EGTA	NNP	O
and	CC	O
100	CD	O
mM	NNS	O
MgCl2	NNP	O
)	)	O
and	CC	O
10	CD	O
μl	NN	O
of	IN	O
distilled	JJ	O
water	NN	O
.	.	O
Thereto	NNP	O
was	VBD	O
added	VBN	O
10	CD	O
μl	NN	O
of	IN	O
an	DT	O
ATP	NNP	O
solution	NN	O
(	(	O
5	CD	O
μl	NN	O
of	IN	O
500	CD	O
μM	JJ	O
ATP	NNP	O
,	,	O
4.9	CD	O
μl	NN	O
of	IN	O
distilled	JJ	O
water	NN	O
and	CC	O
0.1	CD	O
μl	NN	O
of	IN	O
γ-32P	JJ	O
ATP	NNP	O
(	(	O
6000	CD	O
Ci/mmol	NNP	O
,	,	O
product	NN	O
of	IN	O
NEN	NNP	O
Co.	NNP	O
,	,	O
Ltd.	NNP	O
)	)	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
was	VBD	O
started	VBN	O
at	IN	O
30°	CD	O
C.	NNP	O
and	CC	O
continued	VBD	O
for	IN	O
2	CD	O
,	,	O
5	CD	O
,	,	O
10	CD	O
and	CC	O
20	CD	O
minutes	NNS	O
.	.	O
The	DT	O
time	NN	O
10	CD	O
minutes	NNS	O
was	VBD	O
set	VBN	O
as	IN	O
incubation	NN	O
time	NN	O
because	IN	O
a	DT	O
straight-line	JJ	O
increase	NN	O
was	VBD	O
observed	VBN	O
around	IN	O
10	CD	O
minutes	NNS	O
in	IN	O
incorporation	NN	O
of	IN	O
phosphoric	JJ	O
acid	NN	O
into	IN	O
PI	NNP	O
in	IN	O
the	DT	O
assaying	NN	O
process	NN	O
described	VBD	O
below	IN	O
.	.	O
After	IN	O
completion	NN	O
of	IN	O
the	DT	O
reaction	NN	O
,	,	O
PI	NNP	O
was	VBD	O
fractionated	VBN	O
by	IN	O
the	DT	O
solvent	JJ	O
extraction	NN	O
method	NN	O
and	CC	O
finally	RB	O
re-suspended	JJ	O
in	IN	O
chloroform	NN	O
.	.	O
The	DT	O
suspension	NN	O
was	VBD	O
developed	VBN	O
by	IN	O
thin	JJ	O
layer	NN	O
chromatography	NN	O
(	(	O
TLC	NNP	O
)	)	O
and	CC	O
the	DT	O
radioactivity	NN	O
of	IN	O
the	DT	O
reaction	NN	O
product	NN	O
at	IN	O
the	DT	O
PI4P-position	NNP	O
was	VBD	O
assayed	VBN	O
using	VBG	O
an	DT	O
analyzer	NN	O
(	(	O
trade	NN	O
name	NN	O
:	:	O
Bio-Image	NN	O
;	:	O
product	NN	O
of	IN	O
Fuji	NNP	O
Photo	NNP	O
Film	NNP	O
Co.	NNP	O
,	,	O
Ltd.	NNP	O
)	)	O
.	.	O
FIG	NNP	O
.	.	O
1	CD	O
shows	VBZ	O
the	DT	O
results	NNS	O
.	.	O
FIG	NNP	O
.	.	O
1	CD	O
is	VBZ	O
an	DT	O
analytical	JJ	O
diagram	NN	O
of	IN	O
the	DT	O
results	NNS	O
of	IN	O
assaying	VBG	O
the	DT	O
radioactivity	NN	O
based	VBN	O
on	IN	O
TLC	NNP	O
as	IN	O
mentioned	VBN	O
above	IN	O
.	.	O
The	DT	O
right	JJ	O
lane	NN	O
(	(	O
2	CD	O
)	)	O
is	VBZ	O
the	DT	O
fraction	NN	O
of	IN	O
Sf-9	NNP	O
cell	NN	O
cytoplasm	NN	O
infected	VBN	O
with	IN	O
the	DT	O
NPIK-containing	NNP	O
virus	NN	O
,	,	O
whereas	IN	O
the	DT	O
left	NN	O
lane	NN	O
(	(	O
1	CD	O
)	)	O
is	VBZ	O
the	DT	O
fraction	NN	O
of	IN	O
uninfected	JJ	O
Sf-9	NNP	O
cell	NN	O
cytoplasm	NN	O
.	.	O
Also	RB	O
,	,	O
predetermined	VBD	O
amounts	NNS	O
of	IN	O
Triton	NNP	O
X-100	NNP	O
and	CC	O
adenosine	NN	O
were	VBD	O
added	VBN	O
to	TO	O
the	DT	O
above	JJ	O
reaction	NN	O
system	NN	O
to	TO	O
check	VB	O
how	WRB	O
such	JJ	O
addition	NN	O
would	MD	O
affect	VB	O
the	DT	O
PI4	NNP	O
Kinase	NNP	O
activity	NN	O
.	.	O
The	DT	O
PI4	NNP	O
Kinase	NNP	O
activity	NN	O
was	VBD	O
assayed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
above	NN	O
.	.	O
FIG	NNP	O
.	.	O
2	CD	O
shows	VBZ	O
the	DT	O
results	NNS	O
.	.	O
The	DT	O
results	NNS	O
confirmed	VBD	O
that	IN	O
NPIK	NNP	O
had	VBD	O
a	DT	O
typical	JJ	O
PI4	NNP	O
Kinaze	NNP	O
activity	NN	O
accelerated	VBN	O
by	IN	O
Triton	NNP	O
X-100	NNP	O
and	CC	O
inhibited	VBN	O
by	IN	O
adenosine	NN	O
.	.	O
Example	JJ	O
10	CD	O
Nel-Related	JJ	O
Protein	NNP	O
Type	NNP	O
1	CD	O
(	(	O
NRP1	NNP	O
)	)	O
Gene	NNP	O
and	CC	O
Nel-Related	NNP	O
Protein	NNP	O
Type	NNP	O
2	CD	O
(	(	O
NRP2	NNP	O
)	)	O
Gene	NNP	O
(	(	O
1	CD	O
)	)	O
Cloning	NN	O
and	CC	O
DNA	NNP	O
Sequencing	NNP	O
of	IN	O
NRP1	NNP	O
Gene	NNP	O
and	CC	O
NRP2	NNP	O
Gene	NNP	O
EGF-like	NNP	O
repeats	NNS	O
have	VBP	O
been	VBN	O
found	VBN	O
in	IN	O
many	JJ	O
membrane	NN	O
proteins	NNS	O
and	CC	O
in	IN	O
proteins	NNS	O
related	VBN	O
to	TO	O
growth	NN	O
regulation	NN	O
and	CC	O
differentiation	NN	O
.	.	O
This	DT	O
motif	NN	O
seems	VBZ	O
to	TO	O
be	VB	O
involved	VBN	O
in	IN	O
protein-protein	JJ	O
interactions	NNS	O
.	.	O
Recently	RB	O
,	,	O
a	DT	O
gene	NN	O
encoding	VBG	O
nel	NNS	O
,	,	O
a	DT	O
novel	JJ	O
peptide	NN	O
containing	VBG	O
five	CD	O
EGF-like	JJ	O
repeats	NNS	O
,	,	O
was	VBD	O
cloned	VBN	O
from	IN	O
a	DT	O
chick	NN	O
embryonic	JJ	O
cDNA	NN	O
library	JJ	O
[	NNP	O
Matsuhashi	NNP	B
,	,	I
S.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Dev	NNP	I
.	.	I
Dynamics	NNS	I
,	,	I
203	CD	I
,	,	I
212-222	CD	I
(	(	I
1995	CD	I
)	)	I
]	NN	O
.	.	O
This	DT	O
product	NN	O
is	VBZ	O
considered	VBN	O
to	TO	O
be	VB	O
a	DT	O
transmembrane	NN	O
molecule	NN	O
with	IN	O
its	PRP$	O
EGF-like	JJ	O
repeats	NNS	O
in	IN	O
the	DT	O
extracellular	JJ	O
domain	NN	O
.	.	O
A	DT	O
4.5	CD	O
kb	NN	O
transcript	NN	O
(	(	O
nel	JJ	O
mRNA	NN	O
)	)	O
is	VBZ	O
expressed	VBN	O
in	IN	O
various	JJ	O
tissues	NNS	O
at	IN	O
the	DT	O
embryonic	JJ	O
stage	NN	O
and	CC	O
exclusively	RB	O
in	IN	O
brain	NN	O
and	CC	O
retina	NN	O
after	IN	O
hatching	VBG	O
.	.	O
Following	VBG	O
the	DT	O
procedure	NN	O
of	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
,	,	O
cDNA	JJ	O
clones	NNS	O
were	VBD	O
randomly	RB	O
selected	VBN	O
from	IN	O
a	DT	O
human	JJ	O
fetal	NN	O
brain	NN	O
cDNA	NN	O
library	NN	O
and	CC	O
subjected	VBN	O
to	TO	O
sequence	VB	O
analysis	NN	O
,	,	O
followed	VBN	O
by	IN	O
database	NN	O
searching	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
two	CD	O
cDNA	NN	O
clones	NNS	O
with	IN	O
significantly	RB	O
high	JJ	O
homology	NN	O
to	TO	O
the	DT	O
above-mentioned	JJ	O
nel	NNS	O
were	VBD	O
found	VBN	O
and	CC	O
named	VBN	O
GEN-073E07	NNP	O
and	CC	O
GEN-093E05	NNP	O
,	,	O
respectively	RB	O
.	.	O
Since	IN	O
both	DT	O
clones	NNS	O
were	VBD	O
lacking	VBG	O
in	IN	O
the	DT	O
5′	CD	O
portion	NN	O
,	,	O
5′	CD	O
RACE	NNP	O
was	VBD	O
performed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
2	CD	O
(	(	O
2	CD	O
)	)	O
to	TO	O
obtain	VB	O
the	DT	O
entire	JJ	O
coding	NN	O
regions	NNS	O
.	.	O
As	IN	O
for	IN	O
the	DT	O
primers	NNS	O
for	IN	O
5′	CD	O
RACE	NNP	O
,	,	O
primers	NNS	O
having	VBG	O
an	DT	O
arbitrary	JJ	O
sequence	NN	O
obtained	VBN	O
from	IN	O
the	DT	O
cDNA	NN	O
sequences	NNS	O
of	IN	O
the	DT	O
above	JJ	O
clones	NNS	O
were	VBD	O
synthesized	VBN	O
while	IN	O
the	DT	O
anchor	NN	O
primer	NN	O
attached	VBN	O
to	TO	O
a	DT	O
commercial	JJ	O
kit	NN	O
was	VBD	O
used	VBN	O
as	IN	O
such	JJ	O
.	.	O
5′	CD	O
RACE	NNP	O
clones	NNS	O
obtained	VBN	O
from	IN	O
the	DT	O
PCR	NNP	O
were	VBD	O
sequenced	VBN	O
and	CC	O
the	DT	O
sequences	NNS	O
seemingly	RB	O
covering	VBG	O
the	DT	O
entire	JJ	O
coding	NN	O
regions	NNS	O
of	IN	O
both	DT	O
genes	NNS	O
were	VBD	O
obtained	VBN	O
.	.	O
These	DT	O
genes	NNS	O
were	VBD	O
respectively	RB	O
named	VBN	O
nel-related	JJ	O
protein	NN	O
type	NN	O
1	CD	O
(	(	O
NRP1	NNP	O
)	)	O
gene	NN	O
and	CC	O
nel-related	JJ	O
protein	NN	O
type	NN	O
2	CD	O
(	(	O
NRP2	NNP	O
)	)	O
gene	NN	O
.	.	O
The	DT	O
NRP1	NNP	O
gene	NN	O
contains	VBZ	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
2,430	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:35	NNP	O
,	,	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
deduced	VBD	O
therefrom	JJ	O
comprises	NNS	O
810	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:34	NNP	O
,	,	O
and	CC	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
entire	JJ	O
cDNA	NN	O
clone	NN	O
of	IN	O
said	VBD	O
NRP1	NNP	O
gene	NN	O
comprises	VBZ	O
2,977	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:36	NNP	O
.	.	O
On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
the	DT	O
NRP2	NNP	O
gene	NN	O
contains	VBZ	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
2,448	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:38	NNP	O
,	,	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
deduced	VBD	O
therefrom	JJ	O
comprises	NNS	O
816	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:37	NNP	O
,	,	O
and	CC	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
entire	JJ	O
cDNA	NN	O
clone	NN	O
of	IN	O
said	VBD	O
NRP2	NNP	O
gene	NN	O
comprises	VBZ	O
3,198	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:39	NNP	O
.	.	O
Furthermore	RB	O
,	,	O
the	DT	O
coding	NN	O
regions	NNS	O
were	VBD	O
amplified	VBN	O
by	IN	O
RT-PCR	NNP	O
to	TO	O
exclude	VB	O
the	DT	O
possibility	NN	O
that	IN	O
either	DT	O
of	IN	O
the	DT	O
sequences	NNS	O
obtained	VBN	O
was	VBD	O
a	DT	O
chimeric	JJ	O
cDNA	NN	O
.	.	O
The	DT	O
deduced	JJ	O
NRP1	NNP	O
and	CC	O
NRP2	NNP	O
gene	NN	O
products	NNS	O
both	DT	O
showed	VBD	O
highly	RB	O
hydrophobic	JJ	O
N	NNP	O
termini	NN	O
capable	NN	O
of	IN	O
functioning	VBG	O
as	IN	O
signal	JJ	O
peptides	NNS	O
for	IN	O
membrane	NN	O
insertion	NN	O
.	.	O
As	IN	O
compared	VBN	O
with	IN	O
chick	NN	O
embryonic	JJ	O
nel	NNS	O
,	,	O
they	PRP	O
both	DT	O
appeared	VBD	O
to	TO	O
have	VB	O
no	DT	O
hydrophobic	JJ	O
transmembrane	NN	O
domain	NN	O
.	.	O
Comparison	NNP	O
among	IN	O
NRP1	NNP	O
,	,	O
NRP2	NNP	O
and	CC	O
nel	NNS	O
with	IN	O
respect	NN	O
to	TO	O
the	DT	O
deduced	VBN	O
peptide	NN	O
sequences	NNS	O
revealed	VBD	O
that	IN	O
NRP2	NNP	O
has	VBZ	O
80	CD	O
%	NN	O
homology	NN	O
on	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
level	NN	O
and	CC	O
is	VBZ	O
more	RBR	O
closely	RB	O
related	VBN	O
to	TO	O
nel	NNS	O
than	IN	O
NRP1	NNP	O
having	VBG	O
50	CD	O
%	NN	O
homology	NN	O
.	.	O
The	DT	O
cysteine	NN	O
residues	NNS	O
in	IN	O
cysteine-rich	JJ	O
domains	NNS	O
and	CC	O
EGF-like	JJ	O
repeats	NNS	O
were	VBD	O
found	VBN	O
completely	RB	O
conserved	VBN	O
.	.	O
The	DT	O
most	RBS	O
remarkable	JJ	O
difference	NN	O
between	IN	O
the	DT	O
NRPs	NNP	O
and	CC	O
the	DT	O
chick	NN	O
protein	NN	O
was	VBD	O
that	IN	O
the	DT	O
human	JJ	O
homologs	NNS	O
lack	VBP	O
the	DT	O
putative	JJ	O
transmembrane	NN	O
domain	NN	O
of	IN	O
nel	NNS	O
.	.	O
However	RB	O
,	,	O
even	RB	O
in	IN	O
this	DT	O
lacking	JJ	O
region	NN	O
,	,	O
the	DT	O
nucleotide	JJ	O
sequences	NNS	O
of	IN	O
NRPs	NNP	O
were	VBD	O
very	RB	O
similar	JJ	O
to	TO	O
that	DT	O
of	IN	O
nel	NNS	O
.	.	O
Furthermore	RB	O
,	,	O
the	DT	O
two	CD	O
NRPs	NNP	O
each	DT	O
possessed	VBD	O
six	CD	O
EGF-like	JJ	O
repeats	NNS	O
,	,	O
whereas	JJ	O
nel	NN	O
has	VBZ	O
only	RB	O
five	CD	O
.	.	O
Other	JJ	O
unique	JJ	O
motifs	NNS	O
of	IN	O
nel	NN	O
as	IN	O
reported	VBN	O
by	IN	O
Matsuhashi	NNP	O
et	CC	O
al	NN	O
.	.	O
[	NN	O
Matsuhashi	NNP	B
,	,	I
S.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Dev	NNP	I
.	.	I
Dynamics	NNS	I
,	,	I
203	CD	I
,	,	I
212-222	CD	I
(	(	I
1995	CD	I
)	)	I
]	NN	O
were	VBD	O
also	RB	O
found	VBN	O
in	IN	O
the	DT	O
NRPs	NNP	O
at	IN	O
equivalent	JJ	O
positions	NNS	O
.	.	O
Since	IN	O
as	RB	O
mentioned	VBN	O
above	IN	O
,	,	O
it	PRP	O
was	VBD	O
shown	VBN	O
that	IN	O
the	DT	O
two	CD	O
deduced	VBD	O
NRP	NNP	O
peptides	NNS	O
are	VBP	O
not	RB	O
transmembrane	JJ	O
proteins	NNS	O
,	,	O
the	DT	O
NRPs	NNP	O
might	MD	O
be	VB	O
secretory	JJ	O
proteins	NNS	O
or	CC	O
proteins	NNS	O
anchored	VBN	O
to	TO	O
membranes	NNS	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
posttranslational	JJ	O
modification	NN	O
.	.	O
The	DT	O
present	JJ	O
inventors	NNS	O
speculate	VBP	O
that	IN	O
NRPs	NNP	O
might	MD	O
function	VB	O
as	IN	O
ligands	NNS	O
by	IN	O
stimulating	VBG	O
other	JJ	O
molecules	NNS	O
such	JJ	O
as	IN	O
EGF	NNP	O
receptors	NNS	O
.	.	O
The	DT	O
present	JJ	O
inventors	NNS	O
further	RBR	O
found	VBD	O
that	IN	O
an	DT	O
extra	JJ	O
EGF-like	JJ	O
repeat	NN	O
could	MD	O
be	VB	O
encoded	VBN	O
in	IN	O
nel	NNS	O
upon	IN	O
frame	JJ	O
shifting	NN	O
of	IN	O
the	DT	O
membrane	NN	O
domain	NN	O
region	NN	O
of	IN	O
nel	NN	O
.	.	O
When	WRB	O
paralleled	VBN	O
and	CC	O
compared	VBN	O
with	IN	O
NRP2	NNP	O
and	CC	O
nel	RB	O
,	,	O
the	DT	O
frame-shifted	JJ	O
amino	NN	O
acid	NN	O
sequence	NN	O
showed	VBD	O
similarities	NNS	O
over	IN	O
the	DT	O
whole	JJ	O
range	NN	O
of	IN	O
NRP2	NNP	O
and	CC	O
of	IN	O
nel	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
NRP2	NNP	O
might	MD	O
be	VB	O
a	DT	O
human	JJ	O
counterpart	NN	O
of	IN	O
nel	NNS	O
.	.	O
In	IN	O
contrast	NN	O
,	,	O
NRP1	NNP	O
is	VBZ	O
considered	VBN	O
to	TO	O
be	VB	O
not	RB	O
a	DT	O
human	JJ	O
counterpart	NN	O
of	IN	O
nel	NNS	O
but	CC	O
a	DT	O
homologous	JJ	O
gene	NN	O
.	.	O
(	(	O
2	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
2	CD	O
)	)	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
entire	JJ	O
sequences	NNS	O
of	IN	O
both	DT	O
clones	NNS	O
cDNAs	VBP	O
were	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
,	,	O
the	DT	O
PCR	NNP	O
products	NNS	O
were	VBD	O
purified	VBN	O
and	CC	O
labeled	VBN	O
with	IN	O
[	JJ	O
32P	CD	O
]	JJ	O
-dCTP	NNP	O
(	(	O
random-primed	JJ	O
DNA	NNP	O
labeling	VBG	O
kit	NN	O
,	,	O
Boehringer	NNP	O
Mannheim	NNP	O
)	)	O
and	CC	O
human	JJ	O
normal	JJ	O
tissues	NNS	O
were	VBD	O
examined	VBN	O
for	IN	O
NRP	NNP	O
mRNA	NN	O
expression	NN	O
using	VBG	O
an	DT	O
MTN	NNP	O
blot	NN	O
with	IN	O
the	DT	O
labeled	JJ	O
products	NNS	O
as	IN	O
two	CD	O
probes	NNS	O
.	.	O
Sixteen	JJ	O
adult	NN	O
tissues	NNS	O
and	CC	O
four	CD	O
human	JJ	O
fetal	JJ	O
tissues	NNS	O
were	VBD	O
examined	VBN	O
for	IN	O
the	DT	O
expression	NN	O
pattern	NN	O
of	IN	O
two	CD	O
NRPs	NNP	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
the	DT	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
,	,	O
it	PRP	O
was	VBD	O
found	VBN	O
that	IN	O
a	DT	O
3.5	CD	O
kb	NN	O
transcript	NN	O
of	IN	O
NRP1	NNP	O
was	VBD	O
weakly	RB	O
expressed	VBN	O
in	IN	O
fetal	NN	O
and	CC	O
adult	NN	O
brain	NN	O
and	CC	O
kidney	NN	O
.	.	O
A	DT	O
3.6	CD	O
kb	NN	O
transcript	NN	O
of	IN	O
NRP2	NNP	O
was	VBD	O
strongly	RB	O
expressed	VBN	O
in	IN	O
adult	NN	O
and	CC	O
fetal	JJ	O
brain	NN	O
alone	RB	O
,	,	O
with	IN	O
weak	JJ	O
expression	NN	O
thereof	NN	O
in	IN	O
fetal	JJ	O
kidney	NN	O
as	IN	O
well	RB	O
.	.	O
This	DT	O
suggests	VBZ	O
that	IN	O
NRPs	NNP	O
might	MD	O
play	VB	O
a	DT	O
brain-specific	JJ	O
role	NN	O
,	,	O
for	IN	O
example	NN	O
as	IN	O
signal	JJ	O
molecules	NNS	O
for	IN	O
growth	NN	O
regulation	NN	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
these	DT	O
genes	NNS	O
might	MD	O
have	VB	O
a	DT	O
particular	JJ	O
function	NN	O
in	IN	O
kidney	NN	O
.	.	O
(	(	O
3	CD	O
)	)	O
Chromosomal	NNP	O
Mapping	NNP	O
of	IN	O
NRP1	NNP	O
Gene	NNP	O
and	CC	O
NRP2	NNP	O
Gene	NNP	O
by	IN	O
Fish	NNP	O
Chromosomal	NNP	O
mapping	NN	O
of	IN	O
the	DT	O
NRP1	NNP	O
gene	NN	O
and	CC	O
NRP2	NNP	O
gene	NN	O
was	VBD	O
performed	VBN	O
by	IN	O
FISH	NNP	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
3	CD	O
)	)	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
it	PRP	O
was	VBD	O
revealed	VBN	O
that	IN	O
the	DT	O
chromosomal	JJ	O
locus	NN	O
of	IN	O
the	DT	O
NRP1	NNP	O
gene	NN	O
is	VBZ	O
localized	VBN	O
to	TO	O
11p15.1-p15.2	CD	O
and	CC	O
the	DT	O
chromosomal	JJ	O
locus	NN	O
of	IN	O
the	DT	O
NRP2	NNP	O
gene	NN	O
to	TO	O
12q13.11-q13.12	CD	O
.	.	O
According	VBG	O
to	TO	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
the	DT	O
novel	JJ	O
human	JJ	O
NRP1	NNP	O
gene	NN	O
and	CC	O
NRP2	NNP	O
gene	NN	O
are	VBP	O
provided	VBN	O
and	CC	O
the	DT	O
use	NN	O
of	IN	O
said	VBD	O
genes	NNS	O
makes	VBZ	O
it	PRP	O
possible	JJ	O
to	TO	O
detect	VB	O
the	DT	O
expression	NN	O
of	IN	O
said	VBD	O
genes	NNS	O
in	IN	O
various	JJ	O
tissues	NNS	O
and	CC	O
produce	VB	O
the	DT	O
human	JJ	O
NRP1	NNP	O
and	CC	O
NRP2	NNP	O
proteins	NNS	O
by	IN	O
the	DT	O
technology	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
.	.	O
They	PRP	O
can	MD	O
further	RB	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
study	NN	O
of	IN	O
the	DT	O
brain	NN	O
neurotransmission	NN	O
system	NN	O
,	,	O
diagnosis	NN	O
of	IN	O
various	JJ	O
diseases	NNS	O
related	VBN	O
to	TO	O
neurotransmission	NN	O
in	IN	O
the	DT	O
brain	NN	O
,	,	O
and	CC	O
the	DT	O
screening	NN	O
and	CC	O
evaluation	NN	O
of	IN	O
drugs	NNS	O
for	IN	O
the	DT	O
treatment	NN	O
and	CC	O
prevention	NN	O
of	IN	O
such	JJ	O
diseases	NNS	O
.	.	O
Furthermore	RB	O
,	,	O
the	DT	O
possibility	NN	O
is	VBZ	O
suggested	VBN	O
that	IN	O
these	DT	O
EGF	NNP	O
domain-containing	NN	O
NRPs	NNP	O
act	NN	O
as	IN	O
growth	NN	O
factors	NNS	O
in	IN	O
brain	NN	O
,	,	O
hence	NN	O
they	PRP	O
may	MD	O
be	VB	O
useful	JJ	O
in	IN	O
the	DT	O
diagnosis	NN	O
and	CC	O
treatment	NN	O
of	IN	O
various	JJ	O
kinds	NNS	O
of	IN	O
intracerebral	JJ	O
tumor	NN	O
and	CC	O
effective	JJ	O
in	IN	O
nerve	DT	O
regeneration	NN	O
in	IN	O
cases	NNS	O
of	IN	O
degenerative	JJ	O
nervous	JJ	O
diseases	NNS	O
.	.	O
Example	JJ	O
11	CD	O
GSPT1-Related	JJ	O
Protein	NNP	O
(	(	O
GSPT1-TK	NNP	O
)	)	O
Gene	NNP	O
(	(	O
1	CD	O
)	)	O
GSPT1-TK	NNP	O
Gene	NNP	O
Cloning	NNP	O
and	CC	O
DNA	NNP	O
Sequencing	VBG	O
The	DT	O
human	JJ	O
GSPT1	NNP	O
gene	NN	O
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
human	JJ	O
homologous	JJ	O
genes	NNS	O
of	IN	O
the	DT	O
yeast	NN	O
GST1	NNP	O
gene	NN	O
that	WDT	O
encodes	VBZ	O
the	DT	O
GTP-binding	NNP	O
protein	NN	O
essential	NN	O
for	IN	O
the	DT	O
G1	NNP	O
to	TO	O
S	NNP	O
phase	NN	O
transition	NN	O
in	IN	O
the	DT	O
cell	NN	O
cycle	NN	O
.	.	O
The	DT	O
yeast	NN	O
GST1	NNP	O
gene	NN	O
,	,	O
first	RB	O
identified	VBN	O
as	IN	O
a	DT	O
protein	NN	O
capable	JJ	O
of	IN	O
complementing	VBG	O
a	DT	O
temperature-sensitive	JJ	O
gst1	NN	O
(	(	O
G1-to-S	NNP	O
transition	NN	O
)	)	O
mutant	NN	O
of	IN	O
Saccharomyces	NNP	O
cerevisiae	NN	O
,	,	O
was	VBD	O
isolated	VBN	O
from	IN	O
a	DT	O
yeast	JJ	O
genomic	JJ	O
library	NN	O
[	NN	O
Kikuchi	NNP	B
,	,	I
Y.	NNP	I
,	,	I
Shimatake	NNP	I
,	,	I
H.	NNP	I
and	CC	I
Kikuchi	NNP	I
,	,	I
A.	NNP	I
,	,	I
EMBO	NNP	I
J.	NNP	I
,	,	I
7	CD	I
,	,	I
1175-1182	CD	I
(	(	I
1988	CD	I
)	)	I
]	NN	O
and	CC	O
encoded	VBD	O
a	DT	O
protein	NN	O
with	IN	O
a	DT	O
target	NN	O
site	NN	O
of	IN	O
cAMP-dependent	JJ	O
protein	NN	O
kinases	NNS	O
and	CC	O
a	DT	O
GTPase	NNP	O
domain	NN	O
.	.	O
The	DT	O
human	JJ	O
GSPT1	NNP	O
gene	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
a	DT	O
KB	NNP	O
cell	NN	O
cDNA	NN	O
library	NN	O
by	IN	O
hybridization	NN	O
using	VBG	O
the	DT	O
yeast	NN	O
GST1	NNP	O
gene	NN	O
as	IN	O
a	DT	O
probe	NN	O
[	NNP	O
Hoshino	NNP	B
,	,	I
S.	NNP	I
,	,	I
Miyazawa	NNP	I
,	,	I
H.	NNP	I
,	,	I
Enomoto	NNP	I
,	,	I
T.	NNP	I
,	,	I
Hanaoka	NNP	I
,	,	I
F.	NNP	I
,	,	I
Kikuchi	NNP	I
,	,	I
Y.	NNP	I
,	,	I
Kikuchi	NNP	I
,	,	I
A.	NNP	I
and	CC	I
Ui	NNP	I
,	,	I
M.	NNP	I
,	,	I
EMBO	NNP	I
J.	NNP	I
,	,	I
8	CD	I
,	,	I
3807-3814	CD	I
(	(	I
1989	CD	I
)	)	I
]	NN	O
.	.	O
The	DT	O
deduced	JJ	O
protein	NN	O
of	IN	O
said	VBD	O
GSPT1	NNP	O
gene	NN	O
,	,	O
like	IN	O
yeast	NN	O
GST1	NNP	O
,	,	O
has	VBZ	O
a	DT	O
GTP-binding	JJ	O
domain	NN	O
and	CC	O
a	DT	O
GTPase	NNP	O
activity	NN	O
center	NN	O
,	,	O
and	CC	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
cell	NN	O
proliferation	NN	O
.	.	O
Furthermore	RB	O
,	,	O
a	DT	O
breakpoint	NN	O
for	IN	O
chromosome	NN	O
re-arrangement	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
in	IN	O
the	DT	O
GSPT1	NNP	O
gene	NN	O
located	VBN	O
in	IN	O
the	DT	O
chromosomal	JJ	O
locus	NN	O
16p13.3	CD	O
in	IN	O
patients	NNS	O
with	IN	O
acute	JJ	O
nonlymphocytic	JJ	O
leukemia	NN	O
(	(	O
ANLL	NNP	O
)	)	O
[	NNP	O
Ozawa	NNP	B
,	,	I
K.	NNP	I
,	,	I
Murakami	NNP	I
,	,	I
Y.	NNP	I
,	,	I
Eki	NNP	I
,	,	I
T.	NNP	I
,	,	I
Yokoyama	NNP	I
,	,	I
K.	NNP	I
Soeda	NNP	I
,	,	I
E.	NNP	I
,	,	I
Hoshino	NNP	I
,	,	I
S.	NNP	I
Ui	NNP	I
,	,	I
M.	NNP	I
and	CC	I
Hanaoka	NNP	I
,	,	I
F.	NNP	I
,	,	I
Somatic	NNP	I
Cell	NNP	I
and	CC	I
Molecular	NNP	I
Genet.	NNP	I
,	,	I
18	CD	I
,	,	I
189-194	CD	I
(	(	I
1992	CD	I
)	)	I
]	NN	O
.	.	O
cDNA	NN	O
clones	NNS	O
were	VBD	O
randomly	RB	O
selected	VBN	O
from	IN	O
a	DT	O
human	JJ	O
fetal	NN	O
brain	NN	O
cDNA	NN	O
library	NN	O
and	CC	O
subjected	VBN	O
to	TO	O
sequence	VB	O
analysis	NN	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
1	CD	O
)	)	O
and	CC	O
database	NN	O
searching	NN	O
was	VBD	O
performed	VBN	O
and	CC	O
,	,	O
as	IN	O
a	DT	O
result	NN	O
,	,	O
a	DT	O
clone	NN	O
having	VBG	O
a	DT	O
0.3	CD	O
kb	NN	O
cDNA	NN	O
sequence	NN	O
highly	RB	O
homologous	JJ	O
to	TO	O
the	DT	O
above-mentioned	JJ	O
GSPT1	NNP	O
gene	NN	O
was	VBD	O
found	VBN	O
and	CC	O
named	VBN	O
GEN-077A09	NNP	O
.	.	O
The	DT	O
GEN-077A09	NNP	O
clone	NN	O
seemed	VBD	O
to	TO	O
be	VB	O
lacking	VBG	O
in	IN	O
the	DT	O
5′	CD	O
region	NN	O
,	,	O
so	IN	O
that	DT	O
5′	CD	O
RACE	NNP	O
was	VBD	O
carried	VBN	O
out	RP	O
in	IN	O
the	DT	O
same	JJ	O
manner	NN	O
as	IN	O
in	IN	O
Example	NNP	O
2	CD	O
(	(	O
2	CD	O
)	)	O
to	TO	O
obtain	VB	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
.	.	O
The	DT	O
primers	NNS	O
used	VBN	O
for	IN	O
the	DT	O
5′	CD	O
RACE	NNP	O
were	VBD	O
P1	NNP	O
and	CC	O
P2	NNP	O
primers	NNS	O
respectively	RB	O
having	VBG	O
the	DT	O
nucleotide	JJ	O
sequences	NNS	O
shown	VBN	O
in	IN	O
Table	JJ	O
11	CD	O
as	IN	O
designed	VBN	O
based	VBN	O
on	IN	O
the	DT	O
known	VBN	O
cDNA	NN	O
sequence	NN	O
of	IN	O
the	DT	O
above-mentioned	JJ	O
cDNA	NN	O
,	,	O
and	CC	O
the	DT	O
anchor	NN	O
primer	NN	O
used	VBN	O
was	VBD	O
the	DT	O
one	CD	O
attached	VBN	O
to	TO	O
the	DT	O
commercial	JJ	O
kit	NN	O
.	.	O
Thirtyfive	JJ	O
cycles	NNS	O
of	IN	O
PCR	NNP	O
were	VBD	O
performed	VBN	O
under	IN	O
the	DT	O
following	JJ	O
conditions	NNS	O
:	:	O
94°	CD	O
C.	NNP	O
for	IN	O
45	CD	O
seconds	NNS	O
,	,	O
58°	CD	O
C.	NNP	O
for	IN	O
45	CD	O
seconds	NNS	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
2	CD	O
minutes	NNS	O
.	.	O
Finally	RB	O
,	,	O
elongation	NN	O
reaction	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
at	IN	O
72°	CD	O
C.	NNP	O
for	IN	O
7	CD	O
minutes	NNS	O
.	.	O
Several	JJ	O
of	IN	O
the	DT	O
5′	CD	O
RACE	NNP	O
clones	NNS	O
obtained	VBN	O
from	IN	O
the	DT	O
above	JJ	O
PCR	NNP	O
were	VBD	O
sequenced	VBN	O
and	CC	O
the	DT	O
base	JJ	O
sequence	NN	O
of	IN	O
that	DT	O
cDNA	NN	O
clone	NN	O
showing	VBG	O
overlapping	VBG	O
between	IN	O
the	DT	O
5′	CD	O
RACE	NNP	O
clones	NNS	O
and	CC	O
the	DT	O
GEN-077A09	NNP	O
clone	NN	O
was	VBD	O
determined	VBN	O
to	TO	O
thereby	VB	O
reveal	VB	O
the	DT	O
sequence	NN	O
regarded	VBD	O
as	IN	O
covering	VBG	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
.	.	O
This	DT	O
was	VBD	O
named	VBN	O
GSPT1-related	JJ	O
protein	NN	O
“	VBZ	O
GSPT1-TK	NNP	O
gene	NN	O
”	NNP	O
.	.	O
The	DT	O
GSPT1-TK	NNP	O
gene	NN	O
was	VBD	O
found	VBN	O
to	TO	O
contain	VB	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
1,497	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:41	NNP	O
.	.	O
The	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
deduced	VBD	O
therefrom	NNS	O
contained	VBD	O
499	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:40	NNP	O
.	.	O
The	DT	O
nucleotide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
whole	JJ	O
cDNA	NN	O
clone	NN	O
of	IN	O
the	DT	O
GSPT1-TK	NNP	O
gene	NN	O
was	VBD	O
found	VBN	O
to	TO	O
comprise	VB	O
2,057	CD	O
nucleotides	NNS	O
,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:42	NNP	O
,	,	O
and	CC	O
the	DT	O
molecular	JJ	O
weight	NN	O
was	VBD	O
calculated	VBN	O
at	IN	O
55,740	CD	O
daltons	NNS	O
.	.	O
The	DT	O
first	JJ	O
methionine	NN	O
code	NN	O
(	(	O
ATG	NNP	O
)	)	O
in	IN	O
the	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
had	VBD	O
no	DT	O
in-frame	JJ	O
termination	NN	O
codon	NN	O
but	CC	O
this	DT	O
ATG	NNP	O
was	VBD	O
surrounded	VBN	O
by	IN	O
a	DT	O
sequence	NN	O
similar	JJ	O
to	TO	O
the	DT	O
Kozak	NNP	O
consensus	NN	O
sequence	NN	O
for	IN	O
translational	JJ	O
initiation	NN	O
.	.	O
Therefore	RB	O
,	,	O
it	PRP	O
was	VBD	O
concluded	VBN	O
that	IN	O
this	DT	O
ATG	NNP	O
triplet	NN	O
occurring	VBG	O
in	IN	O
positions	NNS	O
144-146	CD	O
of	IN	O
the	DT	O
relevant	JJ	O
sequence	NN	O
is	VBZ	O
the	DT	O
initiation	NN	O
codon	NN	O
.	.	O
Furthermore	RB	O
,	,	O
a	DT	O
polyadenylation	NN	O
signal	NN	O
,	,	O
AATAAA	NNP	O
,	,	O
was	VBD	O
observed	VBN	O
13	CD	O
nucleotides	NNS	O
upstream	RB	O
from	IN	O
the	DT	O
polyadenylation	NN	O
site	NN	O
.	.	O
Human	JJ	O
GSPT1-TK	NNP	O
contains	VBZ	O
a	DT	O
glutamic	JJ	O
acid	NN	O
rich	JJ	O
region	NN	O
near	IN	O
the	DT	O
N	NNP	O
terminus	NN	O
,	,	O
and	CC	O
18	CD	O
of	IN	O
20	CD	O
glutamic	JJ	O
acid	NN	O
residues	NNS	O
occurring	VBG	O
in	IN	O
this	DT	O
region	NN	O
of	IN	O
human	JJ	O
GSPT1-TK	NNP	O
are	VBP	O
conserved	VBN	O
and	CC	O
align	VBZ	O
perfectly	RB	O
with	IN	O
those	DT	O
of	IN	O
the	DT	O
human	JJ	O
GSPT1	NNP	O
protein	NN	O
.	.	O
Several	JJ	O
regions	NNS	O
(	(	O
G1	NNP	O
,	,	O
G2	NNP	O
,	,	O
G3	NNP	O
,	,	O
G4	NNP	O
and	CC	O
G5	NNP	O
)	)	O
of	IN	O
GTP-binding	NNP	O
proteins	NNS	O
that	WDT	O
are	VBP	O
responsible	JJ	O
for	IN	O
guanine	JJ	O
nucleotide	JJ	O
binding	NN	O
and	CC	O
hydrolysis	NN	O
were	VBD	O
found	VBN	O
conserved	VBN	O
in	IN	O
the	DT	O
GSPT1-TK	NNP	O
protein	NN	O
just	RB	O
as	IN	O
in	IN	O
the	DT	O
human	JJ	O
GSPT1	NNP	O
protein	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
DNA	NNP	O
sequence	NN	O
of	IN	O
human	JJ	O
GSPT1-TK	NNP	O
was	VBD	O
found	VBN	O
89.4	CD	O
%	NN	O
identical	JJ	O
,	,	O
and	CC	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
deduced	VBD	O
therefrom	IN	O
92.4	CD	O
%	NN	O
identical	JJ	O
,	,	O
with	IN	O
the	DT	O
corresponding	JJ	O
sequence	NN	O
of	IN	O
human	JJ	O
GSPT1	NNP	O
which	WDT	O
supposedly	RB	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
the	DT	O
G1	NNP	O
to	TO	O
S	NNP	O
phase	NN	O
transition	NN	O
in	IN	O
the	DT	O
cell	NN	O
cycle	NN	O
.	.	O
Said	NNP	O
amino	NN	O
acid	NN	O
sequence	NN	O
showed	VBD	O
50.8	CD	O
%	NN	O
identity	NN	O
with	IN	O
that	DT	O
of	IN	O
yeast	NN	O
GST1	NNP	O
.	.	O
(	(	O
2	CD	O
)	)	O
Northern	NNP	O
Blot	NNP	O
Analysis	NNP	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
2	CD	O
)	)	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
GEN-077A09	NNP	O
cDNA	NN	O
clone	NN	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
,	,	O
the	DT	O
PCR	NNP	O
product	NN	O
was	VBD	O
purified	VBN	O
and	CC	O
labeled	VBN	O
with	IN	O
[	JJ	O
32P	CD	O
]	JJ	O
-dCTP	NNP	O
(	(	O
random-primed	JJ	O
DNA	NNP	O
labeling	VBG	O
kit	NN	O
,	,	O
Boehringer	NNP	O
Mannheim	NNP	O
)	)	O
,	,	O
and	CC	O
normal	JJ	O
human	JJ	O
tissues	NNS	O
were	VBD	O
examined	VBN	O
for	IN	O
the	DT	O
expression	NN	O
of	IN	O
GSPT1-TK	NNP	O
mRNA	NN	O
therein	NN	O
using	VBG	O
an	DT	O
MTN	NNP	O
blot	NN	O
with	IN	O
the	DT	O
labeled	JJ	O
product	NN	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
the	DT	O
Northern	NNP	O
blot	NN	O
analysis	NN	O
,	,	O
a	DT	O
2.7	CD	O
kb	NN	O
major	JJ	O
transcript	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
various	JJ	O
tissues	NNS	O
.	.	O
The	DT	O
level	NN	O
of	IN	O
human	JJ	O
GSPT1-TK	NNP	O
expression	NN	O
seemed	VBD	O
highest	JJS	O
in	IN	O
brain	NN	O
and	CC	O
in	IN	O
testis	NN	O
.	.	O
(	(	O
3	CD	O
)	)	O
Chromosome	NNP	O
Mapping	NNP	O
of	IN	O
GSPT1-TK	NNP	O
Gene	NNP	O
by	IN	O
Fish	NNP	O
Chromosome	NNP	O
mapping	NN	O
of	IN	O
the	DT	O
GSPT1-TK	NNP	O
gene	NN	O
was	VBD	O
performed	VBN	O
by	IN	O
FISH	NNP	O
as	IN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
(	(	O
3	CD	O
)	)	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
it	PRP	O
was	VBD	O
found	VBN	O
that	IN	O
the	DT	O
GSPT1-TK	NNP	O
gene	NN	O
is	VBZ	O
localized	VBN	O
at	IN	O
the	DT	O
chromosomal	JJ	O
locus	NN	O
19p13.3	CD	O
.	.	O
In	IN	O
this	DT	O
chromosomal	JJ	O
localization	NN	O
site	NN	O
,	,	O
reciprocal	JJ	O
location	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
very	RB	O
frequently	RB	O
in	IN	O
cases	NNS	O
of	IN	O
acute	JJ	O
lymphocytic	JJ	O
leukemia	NN	O
(	(	O
ALL	NNP	O
)	)	O
and	CC	O
acute	JJ	O
myeloid	NN	O
leukemia	NN	O
(	(	O
AML	NNP	O
)	)	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
it	PRP	O
is	VBZ	O
reported	VBN	O
that	IN	O
acute	JJ	O
nonlymphocytic	JJ	O
leukemia	NN	O
(	(	O
ANLL	NNP	O
)	)	O
is	VBZ	O
associated	VBN	O
with	IN	O
rearrangements	NNS	O
involving	VBG	O
the	DT	O
human	JJ	O
GSPT1	NNP	O
region	NN	O
[	NNP	O
Ozawa	NNP	B
,	,	I
K.	NNP	I
,	,	I
Murakami	NNP	I
,	,	I
Y.	NNP	I
,	,	I
Eki	NNP	I
,	,	I
T.	NNP	I
,	,	I
Yokoyama	NNP	I
,	,	I
K.	NNP	I
,	,	I
Soeda	NNP	I
,	,	I
E.	NNP	I
,	,	I
Hoshino	NNP	I
,	,	I
S.	NNP	I
,	,	I
Ui	NNP	I
,	,	I
M.	NNP	I
and	CC	I
Hanaoka	NNP	I
,	,	I
F.	NNP	I
,	,	I
Somatic	NNP	I
Cell	NNP	I
and	CC	I
Molecular	NNP	I
Genet.	NNP	I
,	,	I
18	CD	I
,	,	I
189-194	CD	I
(	(	I
1992	CD	I
)	)	I
]	NN	O
.	.	O
In	IN	O
view	NN	O
of	IN	O
the	DT	O
above	NN	O
,	,	O
it	PRP	O
is	VBZ	O
suggested	VBN	O
that	IN	O
this	DT	O
gene	NN	O
is	VBZ	O
the	DT	O
best	JJS	O
candidate	NN	O
gene	NN	O
associated	VBN	O
with	IN	O
ALL	NNP	O
and	CC	O
AML	NNP	O
.	.	O
In	IN	O
accordance	NN	O
with	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
the	DT	O
novel	JJ	O
human	JJ	O
GSPT1-TK	NNP	O
gene	NN	O
is	VBZ	O
provided	VBN	O
and	CC	O
the	DT	O
use	NN	O
of	IN	O
said	VBD	O
gene	NN	O
makes	VBZ	O
it	PRP	O
possible	JJ	O
to	TO	O
detect	VB	O
the	DT	O
expression	NN	O
of	IN	O
said	VBD	O
gene	NN	O
in	IN	O
various	JJ	O
tissues	NNS	O
and	CC	O
produce	VB	O
the	DT	O
human	JJ	O
GSPT1-TK	NNP	O
protein	NN	O
by	IN	O
the	DT	O
technology	NN	O
of	IN	O
genetic	JJ	O
engineering	NN	O
.	.	O
These	DT	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
studies	NNS	O
of	IN	O
cell	NN	O
proliferation	NN	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
and	CC	O
further	RB	O
make	VB	O
it	PRP	O
possible	JJ	O
to	TO	O
diagnose	VB	O
various	JJ	O
diseases	NNS	O
associated	VBN	O
with	IN	O
the	DT	O
chromosomal	JJ	O
locus	NN	O
of	IN	O
this	DT	O
gene	NN	O
,	,	O
for	IN	O
example	NN	O
acute	JJ	O
myelocytic	JJ	O
leukemia	NN	O
.	.	O
This	DT	O
is	VBZ	O
because	IN	O
translocation	NN	O
of	IN	O
this	DT	O
gene	NN	O
may	MD	O
result	VB	O
in	IN	O
decomposition	NN	O
of	IN	O
the	DT	O
GSPT1-TK	NNP	O
gene	NN	O
and	CC	O
further	JJ	O
some	DT	O
or	CC	O
other	JJ	O
fused	JJ	O
protein	NNS	O
expressed	VBD	O
upon	NN	O
said	VBD	O
translocation	NN	O
may	MD	O
cause	VB	O
such	JJ	O
diseases	NNS	O
.	.	O
Furthermore	RB	O
,	,	O
it	PRP	O
is	VBZ	O
expected	VBN	O
that	IN	O
diagnosis	NN	O
and	CC	O
treatment	NN	O
of	IN	O
said	VBD	O
diseases	NNS	O
can	MD	O
be	VB	O
made	VBN	O
possible	JJ	O
by	IN	O
producing	VBG	O
antibodies	NNS	O
to	TO	O
such	JJ	O
fused	JJ	O
protein	NN	O
,	,	O
revealing	VBG	O
the	DT	O
intracellular	JJ	O
localization	NN	O
of	IN	O
said	VBD	O
protein	NN	O
and	CC	O
examining	VBG	O
its	PRP$	O
expression	NN	O
specific	NN	O
to	TO	O
said	VBD	O
diseases	NNS	O
.	.	O
Therefore	RB	O
,	,	O
it	PRP	O
is	VBZ	O
also	RB	O
expected	VBN	O
that	IN	O
the	DT	O
use	NN	O
of	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
makes	VBZ	O
it	PRP	O
possible	JJ	O
to	TO	O
screen	VB	O
out	RP	O
and	CC	O
evaluate	VB	O
drugs	NNS	O
for	IN	O
the	DT	O
treatment	NN	O
and	CC	O
prevention	NN	O
of	IN	O
said	VBD	O
diseases	NNS	O
.	.	O
Claims	NNS	O
(	(	O
2	CD	O
)	)	O
Priority	NN	O
Applications	NNP	O
(	(	O
16	CD	O
)	)	O
Applications	NNPS	O
Claiming	NNP	O
Priority	NNP	O
(	(	O
1	CD	O
)	)	O
Related	VBN	O
Parent	NN	O
Applications	NNP	O
(	(	O
1	CD	O
)	)	O
Publications	NNPS	O
(	(	O
2	CD	O
)	)	O
Family	RB	O
ID=26404531	NNP	O
Family	NNP	O
Applications	NNP	O
(	(	O
7	CD	O
)	)	O
Family	NNP	O
Applications	NNP	O
Before	NNP	O
(	(	O
6	CD	O
)	)	O
Country	NN	O
Status	NNP	O
(	(	O
7	CD	O
)	)	O
Families	NNPS	O
Citing	VBG	O
this	DT	O
family	NN	O
(	(	O
50	CD	O
)	)	O
Citations	NNPS	O
(	(	O
4	CD	O
)	)	O
Family	RB	O
Cites	VBZ	O
Families	NNS	O
(	(	O
3	CD	O
)	)	O
Patent	NN	O
Citations	NNP	O
(	(	O
5	CD	O
)	)	O
Non-Patent	JJ	O
Citations	NNP	O
(	(	O
61	CD	O
)	)	O
Also	RB	O
Published	VBN	O
As	IN	O
Similar	JJ	O
Documents	NNP	O
Legal	NNP	O
Events	NNP	O
Effective	JJ	O
date	NN	O
:	:	O
20160131	CD	O
